var title_f28_48_29440="Mechanism antiplatelet agents";
var content_f28_48_29440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Mechanism of action of antiplatelet agents",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the mechanism of action of antiplatelet agents. When vascular cells are damaged, platelets bind to exposed collagen via glycoprotein (GP) Ib/IX receptors complexed to von Willebrand factor. These bound platelets undergo degranulation, releasing adenosine diphosphate (ADP) and numerous other substances, including thromboxane A2, serotonin, and epinephrine, that play a role in the recruitment and aggregation process. The released ADP binds to two types of receptors, a low-affinity type 2 purinergic receptor (P2Y12) and a high-affinity purinergic receptor (P2Y1). Ticlopidine and clopidogrel block the binding of ADP to the type 2 purinergic receptor and prevent activation of the GP IIb/IIIa receptor complex and the subsequent aggregation of platelets. The GP IIb/IIIa receptor antagonists prevent platelet aggregation by blocking the binding of the GP IIb/IIIa receptor to fibrinogen, thereby inhibiting fibrinogen-platelet bridging.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission from Sharis PJ, Cannon CP, Loscalzo J. Ann Intern Med 1998; 129:394.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29440=[""].join("\n");
var outline_f28_48_29440=null;
var title_f28_48_29441="Immunostaining for CD30 in HL";
var content_f28_48_29441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunostaining for CD30 in Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 196px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunostaining for CD30 demonstrates&nbsp;strong membrane and paranuclear staining, and weaker cytoplasmic staining, of the Hodgkin cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Weiss LM, Warnke RA, Hansmann ML, et al, Pathology of Hodgkin Lymphoma. In: Hodgkin Lymphoma, 2nd ed, Hoppe RT, Mauch PT, Armitage JO, et al, (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29441=[""].join("\n");
var outline_f28_48_29441=null;
var title_f28_48_29442="Lactic acid and sodium-PCA: Drug information";
var content_f28_48_29442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lactic acid and sodium-PCA: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F186410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Topical Skin Product",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F186403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lubricant/moisturizer: Topical: Apply twice daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F186404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F186394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: 10% (113 g [DSC], 227 g [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotion, topical: 10% (355 mL [DSC], 473 mL [DSC])",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F186385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F186395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lubricate and moisturize the skin counteracting dryness and itching",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F186408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined: Dermatologic: Burning, mild stinging, peeling",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F186397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to lactic acid or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F186388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: May cause photosensitivity; minimize exposure to the sun of areas being treated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin Irritation: Mild burning, stinging, or peeling may occur with use; discontinue if irritation occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For external use only; not for use near eyes, lips, or mucous membranes.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Lacticare External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (222 mL): $8.52",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F186399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acidum Lacticum (PL)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10067 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-AEB5EC0217-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29442=[""].join("\n");
var outline_f28_48_29442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186410\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186403\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186404\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186394\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186385\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186395\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186408\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186397\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186388\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299566\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221206\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323269\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186399\">",
"      International Brand Names",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10067\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10067|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29443="Embedded earring";
var content_f28_48_29443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F88538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F88538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Embedded earring",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Ear ring embedded in the lobule of the ear.",
"    <br/>",
"    (B) The lobule is infiltrated with local anesthetic and posterior surface incised with a #11 blade.",
"    <br/>",
"    (C) The embedded earring is removed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29443=[""].join("\n");
var outline_f28_48_29443=null;
var title_f28_48_29444="Aluminum hydroxide, magnesium hydroxide, and simethicone: Patient drug information";
var content_f28_48_29444=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aluminum hydroxide, magnesium hydroxide, and simethicone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/44/25287?source=see_link\">",
"     see \"Aluminum hydroxide, magnesium hydroxide, and simethicone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F132556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alamag Plus [OTC];",
"     </li>",
"     <li>",
"      Aldroxicon I [OTC];",
"     </li>",
"     <li>",
"      Aldroxicon II [OTC];",
"     </li>",
"     <li>",
"      Almacone&reg; Double Strength [OTC];",
"     </li>",
"     <li>",
"      Almacone&reg; [OTC];",
"     </li>",
"     <li>",
"      Gelusil&reg; [OTC];",
"     </li>",
"     <li>",
"      Maalox&reg; Advanced Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Maalox&reg; Advanced Regular Strength [OTC];",
"     </li>",
"     <li>",
"      Mi-Acid Maximum Strength [OTC] [DSC];",
"     </li>",
"     <li>",
"      Mi-Acid [OTC];",
"     </li>",
"     <li>",
"      Mintox Plus [OTC];",
"     </li>",
"     <li>",
"      Mylanta&reg; Classic Maximum Strength Liquid [OTC];",
"     </li>",
"     <li>",
"      Mylanta&reg; Classic Regular Strength Liquid [OTC];",
"     </li>",
"     <li>",
"      Rulox  [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F132557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diovol Plus&reg;;",
"     </li>",
"     <li>",
"      Gelusil&reg;;",
"     </li>",
"     <li>",
"      Mylanta&reg; Double Strength;",
"     </li>",
"     <li>",
"      Mylanta&reg; Extra Strength;",
"     </li>",
"     <li>",
"      Mylanta&reg; Regular Strength",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691593",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease too much gas in the stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691873",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartburn and upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701480",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aluminum, magnesium, simethicone, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other drugs within 1 hour of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        Products with aluminum and calcium:",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705591",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        Products with magnesium:",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chew or crush tablet well. Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11060 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-218.28.111.102-3C51B1EE61-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29444=[""].join("\n");
var outline_f28_48_29444=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132556\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F132557\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021058\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021060\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021059\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021064\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021065\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021067\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021062\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021063\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021068\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021069\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/44/25287?source=related_link\">",
"      Aluminum hydroxide, magnesium hydroxide, and simethicone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29445="Fosinopril and hydrochlorothiazide: Patient drug information";
var content_f28_48_29445=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fosinopril and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28919?source=see_link\">",
"     see \"Fosinopril and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F174489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Monopril-HCT&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F174490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Monopril-HCT&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702168",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to fosinopril, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698359",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sunburn.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12499 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29445=[""].join("\n");
var outline_f28_48_29445=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174489\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174490\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019414\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019416\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019415\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019420\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019421\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019423\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019418\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019419\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019424\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019425\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28919?source=related_link\">",
"      Fosinopril and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29446="Pentazocine: Drug information";
var content_f28_48_29446=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pentazocine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?4/29/4564?source=see_link\">",
"    see \"Pentazocine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"    see \"Pentazocine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F208028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Talwin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F208029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Talwin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F208070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Opioid;",
"     </li>",
"     <li>",
"      Analgesic, Opioid Partial Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F208032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Analgesic:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., SubQ: 30-60 mg every 3-4 hours; do",
"     <b>",
"      not",
"     </b>",
"     exceed 60 mg/dose (maximum: 360 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 30 mg every 3-4 hours; do",
"     <b>",
"      not",
"     </b>",
"     exceed 30 mg/dose  (maximum: 360 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Labor pain:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 30 mg once",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 20 mg every 2-3 hours as needed (maximum total dose: 60 mg)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F208054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=see_link\">",
"      see \"Pentazocine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Analgesia (unlabeled use):",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 5-8 years: 15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 9-14 years: 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Preoperative/preanesthetic:",
"     </b>",
"     Children 1-16 years: I.M.: 0.5 mg/kg",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F208033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; may be more sensitive to analgesic and sedative effects; decrease initial dose and monitor closely",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F208034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer 75% of normal dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer 50% of normal dose.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F208035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduce dose or avoid use in patients with liver disease.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F208001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Talwin&reg;: 30 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Talwin&reg;: 30 mg/mL (10 mL) [contains sodium bisulfite]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F207985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F208072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-IV",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F208005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rotate injection site for I.M.; avoid intra-arterial injection; avoid SubQ use unless absolutely necessary (may cause tissue damage)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F208078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Heparin, hydrocortisone sodium succinate, potassium chloride, vitamin B complex with C.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Nafcillin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Atropine, butorphanol, chlorpromazine, cimetidine, dimenhydrinate, diphenhydramine, droperidol, fentanyl, hydromorphone, hydroxyzine, meperidine, methotrimeprazine, metoclopramide, morphine, prochlorperazine edisylate, promethazine, ranitidine, scopolamine, trimethobenzamide.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Glycopyrrolate, heparin, pentobarbital.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F208004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of moderate-to-severe pain; has also been used as a sedative prior to surgery and as a supplement to surgical anesthesia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5978067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - low; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F208068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Circulatory depression, facial edema, flushing, hyper-/hypotension, shock, syncope, systemic vascular resistance increased, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, CNS depression, confusion, disorientation, dizziness, drowsiness, euphoria, excitement, hallucinations, headache, insomnia, irritability, lightheadedness, malaise, nightmares, sedation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Dermatitis, erythema multiforme, pruritus, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distress, anorexia, constipation, diarrhea, nausea, taste alteration, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis (rare), eosinophilia, WBCs decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction (tissue damage and irritation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, diplopia, miosis, nystagmus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, respiratory depression (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, diaphoresis, physical and psychological dependence",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F208008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pentazocine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F207989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular effects: May increase systemic and pulmonary arterial pressure and systemic vascular resistance; use with caution in patients who may not tolerate these alterations in hemodynamics (eg, heart failure).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: May cause hypotension; use with caution in patients with hypovolemia, cardiovascular disease (including acute MI), or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Injection-site reactions: Severe sclerosis has occurred at the injection-site following multiple injections; avoid SubQ use unless absolutely necessary; rotate sites of injection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Biliary tract impairment: Use with caution in patients with biliary tract dysfunction; acute pancreatitis may cause constriction of sphincter of Oddi.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression/coma: Use with caution in patients with CNS depression or coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obesity: Use with caution in patients who are morbidly obese.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients with a history of seizure disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in this age group due to increased risk of CNS effects (confusion and hallucinations) compared to other narcotics; safer alternative agents preferred (Beers Criteria). If used, use lower initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfites: Injection may contain sulfites which may cause allergic reaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Concurrent use of agonist/antagonist analgesics may precipitate withdrawal symptoms and/or reduced analgesic efficacy  in patients following prolonged therapy with mu opioid agonists. Abrupt discontinuation following prolonged use may also lead to withdrawal symptoms; taper dose to decrease risk of withdrawal symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F207994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): Mixed Agonist / Antagonist Opioids may diminish the analgesic effect of Analgesics (Opioid).  Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F207996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F208012\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pentazocine was not found to be teratogenic in animal studies. Pentazocine has been shown to cross the human placenta. Use should be avoided during labor and delivery of premature infants. Abstinence syndromes in the newborn have been reported after long-term use of pentazocine during pregnancy. Other adverse effects in the newborn have been reported following abuse of pentazocine during pregnancy; these effects may be due to pentazocine, other drugs abused, the mother's lifestyle, or a combination of all factors.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F208038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F208013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pentazocine is excreted in human breast milk. Treatment of the mother with single doses of pentazocine is not expected to cause detrimental effects in nursing infants.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F208011\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Talwin Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg/mL (1 mL): $40.32",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F207998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of pain, respiratory and mental status, blood pressure",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dolapent (FI, PL);",
"     </li>",
"     <li>",
"      Fortal (BE, LU);",
"     </li>",
"     <li>",
"      Fortalgesic[inj.] (CH);",
"     </li>",
"     <li>",
"      Fortalgesic[Suppos.] (CH);",
"     </li>",
"     <li>",
"      Fortalgesic[Tab.] (CH);",
"     </li>",
"     <li>",
"      Fortral (AT, AU, BG, CZ, DE, DK, FR, GB, HR, IE, NL, NZ, PL);",
"     </li>",
"     <li>",
"      Fortralin (FI, NO);",
"     </li>",
"     <li>",
"      Fortralin[inj./rect.] (NO);",
"     </li>",
"     <li>",
"      Fortralin[inj.] (FI, NO);",
"     </li>",
"     <li>",
"      Fortwin (BF, BJ, CI, ET, GH, GM, GN, IN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Ospronim (ZA);",
"     </li>",
"     <li>",
"      Peltazon (JP);",
"     </li>",
"     <li>",
"      Pentagin (JP);",
"     </li>",
"     <li>",
"      Pentajin (JP);",
"     </li>",
"     <li>",
"      Pental (KP);",
"     </li>",
"     <li>",
"      Pentawin (IN);",
"     </li>",
"     <li>",
"      Pentazocina[inj.] (ES);",
"     </li>",
"     <li>",
"      Pentazocinum (PL);",
"     </li>",
"     <li>",
"      Sosegon (AE, BF, BH, BJ, CI, CY, EC, EG, ES, ET, GH, GM, GN, IL, IQ, IR, JO, JP, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, PK, PT, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Sosegon[inj./rect.] (ES, JP);",
"     </li>",
"     <li>",
"      Talwin Lactate (IT, PE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F207988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Agonist of kappa opiate receptors and partial agonist of mu opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; produces analgesia, respiratory depression and sedation similar to opioids",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F208007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: I.M., SubQ: 15-20 minutes; I.V.: 2-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via oxidative and glucuronide conjugation pathways; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 2-3 hours; prolonged with hepatic impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (small amounts as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, 19.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Challoner KR, McCarron MM, and Newton EJ, &ldquo;Pentazocine (Talwin&reg;) Intoxication: Report of 57 Cases,&rdquo;",
"      <i>",
"       J Emerg Med",
"      </i>",
"      , 1990, 8(1):67-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/2351801/pubmed\" id=\"2351801\" target=\"_blank\">",
"        2351801",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Pain,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 2000, 42(1085):73-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/10951654/pubmed\" id=\"10951654\" target=\"_blank\">",
"        10951654",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hanunen K, Olkkola KT, Seppala T, et al, &ldquo;Pharmacokinetics and Pharmacodynamics of Pentazocine in Children,&rdquo;",
"      <i>",
"       Pharmacol Toxicol",
"      </i>",
"      , 1993, 73(2):120-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/8248007/pubmed\" id=\"8248007\" target=\"_blank\">",
"        8248007",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&rdquo; 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ray AD and Gupta M, &ldquo;Clinical Trial of Pentazocine as Analgesic in Pediatric Cases,&rdquo;",
"      <i>",
"       J Indian Med Assoc",
"      </i>",
"      , 1994, 92(3):77-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/8057003/pubmed\" id=\"8057003\" target=\"_blank\">",
"        8057003",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reed DA and Schnoll SH, &ldquo;Abuse of Pentazocine-Naloxone Combination,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1986, 256(18):2562-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/3773159/pubmed\" id=\"3773159\" target=\"_blank\">",
"        3773159",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rita L, Seleny FL, and Levin RM, &ldquo;A Comparison of Pentazocine and Morphine for Pediatric Premedication,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1970, 49(3):377-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/5534413/pubmed\" id=\"5534413\" target=\"_blank\">",
"        5534413",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Waterworth TA, &ldquo;Pentazocine (Fortal) as Postoperative Analgesic in Children,&rdquo;",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 1974, 49(6):488-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/48/29446/abstract-text/4604887/pubmed\" id=\"4604887\" target=\"_blank\">",
"        4604887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9753 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-77.94.48.4-84E1ECB1DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29446=[""].join("\n");
var outline_f28_48_29446=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208028\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208029\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208070\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208032\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208054\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208033\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208034\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208035\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208001\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207985\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208072\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208005\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208078\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208004\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5978067\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208068\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208008\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207989\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299846\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207994\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207996\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208012\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208038\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208013\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208011\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207998\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038763\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207988\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F208007\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9753\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9753|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?4/29/4564?source=related_link\">",
"      Pentazocine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/16/5382?source=related_link\">",
"      Pentazocine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29447="Pregnancy in women with mitral stenosis";
var content_f28_48_29447=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pregnancy in women with mitral stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Samuel C Siu, MD, SM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29447/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/48/29447/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H23166743\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral stenosis (MS) encountered in women of childbearing age is nearly always rheumatic in origin. Maternal and perinatal complications during pregnancy in women with MS reflect the unfavorable interaction between the normal cardiovascular changes of pregnancy and the stenotic mitral valve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review the evaluation and management of women with mitral stenosis during pregnancy. Management of other types of heart disease during pregnancy, including those with MS who have undergone valve replacement, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=see_link\">",
"     \"Acquired heart disease and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/21/35159?source=see_link\">",
"     \"Pregnancy in women with congenital heart disease: Specific lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=see_link\">",
"     \"Pregnancy in women with congenital heart disease: General principles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=see_link\">",
"     \"Management of pregnant women with prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166750\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with heart disease comprise approximately 1 percent of the obstetric population seen in large volume centers in developed countries. In the United States and Canada, women with rheumatic heart disease, of which MS is the most common manifestation, comprise &lt;25 percent of the pregnant women with heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In contrast, MS is a common condition in pregnant women with heart disease in other areas of the world where rheumatic heart disease is prevalent. For example, rheumatic heart disease was the underlying cause in 56 to 88 percent of women in three studies from centers from Brazil, Turkey, and Senegal reporting on a total of 1194 pregnancies in women with heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14617?source=see_link&amp;anchor=H10512869#H10512869\">",
"     \"Natural history, screening, and management of rheumatic heart disease\", section on 'Mitral stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166757\">",
"    <span class=\"h1\">",
"     IMPACT OF CARDIOVASCULAR CHANGES IN PREGNANCY IN WOMEN WITH MITRAL STENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In MS, the stenotic mitral valve restricts diastolic left ventricular filling, resulting in an elevated transmitral gradient and left atrial pressure that are further increased by the physiologic hypervolemia and increased heart rate during pregnancy, thereby increasing the risk of pulmonary congestion or pulmonary edema. The risk of pulmonary congestion remains during labor and delivery, as a result of uterine contraction during labor, and with the autotransfusion of venous return from the lower extremities as the emptied uterus is no longer impeding venous return. Increased atrial irritability and hypercoagulability associated with pregnancy, when combined with increased left atrial pressure, increase the risk of atrial fibrillation and left atrial thrombus formation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39353?source=see_link&amp;anchor=H6#H6\">",
"     \"Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis\", section on 'Hypercoagulability'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166764\">",
"    <span class=\"h1\">",
"     RELATIONSHIP BETWEEN SEVERITY OF MS AND IMPACT OF PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a direct relationship between the severity of MS and the risk of maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=see_link\">",
"     \"Natural history of mitral stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    .) There is an incremental increase in the frequency of maternal and fetal complications with increasing severity of MS (",
"    <a class=\"graphic graphic_table graphicRef83422 \" href=\"UTD.htm?25/41/26268\">",
"     table 1",
"    </a>",
"    ). While those with moderate or severe stenosis represent the higher risk group, elevated event rates are seen in those with even mild MS, reflecting the effects of the 30 to 50 percent increase in cardiac output superimposed on a mildly stenotic valve [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/1\">",
"     1",
"    </a>",
"    ]. History of cardiac complications (including pulmonary edema, arrhythmias, transient ischemic attacks, or stroke) prior to pregnancy and poor baseline maternal functional class are additional risk factors for maternal cardiac complications during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. In the presence of obstetric risk factors (including extremes of maternal age, smoking), the presence of maternal MS confers a risk of perinatal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no contemporary studies that have examined whether pre-existing pregnancy has any subsequent effect on the progression of disease or symptoms in women with MS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166771\">",
"    <span class=\"h1\">",
"     NATURE AND FREQUENCY OF ADVERSE PREGNANCY OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166779\">",
"    <span class=\"h2\">",
"     Maternal outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the four largest contemporary series from North America and Europe of pregnant women with MS (total of 300 pregnancies), there were no maternal deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. In the above cited South American study, among 448 cases of rheumatic valve disease (including 88 patients with MS of which 54 had with moderate to severe mitral stenosis), there were eight deaths (1.4 percent mortality) caused by heart failure due to severe native mitral disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/3\">",
"     3",
"    </a>",
"    ]. In a study of 46 pregnant women with MS from sub-saharan Africa, the maternal mortality rate was even higher at 32 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnant women with MS are at risk for pulmonary edema and atrial arrhythmias (",
"    <a class=\"graphic graphic_table graphicRef83422 \" href=\"UTD.htm?25/41/26268\">",
"     table 1",
"    </a>",
"    ). As discussed above, cardiovascular changes during pregnancy result in an increase in the transmitral gradient and increased left atrial pressure, which in turn increases pulmonary venous pressure, placing pregnant women with MS at risk for pulmonary congestion.",
"   </p>",
"   <p>",
"    The risk of atrial fibrillation also increases during pregnancy, which in turn can precipitate pulmonary edema. Although atrial fibrillation is the most common arrhythmia encountered, other supraventricular arrhythmias can be manifested, including atrial flutter and supraventricular tachycardia. Pulmonary congestion and atrial fibrillation can become a self-perpetuating vicious cycle, and it is not always clear which was the precipitating factor. The peak period of maternal cardiac complications is during the second and third trimester, but complications can occur in the peri- or postpartum period. In one series, 20 percent of the pulmonary edema episodes occurred in the setting of atrial tachyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=see_link\">",
"     \"Supraventricular arrhythmias during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Only one stroke was reported in the above cited North American and European series [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/5-8\">",
"     5-8",
"    </a>",
"    ], perhaps due to increased vigilance and prompt initiation of anticoagulation. In the above cited series from South America, eight episodes of thromboembolism occurred in 448 patients with native mitral valves [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Even when pregnancy is not complicated by the development of pulmonary edema, some women with MS experience deterioration in their functional class or develop new cardiac symptoms. In the two largest North American series (total of 126 pregnancies), 74 and 40 percent of women experienced deterioration of one and two New York Heart Association functional classes, respectively, as their pregnancies progressed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. If not promptly diagnosed and treatment initiated, women who deteriorated to NYHA class III or IV will likely progress to frank pulmonary edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2739821\">",
"    <span class=\"h2\">",
"     Fetal outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perinatal complications, which include premature labor, low fetal weight, fetal complications of prematurity, and perinatal death, are generally increased in women with heart disease and are more frequent with increasing severity of mitral stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2739596\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful cardiac history and physical examination, 12 lead electrocardiogram (ECG), and a comprehensive transthoracic echocardiogram will provide the information necessary for the management of the woman with MS who is either pregnant or is contemplating pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link\">",
"     \"Medical management and indications for intervention in mitral stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=see_link\">",
"     \"Acquired heart disease and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166786\">",
"    <span class=\"h1\">",
"     RISK STRATIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women at highest risk of maternal cardiac complications are those with moderate or severe MS (mitral valve area &lt;1.5 cm",
"    <sup>",
"     2",
"    </sup>",
"    ), baseline maternal New York Heart Association functional class III or IV, a history of cardiac complications (pulmonary edema, arrhythmias requiring treatment, transient ischemic attack, or stroke) prior to pregnancy, central cyanosis, and left ventricular systolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary hypertension (systolic pulmonary artery pressure &gt;60 mmHg) has been suggested as an additional risk factor but this has not been a uniform finding in contemporary studies. It is possible that pulmonary hypertension is a surrogate for moderate or severe MS with marginal compensation, in which the hemodynamic stress of pregnancy would convert asymptomatic pulmonary hypertension to left or right heart failure.",
"   </p>",
"   <p>",
"    Women with MS considering pregnancy should also be assessed by an obstetrician with expertise in medical disorders of pregnancy, to allow for an expert assessment of markers of obstetric risk and to address the obstetric aspects of management. Women with moderate or severe MS are at greatest risk of fetal neonatal complications such as perinatal death, premature delivery, low birth weight, or complications of prematurity (",
"    <a class=\"graphic graphic_table graphicRef83422 \" href=\"UTD.htm?25/41/26268\">",
"     table 1",
"    </a>",
"    ). Obstetric complications such as pregnancy induced hypertension and antepartum hemorrhage are not related to the severity of MS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/1,8\">",
"     1,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166793\">",
"    <span class=\"h1\">",
"     CLINICAL MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166801\">",
"    <span class=\"h2\">",
"     Preconception counseling and management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation prior to preconception counseling includes identification of any markers of increased maternal cardiac risk as determined by history, examination, ECG, and transthoracic echocardiogram as described above (see",
"    <a class=\"local\" href=\"#H23166786\">",
"     'Risk stratification'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of pulmonary edema, arrhythmias requiring treatment, stroke, or transient ischemic attack or stroke prior to pregnancy &nbsp;",
"     </li>",
"     <li>",
"      Functional status by subjective (ie, New York Heart Association functional class) or objective measures (exercise testing)",
"     </li>",
"     <li>",
"      Central cyanosis (oxygen saturation &lt;90 percent by oximetry)",
"     </li>",
"     <li>",
"      Mitral valve area, extent of mitral regurgitation, left ventricular systolic function",
"     </li>",
"     <li>",
"      Systolic pulmonary artery pressure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At the time of prenatal counseling, attention should be paid to smoking history and the use of medications that may be potentially teratogenic. Cessation of smoking prior to conception would reduce the risk of perinatal complications. Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) are contraindicated during pregnancy and should be discontinued prior to pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy\"",
"    </a>",
"    .) Women who are receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy should have the opportunity to make an informed decision about the various options for anticoagulation so that the anticoagulation plan can be implemented once pregnancy is confirmed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18153?source=see_link\">",
"     \"Anticoagulation during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link\">",
"     \"Initial prenatal assessment and patient education\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59617712\">",
"    <span class=\"h3\">",
"     Indications for preconception intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intervention prior to conception is recommended in women with moderate or severe MS who are symptomatic or have significant pulmonary artery hypertension (systolic pulmonary artery pressure &gt;50 mmHg) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Percutaneous mitral valvuloplasty performed in an experienced center is the intervention of choice, assuming that valve morphology is suitable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\"",
"    </a>",
"    .) The management of asymptomatic women with moderate to severe MS and without significant pulmonary artery hypertension is more controversial and requires consideration of patient and institution specific factors.",
"   </p>",
"   <p>",
"    The 2006 (with 2008 focused update)",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    valvular heart disease guidelines do not include a recommendation for preconception intervention for asymptomatic mitral stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/10\">",
"     10",
"    </a>",
"    ]. The 2011 European Society of Cardiology (ESC) guidelines recommend that asymptomatic women with moderate or severe MS should avoid pregnancy and undergo prepregnancy intervention, favoring a percutaneous approach [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/11\">",
"     11",
"    </a>",
"    ]. As this ESC recommendation is based upon weak evidence (expert consensus or observational studies), practitioners should also consider other factors such as the availability of local expertise for percutaneous intervention, patient factors, access of timely antenatal care, and valvular morphology in applying these recommendations. &nbsp;",
"   </p>",
"   <p>",
"    In the asymptomatic women with moderate or severe mitral stenosis and normal pulmonary artery pressure, we recommend exercise testing to determine whether exercise capacity is normal and to evaluate for the presence of exercise induced pulmonary hypertension. We suggest not routinely intervening in women with moderate or severe MS who are asymptomatic with normal pulmonary artery pressure and excellent exercise capacity. However, in situations where patient compliance is an issue, or where there are barriers to provision of timely antenatal care or urgent percutaneous valvuloplasty, then there is a compelling reason to recommend elective percutaneous intervention on asymptomatic women with moderate to severe MS prior to pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166808\">",
"    <span class=\"h2\">",
"     Antepartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with MS should undergo cardiovascular assessment as early during pregnancy as possible, especially if there has been no opportunity for a prepregnancy assessment. The approach at the first antenatal visit is the same as for prepregnancy assessment, with additional attention to the cessation of medications that may be teratogenic, such as ACE inhibitors or ARBs. Patients with high risk features, such as severe MS or pulmonary hypertension, are best managed with a multi-disciplinary conference involving obstetrics, cardiology, perinatology, nursing, and social work to ensure that there is a written plan for follow-up during the antepartum period and also for labor and delivery.",
"   </p>",
"   <p>",
"    The frequency of cardiac follow-up during pregnancy will be determined by the risk level. The 2011 ESC guidelines recommend monthly or bimonthly follow-up for moderate to severe MS (mitral valve area &lt;1.5 cm",
"    <sup>",
"     2",
"    </sup>",
"    ), and at every trimester and prior to pregnancy for mild MS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/11\">",
"     11",
"    </a>",
"    ]. As pregnant women with MS will also be undergoing serial obstetric assessment, caregivers should consider establishing a combined clinic where cardiac and obstetric assessment can be scheduled during the same clinic visit, reducing the need for travel for patients in whom functional deterioration is common as pregnancy advances.",
"   </p>",
"   <p>",
"    While there are no specific recommendations for echocardiographic assessments, at the minimum, an echocardiogram should be performed at the first antepartum visit and again during the third trimester visit. Transmitral gradient will increase as pregnancy progresses but pressure half-time and planimetry are less preload dependent methods to measure mitral valve area. Systolic pulmonary artery pressure may also increase.",
"   </p>",
"   <p>",
"    At the time of each clinical assessment, history and signs of functional class deterioration, pulmonary congestion, and arrhythmias should be sought. Functional deterioration can be treated by restriction of activities and beta blockers (avoiding",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    since its use is associated with low birthweight) to reduce tachycardia and improve LV filling as well as a small dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/12\">",
"     12",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     Digoxin",
"    </a>",
"    can also be used but may be less effective in reducing heart rate than beta blockers, as renal clearance of digoxin is increased during pregnancy. Patients with pulmonary edema should be admitted to a hospital and treated with oxygen, intravenous furosemide, and introduction of beta blockers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=see_link\">",
"     \"Management of heart failure in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sustained or frequent palpitations should be promptly investigated. Atrial fibrillation and other supraventricular tachycardia should be treated to prevent deleterious effect on uteroplacental perfusion. The key considerations in treating atrial fibrillation in pregnant women with mitral stenosis are prompt initiation of anticoagulation and rhythm control to prevent thromboembolic episodes and the risk of pulmonary edema. Low molecular weight",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , or intravenous unfractionated heparin for hospitalized patients, is often used during pregnancy to avoid the potential teratogenicity and fetopathic effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . Rate control with beta blockers or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    is the initial strategy for sustained atrial fibrillation. Beta blockers are more effective at heart rate control than digoxin as the renal clearance of digoxin is increased during pregnancy. As an elevated heart rate is crucial to maintain the augmented cardiac output in later pregnancy, the goal of ventricular rate control should be at 70 to 90 bpm rather than &lt;60 bpm as in nonpregnant state. Electrical cardioversion should be considered when the ventricular rate or symptoms are responding poorly to rate control or when there is hemodynamic instability. If possible, transesophageal echocardiography should be performed prior to electrical cardioversion to exclude left atrial thrombus, which would be a contraindication to electrical cardioversion. The fetal safety profile will need to be considered when choosing an antiarrhythmic agent for maintenance of sinus rhythm.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H13#H13\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Management of AF'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=see_link\">",
"     \"Supraventricular arrhythmias during pregnancy\"",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    With state of the art care and judicious use of beta blockers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diuretics, most women with MS can undergo pregnancy without the need for invasive interventions. Intervention during pregnancy (preferably by percutaneous mitral valvotomy) is reserved for those patients with severe symptoms or heart failure despite maximal medical therapy and admission to hospital. Abdominal shielding should be employed and the procedure is best done past the period of organogenesis (&gt;20 weeks) but prior to mid to late third trimester when the gravid uterus can interfere with catheter access and hemostasis with the femoral approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H17#H17\">",
"     \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A large observational study including pregnant women with mitral stenosis as well as other heart lesions reported an association between antepartum cardiac complications and the frequency of premature labor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. This observation is pertinent to planning the timing of delivery for the women with MS who developed cardiac complications close to term.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166815\">",
"    <span class=\"h2\">",
"     Peripartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;A planned or induced delivery should be considered in women with MS with high risk features (moderate to severe MS, pulmonary hypertension, history of cardiac complications prior to or during pregnancy) or in those who live a considerable distance from the delivering hospital. With the use of regional anesthesia to attenuate the spikes in cardiac output during labor, almost all women with MS can undergo vaginal delivery with an assisted second stage. Caesarian delivery is reserved for obstetric indications and in whom anticoagulation cannot be reversed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3657?source=see_link\">",
"     \"Obstetric anesthetic management of women with acquired or congenital heart disease\"",
"    </a>",
"    .) Refractory heart failure resulting in need for intubation and ventilation is the only cardiac indication for cesarean delivery and this should be a rare occurrence with state of the art antepartum cardiac care and careful monitoring.",
"   </p>",
"   <p>",
"    Maternal pulse, oxygen saturation, and blood pressure are generally effectively monitored noninvasively but this practice reflects provider&rsquo;s practice style. Invasive hemodynamic monitoring such as arterial lines, central venous line,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary artery catheters entail some risk and are rarely necessary in current practice [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/15\">",
"     15",
"    </a>",
"    ]. Invasive hemodynamic monitoring is justified only if the hemodynamic status cannot be reliably assessed noninvasively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=see_link&amp;anchor=H18#H18\">",
"     \"Acquired heart disease and pregnancy\", section on 'Management of labor and delivery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endocarditis prophylaxis is not routinely recommended for uncomplicated vaginal or cesarean delivery. In patients with the highest risk lesions (eg, patients with prosthetic heart valves) with established infection that could cause bacteremia (such as chorioamnionitis or pyelonephritis) the underlying infection should be treated in the usual fashion; treatment should include an intravenous regimen effective for infective endocarditis prophylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=see_link\">",
"     \"Intraamniotic infection (chorioamnionitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/40/43657?source=see_link&amp;anchor=H18#H18\">",
"     \"Urinary tract infections and asymptomatic bacteriuria in pregnancy\", section on 'Acute pyelonephritis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166822\">",
"    <span class=\"h2\">",
"     Postpartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Those who are high risk should be monitored in a special care unit after delivery, such as an intensive care, coronary care, or recovery room setting, where cardiac complications can be monitored and promptly treated. For patients who are admitted to a special care unit, they should be monitored for 24 hours, as post-delivery fluid shifts may be delayed in the presence of regional anesthesia. For those women who required ongoing anticoagulation, anticoagulation can be resumed once there is no evidence of early or late antepartum hemorrhage.",
"   </p>",
"   <p>",
"    While there are no specific guidelines on the timing of postpartum assessments, cardiac assessment at four to six weeks postpartum will provide an opportunity to screen for postpartum deterioration, adjust cardiac medications, and discuss contraception choices.",
"   </p>",
"   <p>",
"    Most cardiac medications are excreted in breast milk but in such small amounts that their use in lactating women is generally safe [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/16\">",
"     16",
"    </a>",
"    ]. An exception is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , which affects the newborn thyroid, so breastfeeding is contraindicated during maternal use of amiodarone.",
"   </p>",
"   <p>",
"    Contraception can be restarted based on guidelines extrapolated from non-heart disease population. In general, estrogen-based oral contraceptive can be utilized for most patients with MS except for those with increased thromboembolic risk such as severe MS, pulmonary hypertension, or New York Functional class IV as shown in the &ldquo;Valvular heart disease&rdquo; section of the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef83911 \" href=\"UTD.htm?29/11/29881\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29447/abstract/17\">",
"     17",
"    </a>",
"    ]. Progesterone based preparations are not associated with thromboembolic risk; irregular uterine bleeding is a common side-effect that results in high discontinuation rates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24713?source=see_link\">",
"     \"Postpartum and postabortion contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As the cardiovascular changes of pregnancy do not fully resolve until the sixth postpartum month, a repeat clinical assessment with echocardiography after the sixth postpartum month will serve as the baseline for future follow-up, including risk stratification for future pregnancies. Elective cardiovascular invasive procedures should be delayed until after the sixth postpartum month to avoid unnecessary thromboembolic risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23166829\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With proper counseling and monitoring, most women with MS should have a successful pregnancy. (See",
"      <a class=\"local\" href=\"#H23166771\">",
"       'Nature and frequency of adverse pregnancy outcomes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23166793\">",
"       'Clinical management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical assessment prior to pregnancy enables identification of those at high risk (moderate to severe MS, history of cardiac complications prior to pregnancy, poor functional class). (See",
"      <a class=\"local\" href=\"#H23166786\">",
"       'Risk stratification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic patients with moderate to severe MS and asymptomatic patients with moderate to severe MS and pulmonary hypertension should undergo intervention, preferably percutaneous balloon mitral valvotomy, before pregnancy. (See",
"      <a class=\"local\" href=\"#H59617712\">",
"       'Indications for preconception intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most common maternal cardiac complications during pregnancy are pulmonary edema and arrhythmias. (See",
"      <a class=\"local\" href=\"#H23166771\">",
"       'Nature and frequency of adverse pregnancy outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt anticoagulation and rhythm control are the cornerstones of treatment of atrial tachyarrhythmias in the pregnant women with MS. (See",
"      <a class=\"local\" href=\"#H23166808\">",
"       'Antepartum'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vaginal delivery with assisted second stage is the preferred mode of delivery with caesarian delivery generally reserved for obstetric reasons. (See",
"      <a class=\"local\" href=\"#H23166815\">",
"       'Peripartum'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10552913\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The UpToDate editorial staff would&nbsp;like to thank Dr. Sorrentino for his contributions as an author to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/1\">",
"      Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/2\">",
"      Kuklina E, Callaghan W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG 2011; 118:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/3\">",
"      Avila WS, Rossi EG, Ramires JA, et al. Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol 2003; 26:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/4\">",
"      Diao M, Kane A, Ndiaye MB, et al. Pregnancy in women with heart disease in sub-Saharan Africa. Arch Cardiovasc Dis 2011; 104:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/5\">",
"      Madazli R, Sal V, Cift T, et al. Pregnancy outcomes in women with heart disease. Arch Gynecol Obstet 2010; 281:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/6\">",
"      Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/7\">",
"      Le��niak-Sobelga A, Tracz W, KostKiewicz M, et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome. Int J Cardiol 2004; 94:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/8\">",
"      Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003; 91:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/9\">",
"      Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/10\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/11\">",
"      European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:3147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/12\">",
"      al Kasab SM, Sabag T, al Zaibag M, et al. Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol 1990; 163:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/13\">",
"      Silversides CK, Harris L, Haberer K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/14\">",
"      Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96:2789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/15\">",
"      Goldszmidt E, Macarthur A, Silversides C, et al. Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. Int J Obstet Anesth 2010; 19:266.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.motherisk.org (Accessed on January 26, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29447/abstract/17\">",
"      Silversides CK, Sermer M, Siu SC. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 2009; 11:298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8133 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29447=[""].join("\n");
var outline_f28_48_29447=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23166829\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166743\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166750\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166757\">",
"      IMPACT OF CARDIOVASCULAR CHANGES IN PREGNANCY IN WOMEN WITH MITRAL STENOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166764\">",
"      RELATIONSHIP BETWEEN SEVERITY OF MS AND IMPACT OF PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166771\">",
"      NATURE AND FREQUENCY OF ADVERSE PREGNANCY OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166779\">",
"      Maternal outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2739821\">",
"      Fetal outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2739596\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166786\">",
"      RISK STRATIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166793\">",
"      CLINICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166801\">",
"      Preconception counseling and management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H59617712\">",
"      - Indications for preconception intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166808\">",
"      Antepartum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166815\">",
"      Peripartum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23166822\">",
"      Postpartum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23166829\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10552913\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8133\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8133|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/41/26268\" title=\"table 1\">",
"      Pregnancy outcomes in women with mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/11/29881\" title=\"table 2\">",
"      Valvular disease and other medical criteria for contraception",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=related_link\">",
"      Acquired heart disease and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18153?source=related_link\">",
"      Anticoagulation during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39353?source=related_link\">",
"      Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=related_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=related_link\">",
"      Management of heart failure in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=related_link\">",
"      Management of pregnant women with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=related_link\">",
"      Maternal cardiovascular and hemodynamic adaptations to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=related_link\">",
"      Medical management and indications for intervention in mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=related_link\">",
"      Natural history of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14617?source=related_link\">",
"      Natural history, screening, and management of rheumatic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3657?source=related_link\">",
"      Obstetric anesthetic management of women with acquired or congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=related_link\">",
"      Percutaneous mitral balloon valvotomy for mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24713?source=related_link\">",
"      Postpartum and postabortion contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=related_link\">",
"      Pregnancy in women with congenital heart disease: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/21/35159?source=related_link\">",
"      Pregnancy in women with congenital heart disease: Specific lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=related_link\">",
"      Supraventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/40/43657?source=related_link\">",
"      Urinary tract infections and asymptomatic bacteriuria in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29448="Single incision fasciotomy lower leg";
var content_f28_48_29448=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F55311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F55311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Single incision fasciotomy of the lower leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 708px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The single-incision technique uses a generous lateral leg incision 1 cm anterior to the fibula. Extensive flaps expose the anterior and lateral compartments. Longitudinal fascial incisions are made in anterior and lateral compartment fascia, taking care to avoid injury to the common, superficial and deep (fibular) peroneal nerves near the fibular head. The lateral flap is extended posteriorly to expose the superficial posterior compartment. Once the gastrocnemius is identified, its fascia is incised longitudinally. The deep posterior compartment is accessed in the plane between the lateral and superficial posterior compartment which exposes the posterior margin of the fibula. The soleus is dissected from the posterior aspect of the fibula beginning distally. During the peri-fibular dissection, the fibular (peroneal) vessels are retracted posteriorly to avoid injury.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29448=[""].join("\n");
var outline_f28_48_29448=null;
var title_f28_48_29449="Granuloma annulare foot";
var content_f28_48_29449=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62354%7EDERM%2F76216%7EDERM%2F61039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62354%7EDERM%2F76216%7EDERM%2F61039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This child with granuloma annulare has a non-scaly, erythematous, annular plaque.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 362px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFqAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDs53iZIwSAVO0iqwXdLJ91lxw2asgkXJk8oMuM4qG2haSVmUAAnp6D2qXqzQLR1aNVcbG5OSKsDYCCcAFeCKasW2FgSCMkY70wxGKItkuoHbsaWqWoEtqCxdVYZxxjvTlEnyCb5kxxnpS6fu+zyMoX1B71ftxjY0kfQYIA4I9frQldCbsLFIvk4kyGHBTPDCq5ZVdolLFEO4g9Rn3q2sSkD5VdM4JPaiWN9ziMZO3OQOc+ta621NIsxrmJj5hjU+UGz15Un+dX7ZHW4VpnQs+Cr54PsPT6VHZKpm3E7G6+uT9K0nmM4KrCm9/vxleC/TI9CawUOpTJWuZEKQSgANgEYyGx2z2pWkj80xhsyMTsxxgdx7nFVlLR2zwyqyoWGdw+ZT7elSXIdIoYIykwU7o9owT61TY0XtOLGR0kYNIDnI53H/CnzSBQfI3YX5WVT80YPBJ9Qe1ULWWOGMKYFU427lb5l56n/Cp/tc8SmI7Xl3bmI58zHRSfTFHNZDtqWGgXIEcmIpDuQPjDKO359asCKSCONk8sMz/cDZJPTj6d6rMYo4EG0SRMu9eclD9O/ofpTraR4p/NljJZF+6TggkcFfY+tLTYC6UKW+8KMI2ArdG55waerLHIxKlpVYNlRwuPT060yyl3bnkJaNV+RCeCO6/WlklkZfKyTCByw6sO2T6jpQ+6I8iS3cpIxMO0dAgGNp9j3FXotqmRSqNPj5UP3QD6H17Vno5Ny20yGVF27T3UdHqwzKHEUZIz+8G7tkf5OKNiJK4kSlCI0J3EEYPJ2juKsMiW0cEysGTYd3qT61BC8cSFgylw3IJ5K9eD29aWXcY2kfy8j+ADgg9hSBq7HCIOEaRAxwWx0wM9/anSRxQq5DlucAAlvlPp71ArP5Z8zAiDbSFPLemR6elTQ5AmMoUHbtAXohPQD3pg7gLOQuDIqKVX7qtg4PUAnikVC83k25DdsvyR7ml8wsF3odoI3KM4bHc56ClbzWMsrbVcED5eB6EZ+lGgXfUkjWJ2WJNw+baZTyD6qP8AOKnAVZNhVWUcDBz06YqojSsAsagA4Tt8i56Ae/c1bRAJcKE7jY3RcU0Zy0FSJpWG4lAwJK9SB9e9LGrsgI6dFJ7Y6EVGVdidpJ7ZU9vbvTnwV2Mi+UDwDk5z3NMljp1EZG5jwd2Sc4P/ANeq4dt2ZCMhT8w4yvTJHY1Lghiwb5gec5BHoR6cU0OXY7yilVJywwC2euPp2oGht1uZT5gTYpC4A/I0zzCHVABvU5Ddm9j6EU6NxsaMFcA44H3j6j2qExldx5IPDN3P1FHmWuzHZ3AAgkHJ2rUMakR7iGKjgHHWpFO50D55yMr/ABDH86QP8oC55+6c8Af4UFFWQcl9vykdAe3tUQCkHHTtVhwpJUD3P/1qrFfLySNvYmmUJIOD0P0pCxMfGAx9OcU3K7m+U47ACmK4UsAMVSYmNlGQccE9qzphgkHmr8jHII7/AKVWnUEE+/61rHczZjXuHD+v9KXQnLfK/Reh96fdLlCRVfSGKTOBgnP3a9HCO90cGIRtTuSAqn5ume1UyjKc5yx45HWrqoETDHAOcn0pPL83buIHpj0rrTscditD87Arwvp/OpJZQBt+9kYNDgIE2HawyT7CoEYqQx5Oeaq19RD4Fy4LfdPQg/zqVczNywwvGfb1pjvuweME4x6U5WCoR94HkEetJgIFRATkKw71FNwSRgg9hUp4QLLwSM596qsdzYx0PWqQEEwJJIyAeMYqG3PltycgnGPSrs2FXAPOe/SqkMQ3hiOvNWnoIicMsSjJB/nSQTFZFZOQDVoKXTJXgnoadBbhHU5AHoR1NfLq59AVrhVbe8g+YnoPT1pIMC3mVlJJHy4qxKhzIyDbL/dqHY0VvFKD8khzjuDRIGixaxKkYWUkFgAeOtTAObd/KKYiILkfeApi3GYQCc7iCuR0NPt4yjSyRkjKZf1b2NHkiLCogUnzASCcnB7VYARI/MBZoWbbtJ5P41CZA1qEVhG7H5iBnIqe3EOwCNgAeGzyPrij0LRHKpREZlR0K7kfoRzyDQTtlG4N5oyyuOp/xqRI08mQo+UbHU8r7io44EVBHKZI2WT74OQhH8Q9jQzQlkVXhMgcE7xuQdenUevPao42PnFrqNmBG5CrfMB6rS3COjYZyXRSXeMfdx6etOEyT20kk+VY424GBx2Hpnqamw0TeaOJWjDAjIBXhx3B9DTmWOOKOdtrKzb0CfKV9vpSb1kZJJxllbn1UEcU62X7RLvCI6HKmMHBx3Kj19qGhkkSqfMLJy5BVc/d56nNKMXEwgM21VyUYrlVb+6D6GmSSKiFUDmNSFDL8xUHt9al2SJGVU74xxu/uN978R7/AIUmgLdrL5fzFiIkZsqvY4/kPWpS0bwZdsypmUmPt6n6dKi8+UQgoNjYbcCOHBHX8fSoLLy42SRlKjO4Be/t/wDWovbQm3UnhBt4Pm8xbhXZWJHPPIP0q3GSPLYlnmlbgAZ57ZPb/CqKqiNvmLrC3B5zj2J7Y4+tSQ3JLBVwq9CSThyf6f0qdgauWpEYzMM7vm2jB6fQ+h7fSn2/lqgedsMTxnnbTo5cSzGONS0oIMUnUYqtGdoeGIbdxCEjkqf7v9M0yVdqxOd00hkTIQcdvmx1x6YoRANowTgc4OO/X6e9PlcrCjKyrFbtlJFHzZPt3HbNRXLR2yyIiE8jahGQuegJ9M80W6iV3oTGeMfMQUHcN2I7H14pFUnsMfeCZ6E//WquGDNueTzGCgEx4YgZHPHarLSiU5cFcuCGYcAdlFC1Fa2w6FQVl5Vgi7iR1I9QPpS/aEk48xnDjBVeWPoM0lx5SgBlDSKcqV6BT1B9hTooolQxNGd2fmbI247fhT9CXbdli3zGQ0gTCr0B4/E+vtTJJk2NtzjI2MRjPsPpT1hhAAEKx/Lxjpn6U1jb5XMaeWPlYHqST0HrTI0uK8yIm1W8xx0xjBz1zTG+cKrcKxB3Yydv+FMPlxyM2EiwNwT+LHr/APWoR2jC4U+ZggKSWIOMg+w9jSHbsMyojU/IcjA7be3404jkbsAop+YdsjvVe0YKB5uZnMe3AXaB9P8AGph5jQh/lBIwrDnHbH/66C2rDZFzIAWCOCACvTPrSkA/dPzc8e1G0japJ4ySB+tNG1doUBhnPHc0gEkUMD2PHTiqzoSfmJ4HarJIcARsCe4P8xUMiKxAHUdM1aGjPf5Dzx7E1HIMhSDgVcnVWO0t9KrEqB8xy38zTSAYOvTK1XnU4OOCDmplcAc8A9Khlf5+Rx3HrWsSGZlwRzg//WrOs38q/JrTusc46d6xZFP2lQCRnrXdhH75x19UbhuDjILBB696VrjGFXnsOcZqBORkZPGMVN5KIFJ57E+lelZHnkgIPLNyRkfSotjM/H4Co3PTaeOmcc06OZUJU43Z4xRbsA2VyoG3IxkYpYSVVW7A9MU+QIV9D1x61GIyW4z060xE8jByQT8p7mmsFBwASD0IqIkoDznsacjfLuPT60rARSNwAQTjsKYCflHT1FLIC7hRz3zUqRFFUSAZxu60wAGIhQCRtH50jg/aEIX5Pesy2u9zgHHHGPWteHbKYuWwecelfNX5tj6NorvK4Eu5QMnC1Yba1pHvjCleCexqtckElcH75qRWfEXZdpyCOtJNrQh3Gw2ysWbec4zg9Kt2sTRhHbJweCO/saZbKBC+9ArFcCpNwWNIpFBBOSwPehK2pF2IiLI6ld0TknOfu0u14pDDsxIec5/zxTSTb5DF+ucdqsAqVPmMryJ91j6mgaIpQwYKSokAwRVtpCbCKSKPcwJJyfve34VC5+URA5VVzu6fhSFI5ZmSORo7WPkbz3xz06U1oaIhmbfFHE/JZyVcDp6g+1TJCuGJyIVHzcE4OMZpYC8U8gYAYwNoPGKmmJa1baDknhQ3HHTipsralFWGSSCUQyEZkU7tvJOehrQ+aT90iAXONwQgYcAfzrPjXyI3JxJGxPl+YuChPUD8asxxsypGVEjlidwGGU47/SkmwuEZVnV4wfNbKkenHIIP6Gp2dbZCrncpGB8xBOfX3FIELN9o3hFKhDJ3Hop/z3qtKzEMxXKN/EpztYen+elEnYasy3G4iiMkkvDnoRg7R3qSJ3aZZPuCM7ZM9F9vxrPQlZTHKrBFYO0St93PTaT/ADrQ8yeJVVcZPysxwd6+47cdalO6Gy15hlaZA2Ywf3mVzu+vv6VJBGojRgwwD17H0PscfyqqYVaZY7ZgAx2pLk5GB90/41bDfIQzmO5JwF25Ibt7YPpQl3IfkR6oZLiM+VIglzujYj5nfoOnQYzRbHy7ZV8v5dg+ZfmA+hot50yXkYKyEDgEDjjbjsc81PEoRyyhgV58tuRz3IHU5pdbjvZWImlbyTDGMxg8Oo5z1596kR1WJCFUDORlhgnuCatMoKASEOpO3jqxIyG+lQwYcCJLeLOPnkAzk+w9aZPMmhVfz32qGWMHcVIALc88jt7U/wAxondI2CnJJ44I7HHY1CU2ybUc72wW5x0H9KsQOYiigjfgkM/G72+lCJaAq7xtGiOHXLOzDJYf57U+13MJDseRwRl+3HY1CZ/LtipVflBZCjZJP4elToS4C2j5CIA7c846Aev9KaJew6VxJOiwMQcgcnOCf/19+lJAmyEvnczErEcE9yDimSSfL5RBxxuULkg/3iR1zUkc5iRjIXPy4RcYCj/GknqTZ20HBF3CWbLMgACbc5x3/rUBJKO2wquMO2Tzk8DP86mM6rGSPkjHI8tgW54A+tQDeskUUfmP5TEqkZA3EjkP6gUxq5KWyQFCDjBHYYqNgGU4I5bLDOBn1NDeakR3jATA+U5wOn4k0ZYoOEwCWIC+vXj2oGlYjUsGkClw/wB3GPfv+FALJnIAUkZJ+6fpUzFRG2G2kEgHuoxwahlZggLZJ4J7/iaTGncSZFVQFPP+z/Kq5JdyWOW6UhZUO3IKk9uQPf6Us/IGADgYOTQmXa25XuF43ADP1zVOfPzHOB1xjtV8ECPjIA7VBMoYqFPzetUJmazsAR3POewFRFwT1JNXJotuUx3xWVOrpMMZC5I5raN9iH2FuMkZrFuW2zI2e9bEzDA96x77A5I4zziuvDu00cdU2bN9qBifmx3FTGQOWYcKKzLWQuFXI9BV6NxlVPGK9ZrU84jn27TjkHk57VFAuBljwTwauSRKFJ6nPzDpUA5Y7Rhc+nSmndCFGWIHb6UoO0HNLIwSPaOeOCOtQudu0MTnHpQA/hnzxntThnoBgYqLeWkwAOOKtKfLQjjd79xQxjYkOM5BGD+FPdSIzuIxgY+lQ87cj0yaV5CSEX7uAKVgORtpCdmD89dVpZEoSNjjPJPvXFW7Mo2547+tdJo91tkjAxx0Jr5mlJX1PpjYigPmODgjnGaS4tyDCU+YhTuXpipI5zIpBQqM4Jqxjz2LgkumFz7VcoowkrMqAYtJMjbwBz2pIQZMbjlAfvrVq5iZrRkVVMjN61WiV7aCZXBHHzLnr+FTsStBzsjqS7/JkKD3HvSyhBKqoJFaQcEDOPeq7I1vEXZl8snOKsxLI0h8xgPlG0r6GnvuUTxRPDbt5gV+uGxyPeo7WPMgCMA564OQwp6SyJMWEgQrwR1zUyB/IEUsYcyEOuwdMep7UW1Hdkao5gZmHdsYHKn0+lSEyks0n+tcAJkZUr0/D61T+1vJKggBj8s5Usclqv2cDyJKyrs3ptKA+/Uen0qU77BsUZVkkZwjearAZU/eGO/1qeEKFd0LJKoyUzkuB1x707y3mkkaSNnZeAo43DPB+uKnyZY0jXyxKpyjMwGD2/H+dC7j5gRt+77AT82A2/7pGPu/SiHau0jAj67SvUjqM1Tn2bQTEyO/O1s/K2cMR7HrjtVyMeXajL42kZYHv2Io3GTOyv5RCxsFyq55A/2fX6GkhyHbeuwD7646fhVedxLMioUwB5hAG0t6/wCe9SzMbiXemFOTz1xjjBP48Gk+40ia3C7GLAIASrKR9xscEVLG4STyjGJF9Og6cE1AC80QijdWODgg5JIGQD/tdqZZTK0O6MFEzltx+6T2B9O1T6DtcszovnCYh9+wNK3UcnAJPc54zUzSFI2YEOFYEkNg5x0INQC4eCQJvDMUI29mHcEf5zUqxrHJ5hwEDYDs2SB7+2eKQn5kixtPt3FYw/ygKenu3p6e9SRKBEA3yCMncwODnuKUBbh2LqTEV3ZC4YY7/jUU2N5dXMjMOegBAH88ce9BO+hOu37LsZSN2cEkAE5yPy6ZpvnQuwR4Vmz1x3/wOajZEI8yXEoVRuXPT0+v060g6FkXkcBVGA2TzuNF2FkTNh0AMeeoRQMkDqSTViCNChDl3I+7GP4gfYVETslDOzZAx8gwvPalJ5G8BAAMBM545GPQ0Le7IeqsifyvLDb8ZzjIPQkelTMyxqqrtk4zgr9315rNMrFdygGPIb5F2hffmrQEUuXlljyeQMkKh9DTTXQlx6sRI45ZEZcEHGCEGM9TinPMVRUO1I3+bCqCAPXjn86cJVdg4kWIouN8SkjceuB+FMk8s7mRpGXtu4APt60bBu9QRz5Iy64VuBtzznjGOtE0cgVslN+wk8YIz/n8ae/7oeYoITJOSeh/vCkkchk8xZH3vkgc5GPvD1x6UC63RXJaNlMeWYfdyRgepqOPcGZiMnOASeD74q2cNH8xRmOcFejY5/DPPFQMRtBUDeTvbcOAD0H5UWLiyGeH5yQMKCM54x+FRHCA5AKr3HWrXyFisj5Xpu65/wDrVUfLEnIwgz9eeaLWLWu5XkLAjnjGBxTinQjk56+lI8YMgkJyjdR3A9qkGEAbBGeQaaBlSfoc8HpWfOgbOTz1wR1rUuNrjb0b1qhODnB6dK2juZsxp2KMVPQ8isy9bch9e9a16mQwI57e1Ydy+dynOR15rqo/EctUu2rbVUKM5rRgYjlmxjpWPaHCbuoPpWjafNgE8fyr3JI8x7mkhaZsgfN6U/asSZXnI5oSVUjCAYIPB9KjZmIO44bqAaxAjKZTcee2KheNtuWPHv2p67nLYz71bIxCQGyG61V7AZ4TywSRz61ICzAZ6HpTjGd/zg7c0912qQCP/rU7iIW3OQi5yeKckZXccEkDB4pFcKzZ9KtqodS2Ryvak3YDz94vKlIPA6itCynDSZzt21FKhEi7sOMcE+vpVYjyTuDd+/NfLu8XfofSRdzrrG8j8yMZ7jk9c1qkPseXhdxJXjrXD2l23nJzg+4rsLO/M0UCNyq9QPWtITVQbi3uF3KY0hOct1x0pywebZvK5+QnG4noanvRHOkRCkDJwx9u1RqHELW6ruEo4Ao5dWZ8plThwjKynZkbcnP6Vdt1j3qfMYfLzgdvSq/muNwcbHibr1P0p0QjnMgLBGJwCO1KMewnFlmIMApyXU5525/OrMk+yIyox2ocFQcYGP8AGqtvE4I3SNtAzkdwKFYtahFJ81zuIK9h2zVaoE9dSUIcK0p5zncverkO6K3ZZpBsk+cMnbHI5qooUrsKsvG0Fuq5p5R4Q0Ebh1DbWPYA9qW2wD5bhJZHlnRlfoNpxlj/ACOKnleMQEmPdNkFiw5x/wDWqmx2sVWF/N5DRbc5X1P+NPDSPKDHkBOMdQw64qWPYntkeaUzOWaMjAZeCB2I/GpJI0UlXiVZejFDjnrkeo9KhkKpBtKNGrNuGxsq2e/tUf2hnt8IiSSKPvbsbl/u49uoouloNBeZbeiookjCqqFei92yKkaZIt6xgnd1YDO7I6/hUZeGMGWXzDI/KiI8Fe/Pce1PRfsVyRw0BTMcm75SG6N/THtUsslDiKNUZVJkxhiMHjuP8afIpDiRdrF1CsNpBVvX6dDSo7KyyOVkmJ+UsQ27j7o9PWpediF3BUoQ2eA3r/SpSC4scTsFBMYIG+QsccjoQfp2pzW7NKhiPmNw2xl2r0zwPXFQ28hnnwxkaJyMHGOR2OO/oe9XpiJN5ZyysqlucNkdCvv7UWTCTaY1JAg2SLgZ+Qu2Qp9Kc23yz5oJG/5wRjI9AfXvTQ7RRuJNoXAz8n3h2+g/rxStmWL5uBt2qpOcH1z6UEiROAyOyqWTDYBzuHYkf5xUs6KJ8ZKPJubanJB78dMdKgR9ke0LuLDll42n0NTrGA43s5Zlx15wRzz6D/ChPoD7k0LAMFcuemOeD6HHrRHMhUMdq85+UZPtio4FDMEQtu2qC2AAGHXnvSvb7V3A5YNtXaAAT7n6imRp1LUTJPMHlYg8npyOKnXyd7NPHE20EqwXG70NUIplWNVaZFy2cbclf89MUMJJFPls7ooxzhQR24NO9iXG5PCVBVlTfKSSQpx9KWS4Z5ihDzFTyuO4+npVMt5apAJI2A5JVTkn3qaAsNwWZvLPPypjd3PPepb6Ibit2PEjFwX/AIOVH3sE8ZIqObKbwjucqW+YHk1N5gGxPPJYDhRER+tLGYHYqzEbVOd5xz7U7MW2pQUt92WRuQBhRgnA657GpneOWOMxycHjYQAQfp3p8uM5lGBt+UY/nVdFIkZkbbhsJ7HFFjTfUYy4ymXLZ5XOMntTIgoDIIh5g/ixyfXmrSAFsn5R/snP1psqqqgDGC2R64x1oC/Qqup52RkhuhHb1qHfIpGQNucfhVsuNhUkcnO0dM+tRbQ4PHT17U7DZVnB3FgOlUrg8A/xVdkjVCSTgH9aqXIKHnrWkdDOSM+4+bnGDXL6l+7mxjgiupmG5Sce1c34gjxEXI5XvXZR3OSsrEunr5sQPbjIz1rVh+XheRWTpUgEEZHXaOK2YXCkMBk5Fe3K550ty5CNvL8g9OKZIheTBwD7mmGTLdSAST06UO4ZiOSMcHuKjW5IzeEzjOelIjhvmJ/AUyRDn5jxmok3SOApPHWqsIvb8tgZ69KSV/lPcHv6UgOxS2e/OahOcFm7c8cVNhkADFwzHC+taVuGbjPYAVWT5/lHQ9quwqsLB2OV29qJMRwrEtc4zwTj6Uy+i8sqd49Tg064jZU3EZycbvSqTkqzIwOc8g181PazPpIksBKkZGe4I610Wl3rJLGc429yKxbdEkjTGQwHUVettikLLkHGBWcPd2KcjqftBnspNzplGDr61LLKVUFkJfgA9OKybadIwEMYJz1NaAkllnhilJYLgDNdEXfYm/YpgF5mMX8R5BpZA8TldoJQcEDHXtVmGOJncSfLtYnJ707cZS2FyD0zQoibIopyscuxSBIuNuO4/rUa3LvkOHMeeFI5HtmryfuokEJY7/lOOoqoZP3m+VG/d8lsZJPrQ07bitcsC4DKvmsx2j8QPSo2TyosCRldm+63p2Gf61XVmZIx8p3/ADgnqQKtuiSxDzFkEp9RxWb8wWhAt27ExoVLDOAzZOPb2qzpbzJmWNW+UfdPOR05+lU1twYyI+Z8YZcD5wPT0NWrFlRg8hZe23Pr047Uk3fUptFglSxEW0s2dpYYGfQ0WoeKX7QciUYIPoe9Mlj6yXTkwF/KDjlkYdvT/Gog4mVfKm80lsbNpHmD0PoaTJRe8uOZnnREjRScRp0BPVh6Z7Cn2xdM+UAXQkB3AI56rz/nNVEcSCJE3uq7sgnBBPGzPpU9tbxoEVizq5AZMHcv4egNK/YofE0ZccMMnlSMZHbHoRU9wizRs0zBWbOwBdzFhzz26dqoGU5+Ty/nO3cDjP09DV1XIhDMu51fdtQ/MD2I9+Km99CmuwsIEQZnLh3VSVXjr0P/ANerbNtH78fMpyMc4GO39argN5sbTjfBklST9zPUEDqO/FWtzSJtMibN3zYHDHHr2B9aLCbHqfNkwAyfMWUe/wDeoZQskgXcy5y2TnPq369Kew8jaEaJ1YEEqeVHo3pj170RlzHHycMSAB3xR5ECq+z5vKaT+Lay5Dnt09v5UxRFIjHypQ+44P3gv4d6tbti7X3hIyGKA5CZ/wA/hTkVCzHjK/c2HrTFzEUc5MhNtEuV+QZ+XaMfrSXBcuikDcF7DjH9abcCMud++R15BH8A+vao0jEfIDqMDhwWy31+tJvoNJbkkkcYkXegY8bgPlbHt+PFPSIttw4Ic8Echj6ZqKUvI6YjXcpLsR8uCPU96UB5ChzG+4lmUnCAdzz0/ChJBrbcmc7BsiGCf3bBCSTzkkZp5fynLBjJErDKYwXHoR6VAsrRq07I4iUEKwIBT3GeSKaJ/M85VH76YcRjOVXbkkn6fzq7E8o+VzNL5cXmeWCSFxjk9AD06dadC7Rx4kwxjwx46ep9fwqXTzb7JkZfMVMLtznCeuO2O/0pxngebqfIX5d47n19xRYV76JEM074Yop2E8gfNtI7j61Ap2iUrtYNhenSpGntQrhGTKcNs+YnIz+PP86gjj2SfMAJM+WNh4Untj17ZosXFdBwJQ7g4Y4+UjjmljIYYEgDlec9TUcj7gWI+XAJ2+tQTOCFYSjYvDHqcjjH+zg0tirXJpQAwYsQ+CpB6GmSn+IduMUJgoMsQ6ev86QYWNgwBI6Z65700JoqzElWAbH05zVPA2qGJwM9auGVGO3kE4Jz2qnOpTlj14wT0poTWhTbgOvHrWJqy77ZkbHPT61uytnI49qytQUNG3UHrXZRdmjkrLQyLM+VEq55HANbFiHkxu6dKyYgBJnkrnFbliVO1egzivoJtWujynuWXUjAQdRzT4o1WPe3Xj61eeNEiPRWAFZsrkuWK474rBO4iG4OcgHj1xTYsISB1oc5JYHr1zSxJsQM2cHtV9AuWEUEEueSailzghT060hkJfBbvxTnwoCg/j70kA2E4BweR1qzGd4bBwo/WqiLnJPDntipN4VfkByRzQ0I5uWcN8incAc4qCS1Ms7c/MBuye9PjtsSPjgn7vuas24dbkIw+YjGTXzj13Po0xtqBgDAwTkj3q+iKy78KcHpjrTI7TGPmw2auPbMEymAehxS5WTfUfCiyAlo+M4FWoG/09txICjAz2quqzKwTbux0xUm9S7BiQ2ec1S0Bskm3llQhWxySpqOMSkkFgrE4OD19qtRq5cquxU7uxxmpWS0kzIUZ2UHhOFJ7VTj1EyjnFyqlyAnBxU1vgQSxh2Wdzhcn5cd80tgyGYtLGuFUnlsVDMCt1J5ZyvDAEZxU30HcjhjxcF8jywdrAc/iKnWQSttjaVmByvG6nSFFt1VvLZiTjZwTSoIVZ5YSVk6BF6fnWbQN33EaRpJ3LqAV+63TH4Uj5uozHEqyMnzttHf2PerJhOz5o/mbLEA5X/eFRRLGr7kysq4IaM43fQetJpgKH82EiEEyyAE7XGxz7j1qu5MAkdN6hgMP0/D61ammSVZZ9ymZ8cAABvf2PrUU84mCxMUaMOHQv8AL8393PbNJq40Wrf5owsm+INHypAIf6+h96a0pNyizBkbGSQc5GODmqkcgnuGaJQrjDtExyJMHnA9farNtMJSdoywJ2I4O3H9329qm9yiwNpiy4B3bVlJIyrD7rD8Pzp7keY0e9HBjIB+g4HHQ4602C3ilijkmysYYKsav95s9Mnt1qCLbEc7zky8gnKg56MPWkykXdyskfksRkqVDDOO24Hsf5ipVIUmP5vMB4IOB+PqD1xUW0IzJKG8yNyC4O0t681JLkeWrODj5gBnHP3h7npzUgPnR/KleGQKxTltvckDb/ntVqNbhF8pZEyMfIDnB9KqRsXiYKWEa7WctkY5449auQh0yucZB+7wT700J7Ekby+WuWT16Ekn1pY1LHJdVViMheOPX2pysFdgu4qCOCOo+o6U1Du+ZLeMeUMHceAfr/hVGfoTrsLbIiQp5OR19RSn51BDlZAxbdxTCUIwBuJXJP8ACuO/9MUsIjIAlKkkHI9KETYhmMIwm4H7p3knI5/xpk7DymjwACxjPf5upPtwe3rTbohSPMK7WBBJ52tngfUio9hjRhEwWRB8u/JD+qk9jnGKrU0SVibZEjozEFjmSPzM4bA4X2z+tVjcG0MctvuityASpUsQGGD7le3tURnMqS70FsFIMkSSb22nvk9BnnNU4pZnbY8qPMD8jsflZc8j/PWlfsaRp33Jby6aaZHja5JjO0tgE9Dxnv2qW3DgQ7mVh13Kcqfw7Cl+dhFveVVhO7ESbyp/ujH+R3pTJFEJSiv5cRDKzEbpM8Ac9TnoBQl3Kv0QQyRQyeUI2kdHMrbj8pUD5R9ckcVZJaKKWXzdxxtZgvV25BH41FYxWjowuF3zyMTiUEKx/Dp7ZpZb9pozFbwKEhIkkFsQ2ewHsM96exm99CRnijYJDlQMFgefmPJ/Cs+cAsvzfdP0O3/GrUpSMMBI9xKQXLDoM9MH29KqSruDDblh3XoRjJJzUyRUFYdbuN+CxUqcA5/rUknXhy6k5/3TVSLhgGJ2kZBxjipwuFcAkAHOOvFC2HJENwGQMQ+GJ5wOgqFpPNhK4yV6juakZkcqqqAx75/nVSabyXBPBHBFO5LjcjkUlFIbdkdu3say7otlxggDPX1rWLE/Kw2nG4Y7g96pXinB4zXXSZy1Y6GErEv8ox2xWxp58tsnoazVQLISDznpWja5zux05xX0ClzQTPHmrSZvw5lXrxgcmqF0p3lTnrxirdpKCuxMEAflTbsKBz0PesVoyWUYwMHPBH61IyeYfl4U9cVHgnqRgdDUhOzgHDBuvrWjEQSAIcD5s9afDEMDdnB96k2KAWHXsPWnBgemcfyouBHKCH2nH8qbtCMRwGwKezrkt3I5FWUgWRQzHGRxSbsgOeSAEKHGGpV5nG4fMOhPWrVvKrSICuCMZzUl4ge5LhRtHBrwWtND30xGAWUOo3Z61a8wiKMFQqnnPrVTyfM2qjkfWrmxhbRjBJU4IoAj81DcqASH9RSsJDC77w8jnvxTfLVZIpVO3uRmkVy9wFCkqOtLyY12IbbGSjfKy/3uRUzMoVjHIWBOduelPiQRXAyQwJz9KbP5b3MvlOIieASOM0nsBJI4aJSwUSMRuHZh3zUTyKl3K8IdUbhRjPFNcOt0scgXdgZ/xrQ877NIXjjAO3aCDkVG+oWvuZysryONokxjg5/T0qQpuuEWFWhDHJ8xqtQMiJK0TBB1YN3PtTlZXkjFwGXJzvUZz7UuXuMaYXkhdjKVdQcccE5qpG7+WqSQlXbIEg6kVJftLazrvUbScrg8D2PvSC4kbcIlPmODvQjAA9RSdrjsQSzTRKqsq/eIzkEH8KltS+6JVZNkr7THjcQP8Krxw+erBgY5U+beq5XHv6U6CS5jk8uRCGXD5Q7T7MDUJlWLcrop3ui7XfadwwynOP8A9RqZplkLA7srwHHBxnrjvVBhP56O581ZQTx1Iz37ZqeFWFxH58ZETjO71x1pehJKrSTyxKWTDtksRjJPGQOwq4Q6XJiJjQPxhuVx2P4VUjui04ulOFLBCMfdHQUrTyRmREaMgnYRwSyk5zjvSa6lI142RZmWIZhI2lGPzHsST69805Gl+YE/ISegzn/6+KpLgbXbZGxBDMGOC3pmtGIklQAwkICs2c/jii1weg+IAy43upxkMp6EegP8qfGqCNmZt8XUMpwc+w7fSozPHJIqqx3E4AAyRjoMe/JzTVUoylW+Rl3g7MAc/wCPehi33L0UpihVXbJ5K9gwPv8A0ptqwmjjG1/kUjGMY55+lQxmNFwjFnPbrt/Cp4ohHl1aTZk5Y9c9cY709xOyJYwDhRhCuST06dz6dqgmf92B5SOdpctjlR659z0obaCdznbxnufXFU7mUyyu5GNo4A/hXtkf1ouOMbslUHcmJgjMo2yE4UEHofTI4zSy37DMD5iuo3yEmjz5noQemQP8aliSURu4aGaJOqPzj0IUcnryKpPepODCCVgVSfKZN/T+EE9R6dx0qilHmfcpyL58aeXCXPIVk5ZCP6dcg02G3aN3UwN9o8wBJY5fkX3APp1+lTSJslKxl1eT5FSM43Dvx2pxdF89nl8y5VdqRTQ7uQMZ+XjHXk0rdza72RNazMFZBIoljUhm3CNmyc5z05PXFQ3Ma3L5uEckKGjijPJJ6kdznsaplllK/aVG1EJVY1MvPHzY6gD0qT7cXkVBGqAN95uASPRjz+X0outhcjT0NLTRayRS3FyIirrlYQwUAD+H1OMVNZuUtXe3+ymST95JIZAN5PoB3A496ztNAN1HKWeWKNw2XXbgnO3I6j39yK10uI0gjZzE0mzkFBywOQR6fSrS0Makde5UkgURTRoXaRRnzJARyTzjsAOwqpJGY2xM+FVPnJHAHqKsyOY4S0cLx20hGRK4O056nvnvVG4lSQhcA7H4wcjr2pOxcbkSlgoSM4YrubJyV9s/r+NMtHICiQ4Utgkdfegq4dQRtVjlk3ck9evamEtuCglyTgqFxg+9Z3NLD5Ih5pGwLg9qLmNHiO8HI6HrSvJtnO5fmycn+lS28ysSpUdMHNNWZnK5kiLyjkcHtn0+lNkKiMkA5x0HNWLpCHGfwNUpInwXVvk9xXTSfQxmrozZ8LcFR35qzbybiMAg49etQX6bgrp/KnWhCoMn0Ne9hnekjxa6tI3bQ7RkH5upHtTpvu7ucdqr2ilhljjvTrhwFGDg9MU+pgIrDaQeQensaUAclwSTzzzVdWCElhn5ulSxyGQH+7ggGqsA51Mj5PG3v60fwNnO7ODSswTcOSPWmjGME4OPSkBXwS5b+Ec4FXoZjhlQg555qBlMn3M1KMQ4Ccnv9ab1AzQuGUsRhulWGHyJzjnPWq15EBZo4O2RTg0s0cj7GU/dXP1rwEe8lctJhgSjASg5FPuPMeJSMpk8jNUrRn+dsjA7HtU4uFO0Zzg0t0VYt2JUOodVYA/MGqKQFppZIWZBuIOOg9KZKxZwEIAPOaZHI0bSRNkufvDsRT8gsS28MhI2kM3rTbcs0pDjJBwTjPNRxtJu/wBHRmB4waksElIJ3bMkhj71Ol9Bsjkl2MfOJKtnkLmpGjRxvtw3yjLKx6j1FPjaWLem8OGJHIzTY5U8llRtjH5SCMjFRfuTzXJXYogjkRZCyjA7rmpLFbiLd9nIljAySeNv4Uy5d53iWZgxQcSIOn19qrNevZqBITtz97HBpXSd2NFvfIUd5YiYnOXR+Qx7HNOuUFtGPLRnVhuZO68dPcVVudSS6jX7M4jkQghADteq8s1wJIXmCbXb164/lQ2ikTWk4F1teNtvIGBnHHQinyuTFFBcLsIzsdxgjPf3FSIY5lO+PDg/LKp7elSXwlW3aR1E0KgKzAfd9D7VGthcxnySyJHGpjwgJjLr9yQjuKJvtH2NCAViVyEb1z6ii7lZNOU7d0SvnIOcE9sVWlvN0MOxtowTg9D9KVulxljykVvlkeBThZM/Ptz147880+3RBI2x38veFEvXHufSsmE+cFJnZ0YYPy449j1NaMFsYW4mXaoDKA33wf8APeptfZF3NKEF4nikchic8jI4PH1OavWck5gIaVAmOCRyo9PpVAl87vKCZIVvmyQR3FXYoljDurqYmwVYjO5u/wCXNNK2w76Gj5s6n94qZUfOn8LDoRntVkG2ZUeEmJgCGVGOQT/Djpj2qipMsBYyAHqcZOce1XIUfai3BcNj5SxwM9ufSi3QhkqxJFghgpYHJBxgmhScKkySbDkDZzj3H86QlvMQ7tyMON2Bj0z+PepizNGGYk7sAL6/5xTSFfuU5nIdlYjG0BnUYwOgz7/SmWzK8zDnJwmScH2HtT5X+ZHz8/zJk+vUfjjNV7eVBMskqy7R8+5EJ2H0Pt3xU9TVL3dDYubcNExgfymX7k0aDAA6Env6YNZt3JHPulmdPtMfzK+3ayN2Knp1qc3NlckFXU3AOMA/ePoF9veoWE0ULG4uJECSKqpsDgHpz781qTCLW5UDyrPKxdZigCLcTqSN3U8AZJ7Y6UzZDcKqAu0duCpuSNiqeWICjkge/U1dIaKNovJlaXeCq7dokc8jBPp7Uy5tPJjcljNMUOcHaVc85Zu4zRY0uRQzPbxwxuBCZW3GdR8z+3HQ9Paopp/tTW4jQM0cLMzSxg+X65zwTmp7dvnSITyhXZYSssm8lurcY4UAde9Vru0ML3AhWMqriPypXKFN3IYHoQR+tS0xpJvXchtQtzOY72Ucjercqz54G0jqD09sVp6cY7fe20BEfY7bN7kkZzx0HYMPxqhZqkxj8ozRxqf3YZssjjr9M+g+tS2RcxyYnETwKY9rjBdSeFY9+T1pxCormxI9xdxNPJarGgUkzM2QMdW2/wBCeawXQh9uSiEnaW+Ue35/kK3jKJ0Mc0Dm2gID20a7iX/28fw/zqtqMSyuJJG2scsBnO7I/QU5K5hTk07GK0YRXDFugGRg8fWojuaXhgh+6WPAx17+vrU80bQ4yoZSobGev1qlJIS7F8nAArGWh0x1JEdGJJZtjcgNzg/41IGxggVSiCBsFhycgGrIZVY7gcYx9KUWKaJGdZhj+LHJB61VkVUBwML3p87DaCuQKZJcmaONXYMEXYuBXRSlqczXYzNQOE3KuVzyBzVa0bLKSeCc/StGdfkOATkYrJVSJCq5HrXu4F3i0eVjI2ZuxPuAGcY6U58EnJ5J61XtQQg44Pc1OE8xuenbNdFjiINu9mYZwDkip87YcKBjFJKSqgKCMd6iRuvr6UwH7cAbhn8alwXHzYwfX0pg5B9OKc0oVSvBBFICdgFwinDAjkUqIfMyecAkVEhwvzHGelNMp6AZIHBzSsBUfa8ee+ORiqszGF1CsW79aupHlEYjaG45qtPZ+VKWkb5T0IrwdbXR9AtCdTC0eNoJakEL28xG0Mp6U0Mixg9c9DVlyHhBDHIxg5p7lXKUjhpNq5VlODk1I0U0kCzZAwduR3FNuogpYuAcj71R2cjiMxxkt/F7VlbWzJa1Lls5LgI5AAqxp9w0YLrypJDAjrVG2CszGTOOTxU8T/ZoysW1w/P0p3YmTRksxkRWDL3HeoGgVnUpIROTls8CmvO5bMaY3cE05IQXT95uPU5PSobuT5iyC5jkcQqJFXjehxiow1wsu26kLrgFoyKlkuAh3gtk9x2qESfawpl3Fichwecilez3KQ4rBHukDMk7NyB0/KlmnSJwXgLQlNuSOh9R71D/AGXPK+6OXc3dSf61bhdYY2hlDqWGPnGR+FFm+lhsbE0kmfssm8YyFIwfy71I07rA+DsGMPG5+9VRd8BDpGPLK8Mp/wA4qSUzXCnzl8xnGQ/elckqTyRE7mRBGSV+nFYlxasskEgkJgJI2s2QPateOwuHjJZQ0J43dsetY2sWtxZrHIzI6lsDH8PvUNXV2huXKaERiVolUufl+YA457YrVtLNXBVppEbkqFj3E+30rAs7hpozHIQZSdq46HHYVvWnnxohglZWdSpBbGc+9XaPVDjJFi0eRAThcnMZQnDL7jPQ59e1XbVgI/3ybmU4ZBwME8/Q5waoGV5JnnupC1wFCOW+8VAwMetagKzyK6sqmRAchsZHcfpxSSvsWW4ppIXQl8ofmDuPwYHHrV21uSoMAj87YdoAGR7DnqKyYJnVmQ/I/TDjgj3Hof51ctWQrGUUhSvzjup3EZpJiZq2+777KPmy2WYY/KopEHmMgDI6DBXORlu2O3rTELzN90ErguvQv7g+o4pkivyzyF8scnP3uec+9DQkMuD5kZBBUr8+B1YdDj9KfZBlmSTeUd8FsdAf7v1qtKrAseNoOXGen0NSRumwrIm+OQYVS5Ut78dcdRQje2hLeWtpOxCqqXDYJTzRlv6g96hjsfKuI1hkaeRfurIDkYyAM9M8nrTZZLaBTC10GQ8tFMNzn09waJI5nA8xpLa3RQwWRuQM87j6dgKrQeqVmySSSRpdyxny0Xy0ySyxD1Pfdnk+1SOWFu0X2iKS5lAVWVcEk/eY56KvXntUdtuWO28ktbQBX2iBQZAnZmz378DOKiZDJdSfZoGliCBXmlbIPzDLMcHOTwAO1O5JLcyWyiJLZZJTChjEkLCPAGPmLnj14561HfJKkgNx5c83liZlA+RIVPQ+re/cVI7XRm+1ARXPkN5a7MLDGf72PQHv6iobd5IPKuRHCxZTJGp+42W2gL64PIHoalu4LQivoC9wtwFksppBvEkbB4pV69uR1ABpIQohMEsUYnhDB1Y8gY4Ix94f/rqZz9hgmgE/myzIoLMNuxgfmQgdF9OwouQksKkwNGYsL9pd9iIOm0nupz25pW1Lvdalm3ESRwyRXrREfKiPGWkA7puX7w+tTz28saKJdzrjcIVH+sY/xM3pjACjp3rKsXkguP3kbeZACDu58ojj5cdR7jnFapkjkxKXjkWNlZtvAOeQMjqO/FaRdzGSszF1JWDbXYEqBvKjgk/5x+FZc5/d4JySoxk8gdq19QCAEAnDYIAXG36+9ZU6gE5wSnvk9KymjaDsiCJ/mYSbmOOrd/rUqylyFB+bGN3f6VERsAIIxyOelM8zgAk8c1mlYqTuTcqcdQeqg85pkqhFTaDwcn1pyqGwCcMTj1zimFVD5JOc4IrWBgxxkVlKhcdyM96zyoSbJwcnP1q+4XbuUnnjnvVJh/pA5PHQ17OBl71vI83GK8bmlbKCudvA96lmdQdq4xmqiSNhQOCB0pQ2GDr96vQseYSOQFIJ5xxVZVLEnHHr71IN20FulKCQSACR1HNO9gHswVRjIc/pTV+9uI9OKbIQm4kc460RMZGyRjFCAlB3kjBA5pZdqpt7kCq883lkBByRj2qFZWzuJHpii1xXLDyKkeMgr1x2p1zKjwB8cqPu1AZUeEErhzTJFAeIL7DnpXz/ADH0A941eNADhW5Jz0pZHMcWVwy9M4/Smyx4mRVfg9qmvD5USx/Lz261L6gyXLPgMAMjoarQotsGZThl61Hc3DKwChskVHcLNJCJCV2k4x3pOXUdyxJMoLBYzlucikit3aEysCyKfyqWCNIossfmbg06W4ENqUGcE5IpNX1kDVwilaAb1xjPQiqvy3DFCxGSTx2p5je4UukhUdl9aeiLFAd68k4J9qz39CbEUEDpECoEinjk8/lUhikiiYwoXh4PK8qaeU3bBBKoUDOKkt0uyzKzOUPZTStZ2Q+pmLfTJKRChXceQx4rUthcuhF3Nvi/u4HBqK43i4XfDvK8FDSxsplYrvVjxsznA9KIt7N3G2aX2GA2oMW5ZMZOT8uazm1GOzkIMLqw67RkVbtPLMpLyk7eApPWlvLmHyVUEKN3IHcVdnutCDClv7pyTbo32ZhgMDz9MVnapPcNCZvJZlTDFccECtm+ht55NkAlUcnEZ74rm74anaTRR37Ktrn5guMsO1LVaMiRW0A+dfyzujJGxzHFnJA7n2rrrWDfKkcEoVmI2lzwCa87gnK64FsJREOcxs3ysDXaaVehoo1kBEyHDDPQf570RStZihI2leRZFN1H+64y/wB5Q2e9WooFkaYCMBAxOeRtPUHHYGrFsibXIxLG67mDDv7+oqNo1jljltpXJYhDG5+XHoT+lEo23N1IsxvmNC7NgDaPMXjHbn0qV40CLNECOTlFP8OOWqC1leKPyLhHVXyED9MexPf3qxNst1gWNnDj/VsTlCD1B7iptdXGiSzYiePErE/K65PJUenoasrKoVWVmf5j8oxgnPWs8+ZCVLQNFGDtD7s49vepYmEzzbSW4GAB94A4yPwpJlWHXD+TG7oC0ag7snoTjI9we1PhhmdS1m487G0wSA7SD2Rv4T+lQ3G51CEZ24cKwwD2/lRanEnMhjYrn5s4x6UdTVbaE9nMxkK2NnGs4PzW86bHz3AfofXmo5by1S5llvbiQmIYhiEeAX9cnhiDxnpUH9pSXEiQ2iGdwcLuTGGHcHr2qxAUW5aS8aHzlxGEeTcyKQc/u8bRk/xU077FONt/+CIMyXCjUnNnGFyYocuxJ+8Cw6HufbgVJBd2iSqscht33HBhDc5H3SO5PU5xjtTYZ4VtTBa/aCrkeYyIckE8lf0HtU8kl3cRsqRRwCNduXOXGRjG0feBHrVEtdDL8xFtWgCrOdpYokpg2MT8yvu4C4wamFpmQrPPb3d64MszCQIqBcfu1PTkdwK0JohDEDeOvmIoBeaHKkDoB2HHHP1rKW6R2d4bOK4aQk+W4GyJQMIWIGN3U4Haly23GrvVf1/X/Dlx5Y4UVbWzFrFvDgeXk7R2OeSPaqrP5UhltVkmiVSPs8oaQ24b1B4YHP4dKeY2lu7aWa5hO8byLdjKAi/7Z689qluL8Sxb5riOVAxZInkIlb13AdvahoNrGbZ7zO81izxvEcnEf3U7MPTHIxzxitOCTy7cTtfKiEgCO3UFn5ySCeATnPFUGmEbu2GguBICHYnAB6A9sY6Go4LlhLK0YjRk++MZWNm6n2B9B+FEdCpRuX7uaOVneJ3Ea/MGkOWI7D059KwpJF8tto+UdR689KuTOZwgSYIhJPmOclzjqF69OMdMVRmIZSGw2eARwT+FOWpCViusm85PQevpTVcBiScMOMetRthHbBAJ7elQiRFJL4LE4GOlY2LLxO3g5xjqDyDUz4aIMxBz7dPrUSPujDbcDkY689805EO4FyCCMfjWqRjJEbPhSy8AnHPQGqrEqeOVPJPcVbuEHzcEAj5veqUzlMR546g16WC0qI4cUrwZowgBAB2P51JHCXYHp36VDaEbF35x7095N3yrXrHkEzAEEIMcYNSCJIwDxjHSq4k8tCoPORkjvUqyblLMM98VLQEU6B2Jz8vpTGBUEdR2qSZhn5eAcZFIFVVy3fNNAVJBwS3HHGabFE0zZA4PP1qaaMuMnp6ClLmM7V4J71V+wiCUp5OCMMD2pz5liTBwwOarJuZHD4GPWrlv8lsWIB44r5tO59CyHLq43LknvTZI3uJyCdpA71K0mYVPcU2aXzZBt4bFJpbCtYZ9meN9wl346kciprif5QpTA4ziktTklX4JP50TTBRLEQCex7inayGlclOx7cscl88GnNbpLEZGky/TBqoExbgrkk88VNaB5I3ycAHP1rNu7sxCCZt6rEoJHQU64ikIDsxjycbaTyxFOSDwB19KS/1BXVYxhtvep6e8wS1JkQRzKrLwOvPWrltOEd3RwCvRT3rGLyTOFIIGKuW9sPKbe7ZbhR6Gjmf2QtY0YJplkZ8BmfqxGc1au7QXMKS5jhcfxA8mqMKlEVFmQP6GpmjumXzAgIQ8lTmmnpZgU7zTg3mPJdtxwCnGax2s7loyQZDGOFfoCa2ZpMOCx+XuMU5r9MDL8jGFA4qeWLJucvdanc6eGjeMiQDgAdfWuZ1vxM6WMqSW7Ts/LKf88V3ty63rs0hQN9wcfrWRd2sdlFILVY2eTIJZQTT5Z9JaGU5aHlekyJNfveGBrcyZCJv6Yr0XTLy1eNWdMyEbAQcHJryH4i6pfaHOqy2xjld90ci/cP8An0qz8Ldemvmnm1CQSzBtiJ0CqAM496qKsrEq9uY+hNNlfy9zuSEJwvUgev0rVKxmaQAFgRuLA9M9CK5bSroARSKfmOARnPHaupWQKsJj2jaSM9fcZq7XRadySJpJ42GQdnzBWAbPbHtShEaJF+eMlipUjCY7E+4P506SJZo/MtGjDMB50ZOMkc59h7daeky3CFZnYM4z16N/XoKiS7m6YyBd22ADEn30Ld2z0z6EcUiSF5WADf63kZO4H6j/ADxTkYSRAMxEi9MDnPcD/CgjN28se3zFb/Vt/GOxB9agpMdLteOR3ZiFY7SPvAf/AKqhjc+a6SKHXP3epz2IpUZZIlYHAUf98jP8qgSbazTAEsxO1Qfw5+nWk1sbQ2LbTxCZWPzMAQbdSY935cnB/CmSy+ddRQxYvbgL8yImXIHbP8I+p6VJFGsZAVmkdsGQg48zPv1wPyp8LW4aa3s3vBMxH7m12qCR3Zjxj60ytFqkBneGbaLGSC6H+qPmmQMozkH+HaOv4VUnmtYtkeoTtJLG5eUwsCFUj+BuycggVPcW1p5bRTm7luXUMYnYqpJ5OQBk49O9V0DRpJFpVlDCkACsPIHmHPOcE8MOoqtSopEEarO2THcJCgVpZ5d8rhc4HyngA+uKnS9hjuLgxi5V0n22Nvbk7gccsBggk56mluXube3cFZEtGO5pPtiB5SScZYc49qisxcTxx22nE2kca7bi6Rzsc9z7/h1pLRlWTV3+Y1I40mlilDxTY+a3iAkMhzkK+3v3OOnSrZ1Ceyt2eO4tbTkkq8XlsSPUDOT6ZrOgIt0aC2FxLOzmQGMqOOm71UDGearLCUWKSea0DbQ0e+Yndz6gUX7DcVLccRd3KKsO9bdVMYkRifM5ztJ6EDPXtTrf7UsUaxz2kcUh3Y+2Lkk9Cw6/hVab7bdELHc5thkLIrlI8d2A64PTpzQ1lHHAjSOsVwG2lZI8tIOucA9alXvcqSVi28Lw+YLi4sIZi2JGJLlVHQcdcn8ahnliiGyCSV5mHMzpsIHbaO2ahKRwkb5huLYV9oZI/X5Opb0NNMfmIHZpBGSSZ5V5fjoPU/pVXMWilIcKVQLwTyc1BHKFO5cjGf8AgVSTMS/yOcnjn+RqsyjymLHjqM+uay6lLY1rNituXcnIGScdM96nWVTBkY44/Gsy3IUZIJyMHJ6CrqtGqqMEA9icgV0RMZEjYZSV5x6njPrVCcFpYyWG0H7vr9asOSzEHI28gGql1lnj2Y5b06V24V2nE4sQvdZoxnzDgZx3FSkKM8ZyOo7VFAwGOmcVIh+bc2MeleyeKCxlmZnJwOPxoWbI2gdO46UNIPmCHgnpjkVEQEDEHOe9MRMCpHvnpQnz89QO1Mji3sHc4OalLdFTrjGfWkMV3DnanQVFsKuG5XOeo5qRQIwSPvZ5HrUahnJ3E47c9KAILtUEbbjhiecc5qAyqkOPMJI7Zqe9kDRhTgEVHaxo6uXX5wOK+alq9D6F6ixo88Oc7e9LCgyBI3XoRTC6pAACQ+elWIBuiyfvZyCKa1YuovlRlgikq4PJzVdAoM/mKWYDAPepCX80OecDrU9okU0ZMzEZ96rcEyGGdkjUEAg/nT4nURsXbaCDyKhnhjik/duTjvVdg0qEseBWTbQ1qW9zzRYjydo5PanxQRADem4nkn0qOBvJgK+vWl2yEq2AYzRbuDJJY9r5g+YfyqaOZptsbrgLyT61WAG4lDknrzV22fyv9chPHFMTY5UiaQ4yhHrzU8SSLIwSVcdwp6/WmIerIqH0J60yaZljG6LHuO9K1iGSXBnClX24HbNY11IjPtChW9RT7iR9hKt+fasq4lkjUlWX3FSyXcWZjHIxjkDYGcGuYuPEsIuiksmDHwTngmti5ncRlMId3VvSua8QPZHTHhljQtySQMfrVqL6GMjk/GN1Z+K45rWO4RvK53gZ2GvLbS9m8PavJ9nl3hGByvGcdK3vECxaZbmXTJhbO/3kH8ea4l3Z3LMck960kuVa7lU1ZabH0p4D8RjVLC3lnMW6X+KLgK3pz3r07Sr1nt9hwXTOf6ivjfwv4hutCuw0OJLd2G+F2wrH1z2PvX0T4Y15BMqMUUkg5jYumccbT3HvST6h8LPWYZPMtGeHLRAqzFeoHbPuPWrcqG5KSYxK5+bAADn1Pp71y+j3y+YN5K5ORz09ciukgdjEWTayxg8ZwSp/nik0mjRMW+aeK43TxeSyn5SOVBPr6VHLP5dxIUBUEgrjouRVn7SBHu+scgzncp6bvUCqmoRKI0e3yE3MPLEmdoA/lWbTWqNEyD7R5ZJAKvGTuUDAI7Ej09RVWKQjC4GDwAOmP6U25eRipkAckbTnn6VGQVbPOMZweazbOmDRrwF7lo45TIkZBU7OC2OwNXY1jij2WhESqfnKkL9ck96wIJMzguW2KOeeT7VpxrE8kcl5sm/iSEDKR+m4fxGqi7lkEKy3m5RdxW1oGw0zMRsA/uHqzH8qksrg7DFpdmHOSwUHKogHLu3qTzyc9ulJf3UdyUtodnzAmR2QZjQcHaTxkjgYqMCfU18pY5JdMiJJCKI45dvHzNwAB3Y5PansaPa7IWjaZlurhkuArEtIQPLLeiD0/wBrpS3VzqGp3IgEyqjNhUTiNR6/QCrklt5kUElxLG5m5AjyGUe56KoGPw+tV0gs/s7SOszCX5khdyQ6Dpn2J560coKS3sVL6eLyDZWLKsGdpdOPM7EsepB/Kor9Y4ZCZnV4ZzjbGMRsvfGec8fhWpFGFntwjF05dRAmXb/Zx0AB/DihVgt5Cw+e5+d3mkXKqF6IPqf4hRa41K2xlQ2Ny8JniAKH94YyCHVc4G5u/sKjlhitYpX1AtDcHBEYuVLBCOhzn2+lSTXZnaSS6ubksoxtEvA44+bvz27Vdt7S6jhE9pZxW+4gILtBK87dygIyPfPBqbLoVJtbmNbeYUVrG28/IwZBGzyevGeAP92phDcSQfa5RhC3lhpn/eN6hR1wPU4FXLm6uXuN91PMzofLELERN/3yvAXtgVBeWuGMt0ITcyEMFVm37T2z2HtTSM5a7lG6Cxsy7kCdsDd+B96gKopI8vdtAIJH8X9auzWskLRlmk3FT8pALZ7fh9earyxOUw5C47A8j0wKDNuxHBwz4BYkdv8APWtAxtGixsxyeHA5Gf60y1jP2iNVwYwdzEDGfQfjVmbAMpbavOcZ6egrWK0Mmym6qznyycA9fWqty2BgDIU54qYqWkLKSq9T6k+1QTDbEyqRx69a6KDs0zlrq6JraXPJBzWhGpkVCBzjtWHAxZsDp1rftpgiBejdjX0FRWPEa1CVNjDHc9+9MSP+I5K+lSu24Fj1wePWoTJuO1RwOtQriJTjgDlc8UoXYDnGSOtLGQidM9jmnquRlvu8UhkZQyEueD79/aq4YLgZ5x0q3KSRhOvXPeojGADn7+OKaAJYY5WO8YJ4FQRxtHG4xwelWHQh8lufTFLFuEbcZ7V82+59EzLKhw+5cY/lThI0MSnkipzEzRu3AAphk/cFcA96hIiwkcwllAbgY5pI/vlAflB5/pTLSOJ5P3pKj1zTGyJ2SBiVbpmq6agi3GiScHoDjr2pLi03wFoGAVecGmWiEFllyP61ZEqiCQIOv60t1qF2VreLCBpMsTWisibfLZcrjt2qgvzL8p49Ksw3Cr97GacdBXGPboNxTII7Zp8dwgj2TEtjgeopHlWQ/L1z1pQ6IQdgbHUU/QLiM/yFhyvZh2qq9z5ihBI3B5BPSpjdwJlkjxnsapXFws5wIQG9aTS7iZBc3BwwGSB3rn76+XIOeRz1raubA873KqRkgHmsXULS1gRzy575FRyyM22c3rniOGytnkZySBnHpXkfiLxLqWpBkRHihPX3FejeIba0YsWRdqAkD1IryvXr5Jpn2nbg4GBjHt710UodWFOz3MS4mmmbMzMccDNQVO7GT5V6D9ab5LlN2OKmUXJ6altdiKuh8KeJbrQ7+J1YvB91oy2BgntWARjg9abWabRJ9TeFdY86AbZRJOGPzbwQ49j3GK9C0q/a4iDo6shOW/Cvj/wRqZs9TjjuL24gsicuIxk57Y/u+5r6M0DUpDGhVo/K25wGz+XrVpNehPw6HqMcgmISUrsUcMi4bH9aZcARxAeZnDZWRehyKxbC5PGCpGCQWPX1FaEE24Fm+ZGUjGcihq5omV7tV8vemY5AcjBwCfpUErYZlJ+YDkbcYPWrVxGuSsUe6MkDczH5fr/jWc8ErHIlR2UY5O09eh9qxasbQY4TLG+7dgHng1PDcFDkfMx6IhyST2rNu98cZSRMbMgjGQfYGoorgRkFRubIwR2IrO9mdcFdXOl06RLVSWKfaWY7wU3MPRVzwB/tHmrGo3TLYCISJ5bBYlgjHT/ZAPf1PesJbgSRhUA3YwcnJ+tW7WUSTh5SZVhGE6fM5H8gK2i76Iaim7myIoriS4nuF88JiERrlIye4Y9cDjOOpyKLiSH7WI8NLHHmWV2ACkAZCovRVBxz7VUF0rKo3MFQDhzjJ7k/X0qaxfzA09x92X5ApwF8sHOce5HersugnHqWbGO4mE8u9hdOvzlsL5KkZ2nPA4x05yaqrbxXAlKXM/2fyjskU7Vds4JGf+WY/vd6vWINzJciFgI2cSMJOYxwPmbue/tUGlvbXdzdXpkctFlYmlwH2A4LjsBnovpSaWxLurksdk8QgVYLXzgqxxqiZ2LjliTx+JqeGywGuVvdQLsNrSDABOcBQMEgZ702C7USZiAZHkLKWzk9c7ifXk1O10La3Y+X5ZDqPlUsU9frTViJcxlyxwSzskaAOhYIJjvMpJxnJ6Ae1U7y0+yzJJBNh2yxkfLlccHBz1z0PUVsXDiSMMvysDkM428t2A+mM1i6grnJ8136bh06UpWKuZE2WkaRlyZOWYtksPU+hpmPMA2gDoOemPrTpFJ5yME5PvTUVpZfLjbaCPmyOAKzWrJm0XiIxaqi7zklyc9W9eO1J9lRIN8zFnPzbT0FS28UcSmeVlYLwE7M3+ApzxtcN8oJBBwx6ADrW2hk2UNpPCklTzlhyazdRDiJ/KXnvnit4xZCsWJ4x9BWXqrbYjtOfTPf2ranujnrPQo2rBcAjtzitSA5wxzjPesO2bD7m69cVr2rtIoAB2544r6SpGx4sty6oL/L6d84o2quf72eaUFYojnr6ioCxL/PxxWAidD8rE4zjpQ8pLBV9s8UyPMhG0HPQ81KFERPcg0bCFZduCMnI5pyR+a2TnA6GmxqNpY9MYp/mKvyxjgn8qGMZcI3mlsnjrjvUasfK3A4B9Ktu6FwpHXqahu7dVQtG3vXzLWjPon2IpU/0fAYj1AqgElZD5a8A8n1q0rZUk/gKfFITEypx2xS3FbQoRxlwM8DPOasjZ5waMAHHemKjYOcEZzmpJVRgm3hu9NbElmzdHDblyfWm28CfaGL8Kc59Kgt1KSkIRnqamfKSfMcD1FXe9ribEeIpIxiGVB7d6qzBS/dSfwzSyTOJDtbj3pfNSXb5g4+lJNMm4zDAnDA/Sm75Q5U45qOeHa2Yn4/z+tQs7bsqcN0JpbEtkk0rAgFRx04qAySsSUU/hUn2gKFYks3tUVzeFVxkAdwKrlFcrvI4Vt55A6k9K5vWbwRowZ+nYdal1fVCgbDjkelee+JdUdRIzkCTBwAcUlq7InfRGR4y1nEbRxOAB1H96vOHZppM8kk1c1a9a6nPzbgOM0aRbGacHnA9K1tdqC+Zqkloa+iaI1wqsyqQeBz39xW/c+H0SMeWvI4IArb0G3FuiM/THTGPpWpdBGQ7cdOQeta89tjCdRt6HkWs2LRSEhAAO44zWPXd+JYl8p2DDOf/wBVcPKu1jn1rKsrpSNU+ZXHW8phlDqAcdQehr1fwF4gBgSIGRVHqflI78noa8irT0S8+zXaCSRkgJBYj/Copu/usTV1Y+ptBv02xAHeJOU5zn/Cuss5XYBxuJ/i46V4p4T19ZZTslCxcHbGMAn0FemaZqilUy46Y57jsae2jJjJnXQMynK7iTkHJzkU2eB5LrNrCu2VgBltoBx3JqvaOksYZxgkfKFOF/L1q8JkkIG3jGCOxqXG5tGRmSRXAy8BUFcsULA57Ee/0rJMJeZQWJXk4Qcg/jXRvbwkkeXK6kna6ybdo68+9VHsXllXypkVlBI8zgk/3SR6+tYzj3N4VGjPtyqghRxyMnjP1qa2lCMSWJIPGBj8R60PZywPtvENt6hwRk/XpSyQllJVoUAOQgGN30qFfobxmTz3KtGFR03H9CetTwTjcWxnYAF3HOMdqyIjIJmjAkeUjDKFyQPTFTxiaPPmxNnOfukYPvT9oa3sjamcTOQHBRgFdWHBGP5UsZSLDL5coPOGHGc9hVa1VpYZGjQsgPzMMBFzVyK2l8zbbLJM+BtZAADntjP/ANehybM3IufaixzKoAyDsxgcdM1Ot6qSEmNZAuSA/T2yO+KynRwB5m9c4xkHnmmqolJxk4yMFtqj6k0c7IdmXpbpZpJJJGBJwQR0HsazbuUnIXOCMs3t61IkLOR8ykAZIwcewz3NSvarAivJFmVjubcf9WOynsSetHvMhtJmJgNJtUZGc8ZPH1qa3gYL+6jfDcF843f/AKulazuyQrbywhWyZZGOAWY9B+Ap1qn3WmbMUHzINuRLIeefYf0q4xSIlK4j2LQzRC4hb93gCMn5RTjJtWRwgRZMohI4AzyRUlyzXU8j+Yyx/ekcDof7oqrMoLKHOABwi9Ku9noQ2VJJQWwuPT61m36BUctzkce1ackKAtsAXucVm6hgqwGBx0ranfqYVNjFjBdwO4AHFa9owRRt+8M1lROFACjmtK0JWPJb5j04r6aT5opnkTWppgAQncfTIqncktuxjGc+mKcJzITxgU9sbRt6HjFZLR6kEkLiNMZBPAH0qRgWGXOce3WoIowgBfoTzSu4dtoyB7elJoCQSF2CA8DvTiQi/IOc+tRKyoxT+LOcipoiMFm69cmkxjJtwwQenWpI5leEoepqJRvQjdwP50yFgjEEcj3r5i+p9I0PYZTBGM96gjIR2GBVmORdrBsflSCIbhjrRa+qERxyBWIZetVZWO/GMCr09lKwD4B9R0qC6VlZfkwRTd7WIaIQGT51cgE9vepJyGQMSc59aUqShOATmo5xmPGQPanbQhoRpY8rhenWo2ZOSh2giqcrFT9OKBJk4AyevzUr6kPQS4dhnLnIFVFdwdykk/pU0gwp8zBz0A7VEH+QgL9MGhbkkUzyAbt2B6VmXJeUhizcVs8EHzBkD3rN1C7jiRsACr5bks5jVitspZiD/PNeReMNbN1cNDCflU7eD2rp/iF4i8stDC37xv4gcjFeXMxZiT1NP4F5lQXUACTgd63tIhbC+WAx6/T3rO021M86ggYz64r0fSdMQRL8g3LgZ71pT/dq73ZblyLUk0+9IhVXBUdeR+tVNb12G3icBm37ThfXPQ1eutPkBcpwMfl6msW90B752eWQ5yBgDGaI2b1M48l7s4zUtSlvpdzEgYAxmqDMW6mt7WdDNixKtuXt6/jWERg4PWoqqa+I06aDaKKKxEdD4Q1JrXU0SQko4wPUHtivaPD9w7Hzbqd8/wAMfqD6+tfPMbtG4ZCVYHII7V2+geJ9SuzFZ2yKbwfck7ceorVPmWu4mr6n0dp98hVWMjBcevWuht7yJ40Z13spHJOM/lXlHh1r6CCI3ey5ibq6uFcH1xXc2EyYVRKXcngkgc9/pSUmEWdlE0ToVZfKTOdrEkgHr+XWmS2bQlfMJeNj8sqEFWHbp0PtVTT75hG8JOOclWGea1UvtuwRLFu2+W8RXCsPUjv9aUrbmiZC+9So8kyQ7SfLm+ZT+B71Rn0yKQSSxpNbwAZKEBtrdOccha1xax+WGZTuDZ2h+3+yf85okVQyNa3DFzxh0zn1J9R7VnLXc1jIwY4Yoh5bEtjO0wZBJ9Tnr9DUxjmgVWmeR0J5KP8AI6nt7HPWto6epUC2lIuAu1+Pkfnnn+EimJDlWS5aNnGT5ZXbvwO5HWpszTmM5JUmljXymxHw23AOP7uOmKvL1UTNGsBJwQpAI9CaDYxLboIJ0jQZJVx8uR3BHIyDT7Zblox+7ZowASI2HHYEk9BzRd9RNltJkuVRWZvJB+5GMce2e3vUhUvCqiJJUBwA6Dj0Ge5qKQNJJuezkjYfI0iEfMe3Xg0s6XtvCZQFHAAbdtZc8dKq/Vme4wQWVujYSN5kILEMQQT2H0qs8VurrJdrsOC2wHLIB0J9ycYqSKzuA4e4MUaRtlYnOVPvx15oupI44nkGZ7iRuC4yxOOuOw9BS+Qyj9iku5izM6Bufn5b3J9qu3xWCCNYwwjAwuB95u5q3bmdGeWaMG5kUJ8p4VcfzNUQWln8uU4RW3SccRr3Oe1ONkJu5OVMUQQcAqGk3DPzGq1wkY3lRlieKjnuHmkYocLu+QDpyetMcfM0jMVIOMU+a+xMirdYhQqh3ueayZkJOWGcite4J3YwAD0NUZ0y2OvHBHpW8GYz2MB02Tsf4QenvV+2RnUDICjqaiuk/fleinp9auW7rsAQAjGK+goVOakjy6ytIR+GCA854IqxAPl3P1PT3pqxiMBmAPJoVXY99vY1bdzEnLeY21RgdageQAkLz61NKdown3v0xSJGAm9x8+M4AqVoBBHhSWc5BNTCXfGPQVBJ8x+UZFIZdibRyKq1wNCODBIBxVOSPE+0cD1q/k7s9DVG5LfaA2BjNfKS0PpUTRW5Dj0NTyEIQMdKljcfKxovI0kwykbj0Oau2mhDY0XBJU559+gFV7+UMoHGRUckDr8wJ96aYGdRluelTzS2ERB7gKVVcjtTEjkPLcD0q4DJGwUHPPpRKsh6lfwFUncTMa+GORyO9U95HGMZ4ya2ngLqzN29KzJYNqtyfx7UrPciSZHGNzncTz070YSMk8e9QCURx/Kct0+tUrq6KrndkkdMcmqVjKWhNdzBY25xgV53408RRadC5Z8uRtUKec1L4s8QyW1q7KGIA6Z5NeK6pf3GpXRkuGyT0HYVXmTGLlq9iLULuW+unmmYszHvTYISwzirdnYs4DMrE54x6+ldHoWgtcTqzqdoIJXHX2NbRpW9+ZtdR1ZF4d02Qyo5RuCc5X29a9AtomSJTyeMj3PvSWGnLaoOvQ8+ntVxzsjH90dwOaiT5mYTnzO5XllIA7buhrF1DUY4CSxAHX2FQ69q32ZWBxxwT3+lcBqmrz3bEbsL6DtTSUVzSHGF9WWdf1b7W5RGJA468VhUGkrGc3NmoUUUVAC13Xw0ltzcS25AW5z5ise4HpXCVPZ3ElrcxzQsVdGBBFXTlysTV1Y+kNNCzqOQJCOFPG4eoNbSLKNs4Zd468Y3gf1FcR4O1NL6zjFxKuCdyvnlT3/Cu502ZpGeExrcoV/iOAR2IPtTktbGcdNGbkdzcRkJLEyOB8okGQQe4I7V0Ol5CeZw5I656n0rmrJFgjkjjDFWbLKzZP8A+qt3TJArAkAkYBX1+lZ2d9TZM6G3yxAEkAOMgOOT9BU88JCxGORDK7fMByG56n0qhshkXzIblht6oR831HqKuWdnI8pCSedtIPls4A6dj3pPsaxfUY/2yJWURtuBK7eDn2/WhIA8DfaHkWZejbCeR0Xjt71atYZi7LLbNMoJQiNx8p9veqryXNpcMFkkMWeQykA/73vUbbmid9BLeN4WyVMlux4C/MwPcYqX7UhbrgoMgFeW9M5p1vclYSXSaIlg/mdtw/Xmrs9zbzIskohIYk72XAB7+9WlpoxPczrgmNGMBXbjmMc/98+n0pLQ3E0yGaBnjXPyGXjI7tnv7VNOLVNsklvGmBhEVvyJNV5XgaUtEAZWwCpHBHqT2PvUvRh0Lk32i4yv7sYJOC42r61DbxEojyuBvbYmF9D973FQr5JAEyzzHqyIuMn0+n061NCU3M7Ehv4UQH7x9WPp6UXuydiS5YvLKI3Tk9gcAevsKghtVRMfJNJcY+Q/XjP86SWQTOsQc+WpJcov59O/apJmWFjIYwjHiGEdUHq3vjtT9RFIkI7J8uU4DDqe2RUk4jRFTjeBluO9NtE4YyALEz7WbHPTPFNkUSTBUPuSeePeqitCHcpFFZGLAAsQR7Cq0qYQsTnNaMyhpCo2gL8xA6HFZ0zZbHY1tFEtXRjX4CEMM8cVJaERoB3yOvenX6BomB4OaqQnLKSeB3r2MC7wcTzcQramvGpm/HrUmMAqvI4BFVYZS4AHB9R3q0H2E5+8SMiup9jlFYBFJJyMcGoWZi2SPan7jITv+7zx/Wo5T8pQDIHUj1oQDGk3NhB82elCwnlj1HbtTV+TBzz2qwpM3U4wRzTbsG5aRmJAI7cZ6VFeR8BvQ5qKGU8c89qtOd8BJHavltGj6TYVCGhC9/pUQY7iG+tLYlmJBHT2qYr++IPT+VC11IbK6Hhh+hpseSSSMAGpp0CPgHrx9KgVymQRS66kjnJJwOx9adDA8oyWIAyaiMxGDwD7Cm/aHB25IB9ad1uxDp7dsEbuPSs+eAA/MR+dW2ldnyxyKrTqHGc01rsPczJLeMHv6ZNZupiFYSCcnHJq7dliMjAxxXM61dlYz82OPxzVrRGU9DhPG0kaxSdG7cDt6VxuiaA95J5s6lEBztI7Vvap5ur6sFQ4RTg/UH+VdCLddP0/5mGQvORmuim7IhzcI2W5za6YJLs28cY2HAIx+td9o2krbW4O3PGfesfw3bLJOZnx689vauymuI4LbPAHTmlJ3MZPoYV8ViYkNwOa5fXdcitomBY+ox1PtVHxZ4pSOaaKA5bsR0rzu9vJbuVpJWJJOetTpDWRrCHVljVtUlv5WLnC54A9KzaKKwlJyd2ahRRRUgFFFFABS0lFAHXeAta+w3620w3QycAehr3rR7xmixG4wccAflXy3E7RyK6nDA5yK9r8A659qsIs7Q6rtYLnrWl7q5Ml1PWbSUXC5Z9ko4DA9CPWrtrJ0VVIfPzZOMGuesWN0N8h2rnkA4LehrdsnVAqvwrchhUPUEdNp5O1cgSOOhraheKUoWUxyseiEAN7/WuctpED/N8wb+JDgn6Vq2kRdkzLgAZG4csT/D7UttjWJoySRFxgyCRQACCFPvkipXiDW0oeaXceeDkjHfnqKr28aIGSSSSGUkKVZQePx60rW6+egSV2Ucg4BCj0Pv61JomRfaLi2kEZ/esB8pjbKuMfl09aTzIJnV38uRmBbBHyg+g9alBuFjceRHImSCyjOR6EetVmt7eZSUD2x3AjHQjtx61LbL3JzlBvgiAUj5sqMg+2e1Sm5EcRO396w4QD7gB7/WqawzCcrEr3O0gqwQqB9c0KlztaV7aZ1HdWygX3pc9gsSvPLclS37tV+QMcj8sdaSVxGvkJPLIn3sLxn2altriWOUPIXjPVSRkjPce3pVlruCTawVmCZLsw+Zz6HHAz+lC11E1ZiW0sNuuXCgKMlY/4vqaoXOoRuzeXGURWJC9SfatG3mluWJjSNI1G1ScfmfpUCIGuBbJ87ySYZhj5h3b24q9bWJ23KbI/kRxHiJcyfdwzFqegKwMVUKHOASew/wDr1OXDPsTEkhyOO2e5PfGKq3z7C2w7o17nr/nNNWRLRTmZgcfLkiqj8FSOvv61ZuAUQySMA7cgDsKrSrwsh7jI56VrBk2Kky5UrwfasfDBymO9bUigAck46jvWZdL5chYZ9RXp4GfLUt3OLExumT237uM5PXkGp0yX3ScA9KzkeXORtMeBhQMEH696vksUAHr+Veq0ecDyuX+UcgU6NjGDu656UOAEGe46j1pFQsw3d+frU6AKELDJ5FSj5flXoehoLFuFHTGe1OZljBxyc9Khu4IiZSrnrVrzMREegwaY0kb22APmx0FMtypGG5HQ18ttofSNEttOUbB796bJMVc4P1wajZlEnyHv0qOUFjnkYoTdiLE7sWAbOQeeajkY7s8AUiHK4z0ph5JBzn1qrCsI5LMPSlDAnk+/XpUEm7G0cVCQcHqaBFx3Qd+etVrh8k7CADxx61C7HBFVbiRtvB6e+DiqTJZS1CTYsjZwOgJ6GvNfEl+0peGJiWYFQ3pXZa/dmK2bIwSK8za6RryWQ9MndkY5z/KtErmUma+iaelrbh2GeMDcc5H+NY3ivWUMogjk24POOfw+tJr3iZLS0aGIr5oGAAK87mvGkuHlOWLNnBrfSPxChDmfNI9TttZg0zTQ0jbT0wTzXL+IfHFxdo0VoTGvI3d65C5u5bg/vGJHvVasp1UtIjVNLzHu7OxLEk+9MoorBu+5YUUUUgCiiigAooooAKKKKAFrqfA2sjTL7bKWKMRhQe/sK5WtLw9dJZ6zazSqrIrjO7tnjP4VUHqB9FaLfSXaRkwnBXkngfX611FosibfNbdDnHH+eDXKaHdK0CbMAYBBAzmuwtnBj8xHbDgb16kHsRSsRE2LGaOLHQxn8xWvbzFWL87e3p9awIkDENLhlJ6gc/jWpa28eQbdlRz/AMs2PysfY9vxqXc0T0OjtbsTqFuB5karyCc/gPSrDxosaPbyyJE/VD8wRvQDqaxon2SlXVreVRlgOc++O9XkmNsyzOhdW6So3U+w7UXvuaIsRs1rMrCXPGSRx+HtUg1BmZhCz+YeHkf5gB2/H6UxJLaSLe7KpGQEPzHp69/pUhkgeIfZz5JC5KK3QDvSSZa13EiE5DJarMdzZyQQB/hTPsZEbSv84JOQGwDjnn1p08s4mZVuBdAxbn52kJ6fWmDVNr7ZEkiGSQqkenI+lLTqNXewjTRJPE8aGSHBEinq2amcmVhEmGjwPvDkjP3Qf61VlKzqDbFFJ+Vj2H+JqsxlTyx5TYByGc4BPfn+lTzJbl8tyw7Swv8AKdgAKqinPHp9KgtoHZnkVcPJ8ySbsbVzgn8adjzNvm3ETt1KpwAfQk/yrWYweUqKExtHLN0PpgdOaa94h6GdIFtogsaMASCztwCR1/CqE/76fcVIQHoO/t9K0J1a4kkSZwiRnB2jOW9KivfKGOSGdAT6ZxyMU2SZT/NPtyMAHPHQ+lVZss/YfyzWgigzSc7fl43HrVKXI3Bj74Ht6VrAkquOTwOeTiqd2mcPkehq8zLwBkFutV51DIe/tXVSlySTOerC6KMBJJAAwParuRGpAOSc/nVVWCBioO4mnxsA4343cmvf+JXR5ElZ2JVB6/w5p43MQATjPWljYSuoH4irRCopK4JP6VLYiLIQEHrxUDJuJO7H+FPYYYs4ypIoLBsqvA5ANLYCCGQA4Jp0jeWcg8VTZsHP8qeJQ685BFfIxZ9KydpfmBz+lBnUqQRz6f1qr3/p60uMcA/hVRbJZIkhD5BP59Ke0nIxmqzEjk+ucUvmjaeen86pEMsSMNv+cVUZySdx70x5sZzVK4uNowG4/nT3M27lmaQJ0JrLvL9QG5HFUb3UeCN2Dnp61zmo6p5cLHJ/CmnfYhyIfF+rJDbO7MBxgDP6145e6rK80h3sQ3ABPT6VteLdSmvJXjUHYDznv9KwLfTJ7jkK2PWuuMZRXu7suMeVXZRmlaVssT+dRVZvYDbzFGzketVq56l1J824MKKKKgQUUUUAFFFFABRRRQAUUuDSlGHUH8qdmA2ilxRSASnKSpBHUHIptFAHuXgTUBc6Tbugfev8I9PSvSNNmJVDtKqOcV4n8JrrbFLCcY3HBPr6CvY9NmYKrFeM4PPA/Gm9yNmddazrHIGkjWWJh80bH/OD3q3bqY8BTuUjg461jQzRlWDDg/MCD3q5bTM2GQlGH3SR+nvSbLSudHH5cyLHJNx/AGHzKfY1I1s1vvZlke3Y4WQN8pYc8+9ZltuKEsSznptPer8N7dwyNhvKYgbkVch+OpB7+9S2upvFDopbQjBR3kb5tpkI5/Cp0jgZ9yI6Aj7wkwMEdPXrTkUOUEcKNEeXCL8+cdf/AK1LbC0lGxLZvOXJkyxXIz/KlY0J7aGziQyNBmJTtJLkjI9fWrErklZLSFI4I16smUVT1Yj1pkMMSTbYI12SLtO9iBuHXaT36CppIpIR+8cmKVQrFwWCnqAcfzo2JbVx0SQxgpHF5xbh55O69Tgdh0pl9cL9muFZS0bj/V4OFbsw/wAKqRXB2t5kis4woOcDaPamvI24AyR+USdzs3yDH8zSbTWgcut2Qi6h8z/SIFkIQIqYPXHXjvTLZJI1Zo0JVeWJOApP9alhmRHaQ7XJU/Oc9Pb0qSBntohcMm/B3CNxwVPX6n0FSi2LOqwW0aPIvynCoDzz3PpWcZ95BLFtnoenpUt55t0dkJXZuwuRx9M06BRHDgxBlV89eelV1IcShLOsOWBBYDqRn61Vd12hi3JGMe1T3QaU/IrCPODk8n2qq8AAO8Z4wO/+TVRk7kNWK0bqwOTwvoaUqccHIPepYkjVCgTAxTvKGSwBwei10RM5K6MpwEnII75GKjMbO3P3R0NWL8eWwcdAeRT1KGMbD1HPtXu4Oren6HlYiNpXEiIjCjPORhsdauxEmIlgNxqOONEQFsmmb97kjgAcH0rZ6nOTMDK+F+7kcGopD5agjkY9elTCYH5E+96moJcY3Ec4zgVKBmSHDLt6HFNBKAdT2GTTMYOce/1pWOcZ4NfJH0dyyOckdOuKkOMAn0qmj54Bx709FJPzE+uK1iRcfK69CR9apXNx5edpHPX2qxLCTnHOap3EbemQOBjnNNiauZ93fkA+oP1rAvtTlIIXJ5wBXR/2a85Jxx70HRowPnX6kVk4zkLlPOr+5uyWCIxz04qkba8nwW4IHJI+76V6e+lRfxR80Np8KqPk5I9K1pwlHqQ4tHl6+HQyl5IwQOenei5sY7W3diAG6kYr0S5tkRDx7fWuL8WDGm3BwDhD16V1wk27GDbvY8d1OUS3kjKSRnqap0+U5kbPrTK56j5pNnQwoooqBBRS0+ONpGwgyaaTbsgSuMxSgEnAHNa9ro8kgVmBOegroNP8N8jchP6ACu6ll9Se+hTUYK8nY5O3sJpudpA+ladpoLycsD+Irv7HQgAoCYFai6UkaADI65zXp08thHdXMJYmK+FHn0WhBVwB14p0mkKqsSCP6V3z6eI1Jx9Kyri2JZjjAArp9gktBRxc2ee6hppUsQOnp3rGdSpwa9A1W3BygHvx1rktQtdpJA56jNeXi8Kn70dzqX72PMtzKopTSV5Bmdn8N7kRX0gLY2/MPftXvGilJYiFwQeozkA186eCpki1yPeobcpABPevf9Cm2xIinA69ap9CJbnVWpUYAAODwTya2LeLeF3EoRzzyKx7Jtz57HjIrZhbaTt4H3T3/CpsWi9ApXcwyAPvAdK0g0lwI8gGVRhGUcuv90j2rLhd/MTaWBA4x1q/A+0mSAkSghwOuSP7voaVzaLLKKQGljVpo/vFlByp9x2qeV1nnZyoywGH79Ogx71BNOVzfW5I3n94uMbH9MehqPzYbuUm3KWbFAVUAlSf4snqKhvWxokzVeOHyVKvNGMZyTnB74FKFjXMcl1cCIEFVeTO4Z5OBWNbm8O6JwqInzkSN0zwD+PtVwWrwFpZmjlCgNlThee2Byad1ukHL3ZYdLbzCYi3kM7/AL1gD1GcCqyzst0DAImbcpUsuFHHcfSnSRROUlluDcsRwiDaoUeh69KtQrbn5RFCXbpu4WJezFu5qbPoVdJa6ibUKiHeWtgRuIUZck5PA/lT77ZbwytbBmLL8pkQ5Bxg4zUsZtYLTz5XGyRiQgyGC/wsAOhz+lVGunkAa6m3iPlY5ODjtx3NVayIWrIdOVpSTEEZE+XHvjr+FNuU2CXGMdPfFTQzAKzqpQKwCy9FQ/1J9KpzGS8nIJHlNyXU42j3oG9yOAoI3kdiCwKgdce9V/LMgJKjr0HUU68nU5VSu0fKOMYqvDK8jOyZx3YGhStoS0RuERsnhieadjKYP3eoxSSq52jYoJ6HNGxgMbhnH4VtFmckU71PMVkwOR1NZ9q4VDk8g4xWhMWGQ+BgdRWUVX7Scng816eAqWnyvqcGJhdXLyTCYnOQAOaryT7ZNsY471HJKCCE9+TSxoEBZskkDNewopas4Cxbu2zLHscZpryNMu0nAHeolRySRwuDkZppYKoRefWly6iKrLlflPPrUe0qw5/DsPapQjDkD2p3lHAJHFfGW6n0YkSZGT1FWFwOhxUSKwyOcUuCcE56YxVp2IJiAQOc96idQDyKcn6UN+lPmGIG2p8o5qNs7snoO1SKMH0qOYYIbviquxNjjtI569qpz/Lkgke2elOlfbnHFULufCEZzniqUu5DZR1OYEHPSvPPG90F02ZeORjFdTq11tViSBxjg15b40vzKAuflySB1/A10UdXdmKXNJHEP99vrTaU9aSuZu5oFFFXtPsmuJB8pI9PWrp05VJcsRpXYy0s3uGGAcfSux0XQh8hZdxz2FXNG0kIBwcn2rutH00RhSwGTjNfQYXBRprzMa1dR92H3lTSfD6hUaRc456VtxaSgwAo/EVrwRAgKM4qwRhMYwemBzivUjBROByMj7IsaKEUZ6Ux4VUEnqK0pAVUnGWxwD61TZGkwDwM9qqwzNngMiEgDaO1ZF3AFyqD8RXRXAJOxRk5rNuIgilic59aiSA5W7tQAWOGNc1qFiZeecjjBFdxLBvZicY6isjUYMghepHNctSB00Kzgzza9g2vlBx3xVKur1Wz25YdTxXN3MRjcnHy54rwcZh+R862O+aTXPHYk0yYwX0Egz8rA8da+h/C0pktEZVA+UN6V83rwQa978BXXnaZb53fMoxu4PT9a4W9DCeyPRbBiyjIxnnOe9blu5aJtgJZfm4rnLFmJUEcHtWzA7RZHTK4GPWkOJsIRtRgMdsqcYqeGVUUsFA9DzkH1rOt5x05II5HY1ci+UooXdGfmBxjp2qW77GyL8SqzsWjCyY6L/E34+tTq+2Msn7kjPzIeeeox3FUMu2SjjJP3R+hqzbK8xcRRKzHkjzOh6dT61Jqmazut7En2s7ZEGIZIzyO5B9fpVacyQYWcrG+PlkHzKw9iO/1quGk+VJJPLG7G3aWJPrUg8syqIiJGIypkJUjHJOBTeoLQfbRtjFopM0mUdQc8e/p9afFFFbJIHCkkkMN2Cceg/SrUV1Gy52lSwO8LIFDGka8tF3iNfLcMGSTO7y+OR75oS6hdlO9NzdqPJt51hBHLHK59fX8KdDayR2zL5kYgwSzJHuJPuTzSyTpI7LtaVznYY2xyfWopbpLVGh81TvxnyznZ7ZPU0mlux3drCvc28EMaiOSZyM7JH3Ip78D+dUfNmZGCARoBjnjOTzTBqOB8gG5/lxncw//AF0x1nKlpiIkC7lTGWbt0FTzX2Dl7jFji8xnnDuOTuxwD6Ad6fG5D/LGfmGG4xVjOY9qwlUUADd29efWoxu2DcMdxnkkVUVYG7kbNywIbPUZFRPnksuB/WrTMBKp2kHGOT1qGdwW4P8AgK0iYvcqXI4BbqRwDWRqC7NsgHQ84rVuCSQp6AcVn3QLKw7988110pcslJGFWN0Vl2qhJ5JHFSxRtIwLnA65Peobb515GQvX2q4X52pyDwa+i57q66nkSVnYWQM2Anp2qMQrGc/xVYZhEgyeoqIjecv1zSTJK2wA/lTmzjAHFL/FR2/KvkT6Kw1Qccjg0rAVIegpv+J/lSYhEXK8ZzRtI569iMVKP9WfrQ/VvrQK5Vdto5zVSWbLc/UVauPuVmTdD9BRfWxIk0uFOKwtTuQMgnjpx1rSuCTnJ7VzOqkkvyeBx+VUZy1Of1+8UKcDd1xzivMdfuDJMwBzzg12fiBiH4JGVWvPNQJM3J7mu1LlpNoILRsq0UVNbAGZM1yRV3YpalzTtPe4YEjj0NdtoekeXt3LuPriqehKvl9B+VdrpgHPA7fzr6TC4aFNaGWJqOHuRLumaftClh710FugYBQMEc/WoIv9Up75NXrPqPoK9WMUkcDLSHaOBkGlPHJBpiE5PNK9NEDWXe2cZFRSABiFHuauL9w/WoV/1wpAmVPKCHcOvXis24t97lzgjr9K2ZPvn/eqre9TSZRz08JA2qML6+lZN4mxD3J610cgHz8DpWNffeFYzQ0cleW+8ksPl61y2qQAM6gYGc13Goda5TVfuqfY1w1oKSaZ6mEk5JxexzHSvWvhvdFtNhQtkKeOcbeeRXk8/wDrWr0n4aD/AEb/AIEa+bmrJrsKS0Z7Tps4OGlXPr7fStiKcMWT7o9D3rnNI7fjXQW4HPHb+tRzOwomjBIqryO+eK0hKpgjGT8mQwPX2rKQDKcD79W7UA3yggEFGyKdzZbFpZVcHLbD9asJJEJFLIznqwXj/wDXTI40KnKL93PSiThlA6Yxj8Ki5Vy0Loso3mdkXop6Y+vanJJbKgdmkIJ+bZgfqar6hwrAcDA4H0qtZ8yc84pSk0aRV0XNiSyKbaK4KnIDySAKcVbi02Mws092piABIjyTz29zTbn/AI+lX+EDgfgKSQn9zz60KK6hctxWdqtso8+TJH+qRNpz2BNNextI8hohvRckBsh27HPoPSrSgC1tsDGRk+/y1lSk7TyeCBVNJLYm7LyQQfZ0Z4kDlNikAJn/AGjVaTyghjhRJZHZSsn3QmOuTUkAD3sgcBgGUAHnjFLMAJLwYGMKMe2aGJPUhlj3RuiIThx+9ycA9wB3FUnXb8qkgA8ZGK0JyVitwpwN54FVtQ/134U2uoNldlbqw+XtVaVyr7tvC1ZyemeKgl++R70bEFSQ5yx6jrVKQEp6n371ZflWz6moyBt6VtTkRJaGTG5S6aMDhhnd6fhVuJvLz1yTziqrf8hMfT+tTD/WL+P86+iwkuekrnk11aRKGcoXc8DtUXnF3KjkE8H0FOn6MPeoLT77/U11xSs2Yn//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This granuloma annulare lesion is an erythematous, non-scaly, annular plaque.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granuloma annulare, localized",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 27-year-old presented with a nine month history of a solitary, slowly enlarging, annular patch of granuloma annulare 10 cm in diameter on the right hand. It has 1 to 1.5 mm skin-colored papules at the periphery and complete clearing in the center of the lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29449=[""].join("\n");
var outline_f28_48_29449=null;
var title_f28_48_29450="Emergent endotracheal intubation in children";
var content_f28_48_29450=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergent endotracheal intubation in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29450/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29450/contributors\">",
"     Joshua Nagler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29450/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29450/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/48/29450/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/48/29450/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/48/29450/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergent endotracheal intubation may be performed in the prehospital setting, as well as in emergency departments or other critical care settings. The need for intubation may be immediately apparent, such as in cardiopulmonary arrest. In other circumstances, the decision to intubate may result from dynamic assessment based on progressive or anticipated deterioration despite maximal medical therapies and non-invasive respiratory support.",
"   </p>",
"   <p>",
"    Emergency intubation is inherently more difficult to perform than planned intubation in the operating room. Patients are not prescreened and often had recent oral intake as opposed to being in the fasted state (ie, nil per os [NPO]). In addition, rapid clinical deterioration may compromise preparation time, and underlying illness or injury may make patients more susceptible to the adverse physiologic effects of this procedure.",
"   </p>",
"   <p>",
"    This topic will focus on the procedure of oral endotracheal (ET) intubation with traditional direct laryngoscopy in children. Direct laryngoscopy and tracheal intubation in adults is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=see_link\">",
"     \"Direct laryngoscopy and tracheal intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Basic airway maintenance techniques for children and adults that assess the need for airway support, rapid sequence intubation, and the difficult pediatric airway are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"     \"Basic airway management in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=see_link\">",
"     \"Initial assessment and stabilization of children with respiratory or circulatory compromise\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link\">",
"     \"The difficult pediatric airway\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous disease processes and clinical situations that may necessitate intubation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link\">",
"     \"Emergent evaluation of acute respiratory compromise in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the emergency department setting, the number of intubations performed on trauma and nontrauma patients is approximately equal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Specific indications for intubation fall into four different categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Inadequate oxygenation or ventilation",
"      </strong>",
"      &ndash; Patients who are unable to maintain adequate oxygenation or ventilation require intubation. Respiratory failure may result from primary pulmonary disease, or from other processes associated with respiratory compromise (",
"      <a class=\"graphic graphic_table graphicRef61637 \" href=\"UTD.htm?27/39/28285\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link&amp;anchor=H16#H16\">",
"       \"Emergent evaluation of acute respiratory compromise in children\", section on 'Evaluation'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Clinical evidence of respiratory failure includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Poor or absent respiratory effort",
"     </li>",
"     <li>",
"      Poor color",
"     </li>",
"     <li>",
"      Obtunded mental status",
"      <br/>",
"      <br/>",
"      Supporting data, such as noninvasive monitoring of oxygen saturation and end-tidal carbon dioxide (EtCO2), or partial pressure of oxygen or carbon dioxide from blood gas analysis can be helpful; however, endotracheal intubation should not be delayed in patients with clinical evidence of respiratory failure in order to obtain such measurements.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Inability to maintain",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       protect the airway",
"      </strong>",
"      &ndash; Any child who cannot maintain",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      airway requires endotracheal intubation. Patients in this category may exhibit the following findings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inability to phonate or produce audible breath sounds despite respiratory effort (complete airway obstruction) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=see_link&amp;anchor=H29#H29\">",
"       \"Emergent evaluation of acute upper airway obstruction in children\", section on 'Signs of airway obstruction'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Inspiratory, obstructive sounds with partial airway obstruction that fail to improve despite repositioning, airway maneuvers, or medical therapies (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=see_link&amp;anchor=H21#H21\">",
"       \"Emergent evaluation of acute upper airway obstruction in children\", section on 'Evaluation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Impaired mental status including head injured patients with a Glasgow Coma Score (GCS) of &le;8 [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/3-5\">",
"       3-5",
"      </a>",
"      ] and patients with systemic illness or poisoning because of the increased risk of aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Patients with depressed mental status can be assessed clinically for loss of protective airway reflexes. In particular, determining a patient's ability to swallow and handle secretions provides the most reliable indication of adequate airway protection. Studies suggest that swallowing and airway protective reflexes may in fact be centrally integrated [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Though commonly assessed, the gag reflex is a less useful indicator of airway status for several reasons: (1) The gag reflex correlates poorly with GCS [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/9\">",
"       9",
"      </a>",
"      ]; (2) A gag may not be elicited in more than one third of healthy subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/10\">",
"       10",
"      </a>",
"      ]; (3) The absence of a gag reflex in patients with prior neurological insults does not correlate with risk of aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/11\">",
"       11",
"      </a>",
"      ]; (4) Attempting to gag a patient to determine the need for intubation increases the risk of vomiting in those whose reflex remains intact.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Potential for clinical deterioration",
"      </strong>",
"      &ndash; Children whose condition will likely deteriorate, such as those with thermal inhalation injuries or epiglottitis, require early intubation in a controlled fashion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=see_link&amp;anchor=H11#H11\">",
"       \"Epiglottitis (supraglottitis): Treatment and prevention\", section on 'Artificial airway'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=see_link&amp;anchor=H11#H11\">",
"       \"Emergency care of moderate and severe thermal burns in children\", section on 'Airway'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Other illnesses, such as severe anaphylaxis or asthma exacerbations, may initially be treated with aggressive medical therapies. However, clinical response must be continuously assessed, with a clear endpoint and plan for airway intervention if the patient does not improve and respiratory failure is anticipated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H20#H20\">",
"       \"Anaphylaxis: Rapid recognition and treatment\", section on 'Airway management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15111?source=see_link&amp;anchor=H3#H3\">",
"       \"Emergency airway management in acute severe asthma\", section on 'the decision to intubate'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Similarly, patients with sepsis may be intubated based on their anticipated course, as well as to maximize oxygen delivery and relieve energy expenditure related to increased work of breathing.",
"     </li>",
"     <li>",
"      <strong>",
"       Prolonged diagnostic studies or patient transport",
"      </strong>",
"      &ndash; Control of the airway through intubation may be the safest alternative for some patients with combative or unstable conditions who require prolonged diagnostic studies. This is particularly true during computed tomography or magnetic resonance imaging, where assessment and support of the child's airway will be less accessible in the event of an acute change. Intubation is also suggested for any patient at risk for deterioration prior to transfer to another facility. Securing the airway prior to departure avoids the need for emergent advanced airway management in a less controlled setting such as an ambulance or a helicopter transport.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS AND PRECAUTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment and management of the airway is always the first priority in caring for acutely ill or injured children. Thus, there are no absolute contraindications for endotracheal intubation (ETI) by appropriately trained providers.",
"   </p>",
"   <p>",
"    Relative contraindications are uncommon, but do exist and primarily relate to the need to move to a more controlled environment or to perform a surgical approach to the airway:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In order to preserve airway reflexes and spontaneous respiratory efforts in case of a failed intubation, rapid sequence intubation with neuromuscular blockade should be avoided in patients who are known or expected to be difficult to intubate and difficult to ventilate with bag and mask, without an appropriate back up plan in place. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with a known or suspected laryngeal fracture should be intubated with caution because of the risk of further disrupting a partial laryngeal transection, resulting in complete loss of the airway.",
"     </li>",
"     <li>",
"      High-risk intubations (eg, epiglottitis) are most safely performed in the controlled environment of the operating room whenever delay is secondary to transport will not compromise patient outcome (",
"      <a class=\"graphic graphic_table graphicRef80169 \" href=\"UTD.htm?25/10/25773\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Although very rare, the unstable surgical patient (eg, penetrating trauma to the larynx) deemed to require a surgical airway should not have airway efforts delayed by attempts at direct laryngoscopy and ETI. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/3/16441?source=see_link\">",
"       \"Needle cricothyroidotomy with percutaneous transtracheal ventilation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=see_link\">",
"       \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic features of the airways of infants and children that affect the approach to intubation are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"     \"Emergency airway management in children: Unique pediatric considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Mouth and oropharynx",
"      </strong>",
"      &ndash; The lips define the entrance to the mouth. Immediately behind the lips are the teeth extruding from the gingiva. The mouth is bound superiorly by the hard and soft palate, laterally by buccal mucosa, and inferiorly by the tongue. The uvula hangs down from the roof of the mouth in the midline, and the tonsils lie laterally just behind the palatoglossal folds which define the entrance to the oropharynx (",
"      <a class=\"graphic graphic_figure graphicRef69766 \" href=\"UTD.htm?34/55/35698\">",
"       figure 1",
"      </a>",
"      ). The oropharynx extends inferiorly to the epiglottis.",
"     </li>",
"     <li>",
"      <strong>",
"       Hypopharynx",
"      </strong>",
"      &ndash; Below the oropharynx is the hypopharynx which extends from the epiglottis to the cricoid cartilage. The epiglottis attaches to the anterior aspect of the hypopharynx and drapes over the glottis. At the junction of the base of the tongue and the epiglottis is a space known as the vallecula. At the base of the vallecula lies the hyoepiglottic ligament, which connects the epiglottis to the hyoid bone anteriorly (",
"      <a class=\"graphic graphic_figure graphicRef59721 \" href=\"UTD.htm?43/26/44452\">",
"       figure 2",
"      </a>",
"      ). The larynx lies in the anterior portion of the hypopharynx, bounded laterally by the piriform recesses. Posteriorly lies the origination of the esophagus. Distinguishing the esophagus from the glottis is crucial during ETI. The esophageal opening has a puckered or ill-defined shape, and has smooth, homogeneous soft tissue structures surrounding it (",
"      <a class=\"graphic graphic_picture graphicRef78195 \" href=\"UTD.htm?22/45/23248\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Larynx",
"      </strong>",
"      &ndash; The larynx is defined anteriorly by the hyoid bone, the thyroid cartilage, the cricothyroid membrane, and the cricoid cartilage. The arytenoid cartilages (cuneiform and corniculate) make up the posterior aspect of the laryngeal inlet. These posterior cartilages are important landmarks as they are the first structures visualized as the epiglottis is lifted during laryngoscopy, and may be the only portion of the glottis visualized in some patients. The aryepiglottic folds, which connect the arytenoids to the epiglottis, make up the lateral borders of the laryngeal inlet. The true vocal cords originate below the epiglottic tubercle anteriorly and connect with the arytenoids posteriorly. The vocal cords cover the entrance to the trachea. An optimal laryngoscopic view will allow visualization of the entire length of both vocal cords (",
"      <a class=\"graphic graphic_picture graphicRef67789 \" href=\"UTD.htm?5/44/5827\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Trachea",
"      </strong>",
"      &ndash; The trachea begins at the base of the cricoid cartilage, and ends inferiorly at the carina, which defines the bifurcation to the right and left mainstem bronchus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Success in airway management depends on careful patient assessment, implementation of an appropriate endotracheal intubation (ETI) plan, and gathering and testing of all necessary equipment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Rapid assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should perform a focused assessment of the child's history and physical findings to identify conditions and clinical features that will impact bag-mask ventilation, laryngoscopy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ETI. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital abnormalities associated with airway difficulties (eg, Pierre-Robin, Treacher-Collins) (",
"      <a class=\"graphic graphic_table graphicRef79504 \" href=\"UTD.htm?43/15/44283\">",
"       table 3",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link&amp;anchor=H3#H3\">",
"       \"The difficult pediatric airway\", section on 'Causes of the difficult pediatric airway'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Known difficult ETI in the past",
"     </li>",
"     <li>",
"      Anatomic characteristics associated with difficult airway management, such as poor mouth opening, large tongue or tonsils, small chin, short mandible, or decreased neck mobility (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link&amp;anchor=H12#H12\">",
"       \"The difficult pediatric airway\", section on 'Identification of the difficult pediatric airway'",
"      </a>",
"      )",
"      <br/>",
"      <br/>",
"      Some clinicians advocate for the use of the Mallampati score (",
"      <a class=\"graphic graphic_figure graphicRef75229 \" href=\"UTD.htm?2/36/2626\">",
"       figure 3",
"      </a>",
"      ) or LEMON&copy; approach (",
"      <a class=\"graphic graphic_table graphicRef64336 \" href=\"UTD.htm?0/46/747\">",
"       table 4",
"      </a>",
"      ) although their use has not been validated in children (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link&amp;anchor=H12#H12\">",
"       \"The difficult pediatric airway\", section on 'Identification of the difficult pediatric airway'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Evidence of partial upper airway obstruction from infectious, traumatic, or inflammatory etiologies (",
"      <a class=\"graphic graphic_table graphicRef71326 \" href=\"UTD.htm?4/52/4939\">",
"       table 5",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Intubation plan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation has been shown to be safe and effective in children and should be planned for most emergent pediatric intubations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, in any child in whom laryngoscopy and intubation may be more difficult (",
"    <a class=\"graphic graphic_table graphicRef71326 \" href=\"UTD.htm?4/52/4939\">",
"     table 5",
"    </a>",
"    ), an alternative plan that involves assistance from specialists (anesthesiologists, otolaryngologists)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intubation with sedation but without paralysis should be employed.",
"   </p>",
"   <p>",
"    A contingency plan in the event of a failed intubation must be developed for all patients, ideally before rapid sequence intubation is attempted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link&amp;anchor=H17#H17\">",
"     \"The difficult pediatric airway\", section on 'Alternative airway techniques'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinician in charge should clearly assign roles to each health care provider, including an assistant to the person performing endotracheal intubation. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Materials, equipment, and personnel'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Patient counseling/Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most circumstances, emergent endotracheal intubation is performed for life-threatening circumstances, and thus, consent is implied. Whenever possible, the procedure should be explained to both the parents and the child prior to intubation with emphasis on the indications for intubation and benefits of the procedure (eg, correction of hypoxemia or protection of the airway to prevent aspiration). Key components of the discussion include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medications will provide sedation and pain control throughout the procedure.",
"     </li>",
"     <li>",
"      Endotracheal intubation may not be successful.",
"     </li>",
"     <li>",
"      The subsequent planned actions if the child cannot be successfully intubated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Urgency of this procedure often precludes extensive discussion about minor risks, including the possibility of oral or dental trauma and post-extubation throat discomfort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Materials, equipment, and personnel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functioning airway equipment in a full range of sizes from neonate to",
"    <span class=\"nowrap\">",
"     adolescent/adult",
"    </span>",
"    should be readily available wherever critically ill or injured children receive medical care (",
"    <a class=\"graphic graphic_table graphicRef71484 \" href=\"UTD.htm?10/35/10812\">",
"     table 6",
"    </a>",
"    ). Equipment should always be checked prior to performing this procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2371996\">",
"    <span class=\"h3\">",
"     Preintubation supplies",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Personnel",
"      </strong>",
"      &ndash; Ideally, at least three practitioners are present during emergency intubation. In addition to the",
"      <span class=\"nowrap\">",
"       laryngoscopist/intubator,",
"      </span>",
"      an assistant can be utilized to hold cricoid pressure (when used), pass equipment, and watch the monitor, and an additional provider can be assigned to infuse medications when RSI is utilized. When possible, the resuscitation leader should not be the provider performing the intubation. A respiratory therapist, when available, can function as the assistant during intubation, and is particularly helpful to assist with ventilator management after intubation.",
"     </li>",
"     <li>",
"      <strong>",
"       Monitoring equipment",
"      </strong>",
"      &ndash; Any patient undergoing ET intubation should be placed on continuous monitoring equipment including heart rate, respiratory rate, blood pressure, and continuous oxygen saturation monitoring. Capnography should be employed when available.",
"     </li>",
"     <li>",
"      <strong>",
"       Oxygen supply",
"      </strong>",
"      &ndash; Supplemental oxygen must be available, either from a wall source or a portable tank with a flow meter that allows at least 10",
"      <span class=\"nowrap\">",
"       L/min.",
"      </span>",
"     </li>",
"     <li>",
"      <strong>",
"       Suction",
"      </strong>",
"      &ndash; Wall suction or portable devices should be available. Pressures should be limited to 80 to 120 mmHg to decrease the risk of trauma to airway mucosa. Yankauer or wide-bore tonsil tip catheters are most appropriate for suctioning particulate matter (eg, thick secretions and vomitus). Flexible suction catheters can be used for thin secretions in the nose, mouth, and hypopharynx, as well as for deep suctioning through the ET tube.",
"     </li>",
"     <li>",
"      <strong>",
"       Bag and mask",
"      </strong>",
"      &ndash; Selecting an appropriately sized bag and mask for bag-mask ventilation (BMV) is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link&amp;anchor=H12#H12\">",
"       \"Basic airway management in children\", section on 'Bag-mask ventilation'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      BMV can provide a temporizing means for oxygenation and ventilation while preparing for intubation in the child in respiratory failure. In addition, children desaturate more quickly than adults during rapid sequence intubation and may require assisted ventilation after administration of sedatives or neuromuscular blockade agents and prior to laryngoscopy and endotracheal intubation (ETI). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"       \"Emergency airway management in children: Unique pediatric considerations\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Bag-mask ventilation (BMV) is as effective as ETI and ventilation for providing temporary respiratory support. For example, a randomized controlled trial of prehospital BMV versus ETI in 820 pediatric patients found no difference in survival to hospital discharge or good neurologic outcomes between the two groups. Median scene and transport times were 15 minutes in the BMV group and 17 minutes in the ETI group, suggesting that BMV was equivalent to ETI for short-term airway and ventilatory support among paramedics [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/13\">",
"       13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, BMV does not provide a secure airway and may result in gastric distention, which increases the risk for vomiting and aspiration. Thus, any child requiring prolonged respiratory support is best managed with endotracheal intubation, especially when performed by appropriately trained providers in the emergency department or other critical care settings.",
"     </li>",
"     <li>",
"      <strong>",
"       Artificial airways",
"      </strong>",
"      &ndash; Oro- and nasopharyngeal airways should be available to facilitate bag-mask ventilation in case it is necessary during the process of intubation, or in the event that an endotracheal tube cannot be passed successfully. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"       \"Basic airway management in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"       \"Basic airway management in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Endotracheal tube",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1618840\">",
"    <span class=\"h4\">",
"     Cuffed versus uncuffed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthesia literature, as well as Pediatric Advanced Life Support Guidelines, now supports that, beyond the newborn period, cuffed endotracheal (ET) tubes are equally as safe as uncuffed tubes, and are favored in some clinical circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children at risk for aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Burn victims [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with severe lung disease who may require high ventilator pressures (eg, bronchiolitis, status asthmaticus, chronic lung disease) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/15,18\">",
"       15,18",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When using cuffed tubes, care must be taken to avoid cuff pressures greater than 20 cm H2O, which can increase the risk of tracheal mucosal ischemia. Clinical assessment of cuff pressure is often inaccurate, therefore an ET cuff manometer should be considered in any patient requiring prolonged intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Traditionally, uncuffed ET tubes have been preferred for all children younger than eight years of age to avoid potential pressure-induced ischemic damage to tracheal mucosa from a cuffed tube. In contrast to adults, in whom the vocal cords comprise the narrowest portion of the airway, the cricoid ring has been shown to contain the narrowest portion of the pediatric airway in children younger than eight years of age. This natural anatomic narrowing can create an effective anatomic seal without the need for a cuffed ET tube in younger children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"     \"Emergency airway management in children: Unique pediatric considerations\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    However, ET tubes are now available with low pressure, high volume cuffs in sizes suitable for infants and children. Three prospective studies, including a randomized controlled trial, have demonstrated no increase in postextubation stridor, need for racemic epinephrine, or long-term complications when using cuffed tubes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/18,21,22\">",
"     18,21,22",
"    </a>",
"    ]. The ability to adjust cuff inflation for excessive air leak also results in less frequent need for tube change secondary to inappropriate sizing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1618848\">",
"    <span class=\"h4\">",
"     Endotracheal tube size",
"    </span>",
"    &nbsp;&mdash;&nbsp;The size of the ET tube is determined by the internal diameter, measured in millimeters (mm). Available sizes range from 2.5 mm (suitable for a preterm infant) to adult sizes of 7.0 mm or more. The appropriate size ET tube for any given patient should be small enough to pass easily through the vocal cords, but large enough to minimize resistance to air flow. Uncuffed tubes should fit snugly in the subglottic trachea to minimize air leak, while cuffed tubes allow for some adjustment through cuff inflation to provide appropriate endotracheal fit.",
"    <br/>",
"    <br/>",
"    For uncuffed ET tube sizing, the age-based formula 4 + (age in years",
"    <span class=\"nowrap\">",
"     /4)",
"    </span>",
"    has been shown to be effective and accurate in children [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/23\">",
"     23",
"    </a>",
"    ]. When using a",
"    <strong>",
"     cuffed",
"    </strong>",
"    ET tube, selecting a tube one full size smaller than determined by the above formula was accurate 99 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/24\">",
"     24",
"    </a>",
"    ], though with the development of newer, lower profile, thinner walled cuffed ET tubes, using a tube one half size smaller than the age-based calculation is recommended (",
"    <a class=\"graphic graphic_table graphicRef72932 \" href=\"UTD.htm?2/4/2123\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/15,25\">",
"     15,25",
"    </a>",
"    ]. A calculator for determining the appropriate sized ET tube for children age one to eight years is provided (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?18/26/18849?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"    <br/>",
"    <br/>",
"    Other methods that have been proposed for estimating the best size uncuffed ET tube in children include comparison of the outer ET tube diameter width with the child's fifth finger or the width of the child's fifth fingernail with inner ET tube diameter, and a derivation based on the child's length [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/23\">",
"     23",
"    </a>",
"    ]. Of these methods, derivation based on the child's length is best.",
"    <br/>",
"    <br/>",
"    Utilizing length with a length-based resuscitation tape (eg, Broselow-Luten&reg; tape), is as effective as age-based formulae for determining the appropriate ET tube size in children with normal growth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/26\">",
"     26",
"    </a>",
"    ], as well as those with short stature [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/27\">",
"     27",
"    </a>",
"    ]. Current versions of this resuscitation tape, however, do not include sizing for a cuffed ET tube below 5.5 mm.",
"    <br/>",
"    <br/>",
"    Regardless of the method chosen in selecting ET tube size, it is important to have available additional tubes, one size larger and one size smaller than expected, to allow rapid replacement of any poorly-fitting tube.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1618872\">",
"    <span class=\"h4\">",
"     Stylet",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should generally use a stylet during emergent endotracheal intubation to reinforce the rigidity of the ET tube and allow the operator to direct the tube into the glottic opening.",
"    <br/>",
"    <br/>",
"    The largest diameter stylet that fits through the ET tube should be used. Tubes greater than 5.5 mm usually accommodate a larger diameter (ie, adult) stylet. Two small (pediatric) stylets may improve rigidity in smaller tubes if a single small stylet does not provide significant rigidity. If the stylet does not have a friction reducing surface coating, the provider should lubricate it with water soluble lubricant to facilitate removal. Bending the styletted ET tube into a hockey stick configuration enhances the ability to direct the ET tube anteriorly through the glottis (",
"    <a class=\"graphic graphic_picture graphicRef53547 \" href=\"UTD.htm?26/36/27215\">",
"     picture 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    To avoid injury to the tracheal mucosa, care must be taken to ensure that the tip of the stylet does not pass beyond the distal end of the ET tube. Bending the proximal end of the stylet over the adapter at the proximal end of the tube prevents inadvertent movement during intubation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Laryngoscope handle and blade",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two components to the laryngoscope, the handle and the blade. Pediatric and adult sized handles are available that differ in diameter and length, though either size can be used depending on the clinician's preference. Laryngoscope blades are either curved or straight. The choice of curved or straight blade is best made based on the experience and preference of the laryngoscopist. Curved blades have a large flange which facilitates displacement of the tongue, and a curve that allows easy placement in the vallecula (",
"    <a class=\"graphic graphic_figure graphicRef65358 \" href=\"UTD.htm?1/40/1669\">",
"     figure 4",
"    </a>",
"    ). A straight blade allows direct lifting of the epiglottis to expose the glottic opening, which may be preferred in infants and young children under two years of age in whom the epiglottis is often larger and more acutely angled (",
"    <a class=\"graphic graphic_figure graphicRef77129 \" href=\"UTD.htm?31/39/32374\">",
"     figure 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"     \"Emergency airway management in children: Unique pediatric considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A straight blade may also be preferred in patients in whom cervical spine injury is suspected because laryngoscopy with a straight blade may result in less motion of the cervical spine [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laryngoscope blades range in size from 00 for the extremely premature infant to 4 for large adults. The appropriate size blade for a given patient is one that is large enough to control the tongue and to reach the glottic structures (",
"      <a class=\"graphic graphic_table graphicRef73906 \" href=\"UTD.htm?24/40/25228\">",
"       table 8",
"      </a>",
"      ). Generally, size 0 or 1 blades are used in average-sized newborns, and size 1 blades for most infants beyond the immediate newborn period. The Wis-Hipple is available in a 1.5 size, which is convenient for children one to three years of age. The phrase \"switch to size 2 at age two (years)\" helps to remember this important changeover point for laryngoscope blade sizing.",
"     </li>",
"     <li>",
"      Anatomic landmarks also help identify the appropriate laryngoscope blade size. In a prospective observational study, intubation was more consistently successful on the first attempt when the length of the blade used for laryngoscopy was within one centimeter of the distance between the upper incisors and the angle of the mandible [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372004\">",
"    <span class=\"h3\">",
"     Postintubation and alternative airway supplies",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Confirmation devices",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Colorimetric end-tidal CO2 devices or capnographic monitors should be available for ET tube placement confirmation in any setting in which intubation is performed and are the most accurate means for confirming tracheal intubation in patients who are not in cardiac arrest.",
"      <br/>",
"      <br/>",
"      Disposable qualitative devices use colorimetric methods to detect CO2 in the ET tube during the exhalation phase of positive pressure ventilation. Once the trachea is intubated and the colorimetric detector is attached, six positive pressure breaths are delivered. The device will change color (typically from purple to yellow) during exhalation when CO2 is present. This confirms placement of the ET tube in the tracheo-bronchial tree if the patient has a perfusing cardiac rhythm. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link&amp;anchor=H4#H4\">",
"       \"Carbon dioxide monitoring (capnography)\", section on 'Clinical applications for intubated patients'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Capnography confirms ventilation by producing a continuous tracing of CO2 levels. The presence of a regular waveform indicates successful ventilation. It is the most accurate method for confirming ET tube placement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link&amp;anchor=H4#H4\">",
"       \"Carbon dioxide monitoring (capnography)\", section on 'Clinical applications for intubated patients'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients in cardiac arrest, gas exchange in the lungs is markedly reduced and CO2 may not be detectable, despite proper positioning of the ET tube. In such situations, an esophageal bulb may be used to confirm tracheal placement in children who weigh more than 20 kg [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/15,32\">",
"       15,32",
"      </a>",
"      ]. It relies on the principle that the esophagus is collapsible under negative pressure, whereas the trachea (which is rigid) is not. The bulb is deflated and then placed on the end of the ET tube following intubation. The bulb will remain deflated when the ET tube is in the esophagus, but will reinflate with gas from the trachea and lungs when the ET tube is correctly positioned in the non-collapsible trachea.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Alternative airway supplies",
"      </strong>",
"      &mdash; Alternative strategies and appropriate equipment for providing oxygenation and ventilation must be considered for the child who may be difficult to intubate with direct laryngoscopy. These techniques may be temporizing (such as laryngeal mask airway, Combitube, or a surgical airway) or provide alternative approaches to tracheal intubation (as with fiberoptic intubation, gum elastic bougie, a lighted stylet, or a video laryngoscope). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=see_link&amp;anchor=H17#H17\">",
"       \"The difficult pediatric airway\", section on 'Alternative airway techniques'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39337?source=see_link\">",
"       \"Devices for difficult endotracheal intubation in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Miscellaneous supplies",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Tape or a commercial holder to secure the endotracheal tube",
"     </li>",
"     <li>",
"      Tincture of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/32/27137?source=see_link\">",
"       benzoin",
"      </a>",
"      to enhance the holding power of the tape",
"     </li>",
"     <li>",
"      Gauze or cotton-tipped applicator for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/32/27137?source=see_link\">",
"       benzoin",
"      </a>",
"      application",
"     </li>",
"     <li>",
"      5 to 10 mL syringe for cuff inflation",
"     </li>",
"     <li>",
"      A nasogastric or orogastric tube to decompress the stomach following intubation. Insufflated air from BMV or residual gastric contents should be removed to decrease the risk of aspiration and improve diaphragmatic excursion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct laryngoscopy and endotracheal intubation are complex processes. Developing a systematic and reproducible approach to this procedure will improve success.",
"   </p>",
"   <p>",
"    A mnemonic (STOP MAID!) has been developed to help practitioners remember the preparatory tools and steps for endotracheal intubation (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Preparation'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <strong>",
"     S",
"    </strong>",
"    : Suction",
"   </p>",
"   <p>",
"    <strong>",
"     T",
"    </strong>",
"    : Tools for intubation (laryngoscope blades, handle)",
"   </p>",
"   <p>",
"    <strong>",
"     O",
"    </strong>",
"    : Oxygen",
"   </p>",
"   <p>",
"    <strong>",
"     P",
"    </strong>",
"    : Positioning",
"   </p>",
"   <p>",
"    <strong>",
"     M",
"    </strong>",
"    : Monitors, including ECG, pulse oximetry, blood pressure, end-tidal CO2, and esophageal detectors",
"   </p>",
"   <p>",
"    <strong>",
"     A",
"    </strong>",
"    : Assistant, Ambu&reg; bag with face mask, Airway devices (different sized ETTs, 10 mL syringe, stylets)",
"   </p>",
"   <p>",
"    <strong>",
"     I",
"    </strong>",
"    : Intravenous access",
"   </p>",
"   <p>",
"    <strong>",
"     D",
"    </strong>",
"    : Drugs for pretreatment, induction, neuromuscular blockade (and any adjuncts)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous cardiorespiratory monitoring and pulse oximetry prior to intubation are essential. Capnography should be utilized to confirm and monitor endotracheal tube position after intubation. Patients requiring emergent endotracheal intubation may have significant cardiovascular or respiratory compromise. In addition, profound physiologic changes may occur as a result of medication delivery or the mechanical stimulation from laryngoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endotracheal intubation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Preoxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoxygenation with 100 percent inspired oxygen creates an oxygen reservoir, primarily by washing nitrogen out of the functional residual capacity of the lungs and replacing it with oxygen. This increased lung store of oxygen, in combination with the improved oxygen delivery within the circulation and body tissues, serves to delay or avoid hypoxemia resulting from prolonged apneic periods during endotracheal intubation. Thus, preoxygenation should be performed even in patients with normal oxygen saturation.",
"   </p>",
"   <p>",
"    Patients without spontaneous respirations require immediate institution of bag-mask ventilation (BMV) with 100 percent inspired oxygen.",
"   </p>",
"   <p>",
"    Preoxygenation has traditionally included administration of 100 percent FiO2 for three to five minutes in the spontaneously breathing patient. Although two minutes may be sufficient in healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], emergency intubations are often performed in patients with compromised pulmonary function or respiratory effort who may benefit from more prolonged oxygen delivery prior to the procedure. In general, children have less functional residual capacity and higher oxygen utilization and, thus, will become hypoxic more quickly than adults, regardless of the method of preoxygenation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link&amp;anchor=H17#H17\">",
"     \"Emergency airway management in children: Unique pediatric considerations\", section on 'Lower functional residual capacity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In cooperative adult patients, eight vital capacity breaths with 100 percent FiO2 provides a more rapid means of achieving similar PaO2 levels and time to desaturation than the traditional method [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/35\">",
"     35",
"    </a>",
"    ]. However, similar data are not available for children who may be less cooperative with this technique.",
"   </p>",
"   <p>",
"    Rarely, children with gastric distension after bag-mask ventilation have restricted lung excursion on inhalation and are difficult to preoxygenate. Placement of a gastric tube in these patients is warranted prior to endotracheal intubation despite the risk of vomiting. Venting of a gastric or gastrostomy tube, when present, also relieves gastric distension without adding any additional risk of emesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Suction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two suction devices (eg, Yankauer or wide-bore tonsil tip catheters) should be immediately available at the bedside and attached to a wall unit suction that is turned on and limited to a maximum of 120 mmHg. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Materials, equipment, and personnel'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper positioning aligns the pharyngeal, tracheal, and oral axes into the \"sniffing position\" (",
"    <a class=\"graphic graphic_picture graphicRef69636 \" href=\"UTD.htm?1/55/1908\">",
"     picture 4",
"    </a>",
"    ). This maintains the patency of the airway once the child becomes unconscious, as well as facilitates visualization of laryngeal structures during subsequent intubation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To align the pharyngeal and tracheal axes, the chin is moved anteriorly with respect to the shoulders, such that the external auditory canal is anterior to the shoulder. This may be accomplished in children by placing a towel or roll under the occiput. In infants, because of a prominent occiput, the towel must be placed under the shoulders to achieve this position (",
"      <a class=\"graphic graphic_picture graphicRef78446 \" href=\"UTD.htm?33/4/33857\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"       \"Emergency airway management in children: Unique pediatric considerations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      To align the oral axis with the pharyngeal and tracheal axes, the head is then extended on the neck, such that the nose and mouth are pointing toward the ceiling. This may be accomplished by placing the palm of the right hand on the patient's forehead with the fingers extending onto the occiput, cupping the head and gently rotating the head posteriorly (",
"      <a class=\"graphic graphic_figure graphicRef60302 \" href=\"UTD.htm?21/27/21936\">",
"       figure 6",
"      </a>",
"      ). This maneuver also opens the patient's mouth, facilitating insertion of the laryngoscope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cervical spine immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the child with a suspected cervical spine injury, neck movement must be minimal during positioning and laryngoscopy. Initially, the airway can be opened with the jaw thrust maneuver (",
"    <a class=\"graphic graphic_figure graphicRef53277 \" href=\"UTD.htm?42/28/43470\">",
"     figure 7",
"    </a>",
"    ). If a cervical collar is in place, the front should be opened to allow complete mouth opening and displacement of the chin and mandible [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/36\">",
"     36",
"    </a>",
"    ]. Manual in-line stabilization should be maintained by an assistant during laryngoscopy and intubation (",
"    <a class=\"graphic graphic_figure graphicRef80874 \" href=\"UTD.htm?14/2/14369\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/5,15\">",
"     5,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric-specific data from a simulator-based study support the protective effects of inline stabilization [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/37\">",
"     37",
"    </a>",
"    ]. However, the practice of inline stabilization has been challenged on grounds that it increases laryngoscopic force [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/38\">",
"     38",
"    </a>",
"    ], compromises view and intubation success [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/39\">",
"     39",
"    </a>",
"    ], and inconsistently decreases cervical spine movement. Thus, the balance between minimizing neck movement must be weighed against the possibility of insufficient glottic visualization and an unsuccessful intubation attempt. The safest practice is to provide the minimum amount of force and movement necessary to allow for successful completion of the procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link&amp;anchor=H9#H9\">",
"     \"Pediatric cervical spine immobilization\", section on 'Airway management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Sedation and neuromuscular blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) typically achieves optimal conditions for laryngoscopy in children requiring emergent intubation (",
"    <a class=\"graphic graphic_table graphicRef51456 \" href=\"UTD.htm?17/26/17837\">",
"     table 9",
"    </a>",
"    ). RSI involves the delivery of a sedative and neuromuscular blocking agent to sedate and pharmacologically paralyze so that movement and protective airway reflexes do not interfere with endotracheal intubation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    RSI may be modified in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sedative agents may be omitted in obtunded or comatose patients.",
"     </li>",
"     <li>",
"      Neuromuscular blockade should be avoided in patients with a predicted difficult airway unless a back-up approach is available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once rapid sequence intubation medications are provided, the clinician should make every effort to avoid BMV because of the increased risk of vomiting and aspiration that can occur with gastric distention. However, in patients who cannot be adequately preoxygenated, BMV with small tidal volumes and cricoid pressure is preferable to intubating a hypoxic patient. Nasal cannula oxygen delivery to the apneic patient following administration of RSI medications can also decrease the likelihood of hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cricoid pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricoid pressure has historically been used in rapid sequence intubation to prevent gastric insufflation and passive regurgitation of gastric contents. In this technique, often referred to as the Sellick maneuver, the thumb and fore or middle finger are used to apply pressure over the anterior neck at the cricoid cartilage to compress the esophagus between the cricoid cartilage and the anterior surface of the C6 vertebral body (",
"    <a class=\"graphic graphic_figure graphicRef71800 \" href=\"UTD.htm?21/53/22354\">",
"     figure 9",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link&amp;anchor=H31#H31\">",
"     \"Rapid sequence intubation (RSI) in children\", section on 'Cricoid pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When used, cricoid pressure should be applied lightly in the patient who is receiving bag-mask ventilation before endotracheal intubation to limit gastric insufflation and distention [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/41\">",
"     41",
"    </a>",
"    ]. Increased pressure should be applied after the sedative is administered and prior to complete neuromuscular blockade. It should be maintained until endotracheal tube position is confirmed. &nbsp;",
"   </p>",
"   <p>",
"    Pediatric data exist to suggest that cricoid pressure may decrease the risk of gastric insufflation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]; however, conflicting evidence exists regarding the effectiveness of cricoid pressure for preventing regurgitation. Therefore, cricoid pressure may be used initially with RSI, but should be removed if airway obstruction occurs when ventilation is required or if there is difficulty viewing the larynx [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link&amp;anchor=H31#H31\">",
"     \"Rapid sequence intubation (RSI) in children\", section on 'Cricoid pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Laryngoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laryngeal exposure with visualization of the glottis is the main determinant of success or failure with endotracheal intubation (ETI). Appropriate laryngoscope blade sizing and a discussion of curved versus straight blade use is reviewed above. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Laryngoscope handle and blade'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Direct laryngoscopy is most easily performed with the clinician standing at the patient's head, and the bed adjusted to the level of the laryngoscopist's xiphoid. The endotracheal (ET) tube, with stylet in place, and suction equipment should be easily accessible. ET tubes that are one size above and below the estimated size for age should also be available. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Materials, equipment, and personnel'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Whenever possible, an assistant should stand to the right of the patient's head to assist with optimal positioning and to hand items to the intubator. Once the child is completely relaxed, the following steps are performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Opening the mouth",
"      </strong>",
"      &ndash; The mouth is opened using either of two techniques: a scissor technique in which the thumb of the operator's right hand pushes the lower incisors (or mandibular gum) caudad while the index finger (placed posterior to the thumb) pushes the upper incisors (or maxillary gum) cephalad (",
"      <a class=\"graphic graphic_picture graphicRef56734 \" href=\"UTD.htm?38/19/39219\">",
"       picture 6",
"      </a>",
"      ),",
"      <strong>",
"       or",
"      </strong>",
"      in a patient without cervical spine restrictions, extension of the head will naturally open the mouth. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Positioning'",
"      </a>",
"      above.) This can be augmented by applying caudad pressure on the chin using the fifth finger of the left hand (",
"      <a class=\"graphic graphic_figure graphicRef77129 \" href=\"UTD.htm?31/39/32374\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Inserting the laryngoscope",
"      </strong>",
"      &ndash; The laryngoscope is held in the left hand, regardless of the practitioner's hand dominance. The most common approach is to insert the blade into the right side of the patient's mouth, taking care not to catch the lower lip against the teeth, which may lacerate the lip. Asking an assistant to retract the lip off the teeth can be helpful. Within the oral cavity, the blade is passed under direct visualization along the base of the tongue following the natural contour of the pharynx. The tongue is swept to the left as the laryngoscope is advanced into midline of the hypopharynx (",
"      <a class=\"graphic graphic_figure graphicRef54262 \" href=\"UTD.htm?25/29/26064\">",
"       figure 10",
"      </a>",
"      ). An alternative approach is to pass the blade down the midline. &nbsp;The advantage of this method is that it may avoid the blade getting caught on pharyngeal folds and may also allow for easier identification of recognizable anatomic structures such as the epiglottis.",
"     </li>",
"     <li>",
"      <strong>",
"       Retracting the tongue and soft tissues",
"      </strong>",
"      &ndash; Once in the midline of the oropharynx, the laryngoscope blade should be used to lift the mandibular block. This can be accomplished by applying force away from the laryngoscopist along the long axis of the handle (",
"      <a class=\"graphic graphic_figure graphicRef65358 \" href=\"UTD.htm?1/40/1669\">",
"       figure 4",
"      </a>",
"      ). The laryngoscope should not be \"rocked\" backward, using the upper palate or incisors as the fulcrum for leverage. This improper technique will decrease the space within the oral cavity, making it difficult to pass the ET tube under direct visualization. In addition, injury to the mouth, gingiva, or teeth can occur when the blade is levered against these structures. Keeping the wrist straight will help prevent inadvertent levering.",
"     </li>",
"     <li>",
"      <strong>",
"       Identifying glottic structures",
"      </strong>",
"      &ndash; After the tongue and soft tissues have been retracted, the aim is to identify recognizable anatomic structures within the extrathoracic airway. As the laryngoscope blade is advanced into the pharynx, the epiglottis will often come immediately into view (",
"      <a class=\"graphic graphic_figure graphicRef69513 \" href=\"UTD.htm?23/10/23715\">",
"       figure 11",
"      </a>",
"      ). This is the landmark that is most useful when identifying the remainder of the glottic structures. At this point, suction is often needed to remove saliva, blood, or debris and optimize the glottic view.",
"      <br/>",
"      <br/>",
"      A number of laryngoscopic adjustments can be made if the epiglottis is not seen immediately:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The epiglottis may be lying flat against the posterior pharyngeal wall or folded on itself, making it difficult to distinguish from surrounding mucosal surfaces. Additional elevation of the mandibular block may help separate the epiglottic rim from surrounding tissue.",
"     </li>",
"     <li>",
"      The laryngoscope blade may not be midline, often as a result of challenges in sweeping the tongue from right to left. Repositioning the blade using the uvula as a midline reference point may be helpful.",
"     </li>",
"     <li>",
"      If neither the epiglottis nor the glottic structures are visible, the laryngoscope blade can be advanced fully, placing the blade tip in the esophagus. The blade is then pulled back slowly. The first structure to fall into view will be the glottis, followed by the epiglottis. Some experts recommend routine use of this approach with blind insertion beyond the larynx and locating identifiable structures as the blade is withdrawn, particularly when intubating infants [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Elevating the epiglottis",
"      </strong>",
"      &ndash; After the epiglottis has been identified, it needs to be elevated to expose the underlying vocal cords and glottic opening. The technique employed varies based on the type of blade being used.",
"      <br/>",
"      <br/>",
"      When using a straight blade, the tip of the blade is positioned under the epiglottis to lift it directly (",
"      <a class=\"graphic graphic_figure graphicRef77129 \" href=\"UTD.htm?31/39/32374\">",
"       figure 5",
"      </a>",
"      ). The epiglottis is frequently large, floppy, and covered with airway secretions and therefore may easily slide off the blade. If this occurs, the blade should be repositioned beneath the epiglottis and it should be carefully lifted again.",
"      <br/>",
"      <br/>",
"      When using a curved blade, the tip of the blade is pressed against the deepest portion of the vallecula to place tension on the hyoepiglottic ligament, which will help suspend the epiglottis. Once the blade (straight or curved) is positioned correctly, force is applied upward and forward along the long axis of laryngoscope handle at approximately 45 degrees. This will lift the mandibular block and the epiglottis to expose the glottic opening (",
"      <a class=\"graphic graphic_figure graphicRef65358 \" href=\"UTD.htm?1/40/1669\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef78195 \" href=\"UTD.htm?22/45/23248\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Adjusting for suboptimal view",
"      </strong>",
"      &ndash; Ideally, with appropriate positioning and laryngoscopy, the vocal cords and glottic aperture will be quickly identified. If little or none of the glottic opening is visualized, external laryngeal manipulation (ELM) may improve the view.",
"      <br/>",
"      <br/>",
"      An assistant can be asked to adjust cricoid pressure (if already being utilized) or to apply backward-upward-rightward pressure (BURP) to the larynx. The BURP maneuver has been demonstrated to improve glottic exposure in some patients by moving the larynx more into the line of vision [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]; however, it may compromise visualization when used in conjunction with traditional cricoid pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/46\">",
"       46",
"      </a>",
"      ]. In addition, using significant force when applying BURP may contribute to airway obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/47\">",
"       47",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In contrast, the laryngoscopist can provide their own ELM using bimanual laryngoscopy. While holding the laryngoscope in the left hand, posterior displacement of the larynx is achieved with external pressure applied at the thyroid cartilage with the right hand. Once the optimal laryngeal position is identified, the manipulation is taken over by an assistant to free the laryngoscopist's right hand to place the endotracheal tube. Bimanual laryngoscopy has been shown to improve the laryngeal view in adults, though no data are available specifically for pediatric patients [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/48,49\">",
"       48,49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Passing the endotracheal tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the glottic opening has been identified, the final step is passage of the endotracheal (ET) tube. While maintaining a view of the glottic opening, the intubator receives the tube in",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    right hand from a previously assigned assistant. The tube is held like a pencil, between the thumb and first two fingers (",
"    <a class=\"graphic graphic_figure graphicRef66376 \" href=\"UTD.htm?43/11/44213\">",
"     figure 12",
"    </a>",
"    ). Having an assistant place traction on the right corner of the mouth can provide improved visualization and additional room to accommodate the ET tube entering the mouth (",
"    <a class=\"graphic graphic_figure graphicRef68341 \" href=\"UTD.htm?35/11/36031\">",
"     figure 13",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The tube enters the right side of the mouth and is advanced toward the larynx in a horizontal plane. Passage of the tube directly along the barrel of the laryngoscope blade will obscure the view of the glottic opening, and should be avoided. The ET tube should be passed through the vocal cords under direct visualization. Once the tip has passed through the vocal cords, the tube is rotated to the upright position (",
"    <a class=\"graphic graphic_figure graphicRef68466 \" href=\"UTD.htm?24/15/24831\">",
"     figure 14",
"    </a>",
"    ). Although the tendency is for the intubator to move closer to the patient to improve view, this may compromise binocular vision and depth perception.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Depth of insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal location for the endotracheal (ET) tube tip is at the midpoint between the thoracic inlet and the carina. There are a number of ways to guide the proper depth of insertion for the ET tube [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Placing the double line on the ET tube at the glottis",
"     </li>",
"     <li>",
"      Using the depth provided by the length-based resuscitation tape",
"     </li>",
"     <li>",
"      Inserting the tube until the centimeter marking at the lip is three times the internal diameter of the ET tube",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This last calculation will result in the ET tube being correctly positioned more than 80 percent of the time, when using an appropriately size ET tube [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional techniques, less commonly used during emergent intubation, include deliberately advancing the ET tube to create an endobronchial intubation and then withdrawing the tube 2 cm beyond the passage of the carina [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/53\">",
"     53",
"    </a>",
"    ], and palpation of the tube tip at the suprasternal notch [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Initiate positive pressure ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laryngoscope can now be removed from the mouth while the tube is held securely against the roof of the mouth, or by grasping the tube using the index finger and thumb with the remaining three fingers holding the patient's face. If a cuffed tube is being used, the cuff should be inflated at this time.",
"   </p>",
"   <p>",
"    Positive pressure ventilation should be initiated with 100 percent inspired oxygen via a resuscitation bag with a carbon dioxide detector attached to the endotracheal (ET) tube. The bag should initially be squeezed with enough force and volume to provide chest wall movement.",
"   </p>",
"   <p>",
"    Subsequent ventilatory strategies can be made based on noninvasive measures of oxygenation and ventilation or based on results of blood gas analyses. If a large air leak is noted at this time, cuff inflation may be adjusted accordingly. However, persistent leak may require the tube to be changed to a larger size.",
"   </p>",
"   <p>",
"    If an uncuffed ET tube is in place, then the air leak pressures should ideally occur at less than 25 cm H20, while still allowing for effective ventilation. Air leak pressures up to 40 cm H20 have been shown to be safe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Confirming tube position",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately following intubation, placement of the endotracheal (ET) tube in the trachea must be confirmed. Clinical assessment for appropriate tube position includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Visible chest wall rise",
"     </li>",
"     <li>",
"      Auscultation of breath sounds in both axillae and not heard over the stomach",
"     </li>",
"     <li>",
"      Continuous pulse oximetry should confirm adequate oxygenation",
"     </li>",
"     <li>",
"      Mist should be present in the ET tube",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, because clinical evaluation is not completely accurate, confirmatory devices should be used [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      End-tidal CO2 should be detected using either a colorimetric device or capnography and is the most definitive method of confirming that the ET tube is in the trachea [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/15,56\">",
"       15,56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A self-inflating bulb may also be used for children weighing more than 20 kg, and may be particularly useful for confirming tube position in patients in cardiac arrest. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Materials, equipment, and personnel'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10899057\">",
"    <span class=\"h3\">",
"     Securing the tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;After correct tube position is confirmed, cricoid pressure can be released if it had been utilized during the intubation. The ET tube must be firmly secured. The most common approach is to tear longitudinally down the midline of a length of cloth or silk tape, creating a Y-shape. One segment is wrapped around the tube and the base segment is placed across the cheek (",
"    <a class=\"graphic graphic_figure graphicRef80704 \" href=\"UTD.htm?7/28/7617\">",
"     figure 15",
"    </a>",
"    ). Preparing the underlying skin with a layer of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/32/27137?source=see_link\">",
"     benzoin",
"    </a>",
"    , which is allowed to air dry, can provide additional adherence. Alternatively, commercial tracheal tube holders may be utilized to secure the ETT. These devices have been shown to be rapidly applied in adults and to have reasonable resistance to extubation forces, although in most instances, tape is stronger [",
"    <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/57\">",
"     57",
"    </a>",
"    ]. However, commercial endotracheal tube holders have not been specifically studied in infants and young children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Post-intubation care",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Post-intubation imaging",
"      </strong>",
"      &ndash; After immediate confirmation of ET tube placement as described above, an anterior-posterior chest radiograph should be obtained to confirm the location of the tip of the ET tube [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/58\">",
"       58",
"      </a>",
"      ]. Optimal position is located at a minimum of one to three centimeters above the carina and below the thoracic inlet. Tube depth may be adjusted based on radiographic position. Preliminary evidence suggests that bedside ultrasound, performed by clinicians experienced with this technique, may also be useful for directly determining the position of the ET tube within the trachea, or confirming appropriate position by documenting bilateral lung sliding. However, this is not common practice at this time and should not replace radiography [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/59-61\">",
"       59-61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Gastric decompression",
"      </strong>",
"      &ndash; An orogastric or nasogastric tube should be placed following intubation to decompress the stomach. Gastric distension can occur secondary to crying or insufflation following BMV. In addition, because emergent intubation may be performed on non-fasted patients, residual gastric contents may be present and should be evacuated. Gastric decompression can decrease the risk of aspiration around the ETT, as well as improve diaphragmatic excursion and patient ventilation.",
"     </li>",
"     <li>",
"      <strong>",
"       Minimize head movement",
"      </strong>",
"      &ndash; Care must be taken to avoid significant head movement in patients who have been intubated. Multiple studies have demonstrated that a significant percentage of ETTs can become malpositioned with neck movement [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/62-64\">",
"       62-64",
"      </a>",
"      ]. Flexion of the neck may result in the tube advancing into an endobronchial position with resultant limited ventilation of one lung, while neck extension can lead to unintended extubation.",
"     </li>",
"     <li>",
"      <strong>",
"       Positive pressure ventilation",
"      </strong>",
"      &ndash; Ventilation strategies vary based on underlying disease process, whether ongoing sedation and neuromuscular blockade is needed, and subsequent management plans. These details are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/44/22218?source=see_link\">",
"       \"Acute severe asthma exacerbations in children: Intensive care unit management\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=see_link\">",
"       \"Mechanical ventilation in neonates\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute complications from laryngoscopy and intubation can occur at multiple points during the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Before laryngoscopy/intubation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Gastric distension",
"      </strong>",
"      &ndash; BMV ventilation may cause gastric distension, leading to diminished lung capacity and increased risk of regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Applying cricoid pressure (Sellick maneuver) may decrease this risk.",
"     </li>",
"     <li>",
"      If significant distension has occurred, placing an orogastric or nasogastric tube to suction can help decompress the stomach. However, gastric tube placement may also stimulate vomiting in the patient, which will increase the risk of aspiration of gastric contents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     During laryngoscopy/intubation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hypoxemia",
"      </strong>",
"      &ndash; Sustained periods of inadequate oxygen delivery may lead to ischemic brain injury, the most significant complication of ET intubation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inadequate preoxygenation will shorten safe apnea time. Preoxygenation with FiO2 100 percent for a minimum of three minutes or with bag-mask ventilation (BMV) as needed will increase the oxygen reservoir within the patient's lungs, circulation, and tissues.",
"     </li>",
"     <li>",
"      Prolonged laryngoscopy (even with adequate preoxygenation) will lead to hypoxemia. Monitoring via continuous pulse oximetry is paramount to recognizing inadequate oxygenation. If desaturation occurs, the intubation attempt should be discontinued. Before another attempt is initiated, the patient should receive BMV until oxygen saturations improve. If cricoid pressure is in place, then it should be continued during BMV provided it is not compromising ventilation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Bradycardia",
"      </strong>",
"      &ndash; Profound bradycardia can occur during laryngoscopy and intubation as follows:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vagal response from stimulation of the hypopharynx, lifting the epiglottis, or rarely, the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/58/39845?source=see_link\">",
"       succinylcholine",
"      </a>",
"      can lead to bradycardia, particularly in infants and young children [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypoxemia can also result in secondary bradycardia in infants.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25816?source=see_link\">",
"       Atropine",
"      </a>",
"      may help prevent vagal mediated bradycardia but will be ineffective in cases of hypoxemia. Recommendations support prophylactic use of atropine in infants and young children under five years of age receiving",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/58/39845?source=see_link\">",
"       succinylcholine",
"      </a>",
"      as well as older children who are receiving a second dose of succinylcholine. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Increased intracranial pressure (ICP)",
"      </strong>",
"      &ndash; Intracranial pressure may increase during laryngoscopy as a result of increased cerebral arterial pressure during laryngoscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/66,67\">",
"       66,67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Increases in ICP are of little clinical significance except for patients who already have elevated pressures, and in most circumstances, the benefits of securing the airway and preventing hypoxemia are critical in these patients. Adequate use of sedatives and premedication may help attenuate increases in ICP. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Mechanical trauma",
"      </strong>",
"      &ndash; Soft tissue injury can occur anywhere along the extrathoracic airway.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Laryngoscopy may cause trauma to the alveolar ridge or teeth. Use of the upper incisors or maxillary gums as a fulcrum during laryngoscopy greatly increases this risk.",
"     </li>",
"     <li>",
"      Abrasion or laceration of the lips, tonsils, or pharyngeal mucosa can occur and may lead to bleeding, which can impair visualization and lead to airway obstruction.",
"     </li>",
"     <li>",
"      The laryngoscope blade or ET tube can injure the vocal cords and lead to vocal cord paralysis. Using equipment of appropriate size and ensuring laryngoscopy and intubation are performed under direct visualization minimizes this risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Aspiration",
"      </strong>",
"      &ndash; Aspiration of oral or gastric contents during laryngoscopy or intubation can occur. The severity of any subsequent pneumonitis is related to the acidity, volume, and presence of particulate matter in the aspirated material.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In inadequately sedated patients, direct laryngoscopy may stimulate the gag reflex, which may induce vomiting.",
"     </li>",
"     <li>",
"      Cricoid pressure may help prevent passive regurgitation, although data are limited. Cricoid pressure is not indicated during forceful vomiting due to the risk of esophageal rupture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     After intubation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hypoxemia",
"      </strong>",
"      &ndash; Inadequate oxygenation following laryngoscopy and attempted intubation will have different etiologies than those occurring during the procedure.",
"     </li>",
"     <li>",
"      <strong>",
"       Esophageal tube position",
"      </strong>",
"      &ndash; Unrecognized esophageal tube position is a relatively common etiology of hypoxemia after attempted endotracheal (ET) intubation [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/68,69\">",
"       68,69",
"      </a>",
"      ]. In most cases, this can be identified with",
"      <span class=\"nowrap\">",
"       absence/loss",
"      </span>",
"      of end-tidal CO2 detection even before hypoxemia occurs [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/70,71\">",
"       70,71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The ET tube may be advanced too far, resulting in an endobronchial intubation, most commonly right mainstem, aerating only one lung.",
"     </li>",
"     <li>",
"      An ET tube which is not advanced past the thoracic inlet is at increased risk of becoming dislodged, leading to inadequate oxygenation.",
"     </li>",
"     <li>",
"      Confirming ET tube position by chest radiograph, minimizing head movement following intubation, and utilizing continuous oxygen saturation monitoring and quantitative end-tidal CO2 detection (where available) can help prevent complications from a malpositioned tube.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Tube obstruction",
"      </strong>",
"      &ndash; Obstruction of an ET tube can occur when the tube tip is against a mucosal surface, from intraluminal inspissated secretions, or if the tube kinks. Inadequate air flow can result in hypoxemia and hypercapnia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Repositioning the head may relieve distal tip obstruction or kinking.",
"     </li>",
"     <li>",
"      Deep suctioning with a flexible catheter following instillation of saline is often effective in removing secretions and restoring tube patency.",
"     </li>",
"     <li>",
"      If neither of these techniques resolves the obstruction, the tube should be removed and BMV initiated, until a new ET tube can be placed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Barotrauma",
"      </strong>",
"      &ndash; By definition, positive pressure ventilation puts patients at risk for pulmonary barotrauma, including pneumomediastinum and pneumothorax.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with chronic lung disease and decreased lung compliance are at higher risk.",
"     </li>",
"     <li>",
"      Pneumomediastinum is self-limited and usually requires no intervention.",
"     </li>",
"     <li>",
"      Patients who develop pneumothorax while receiving positive pressure ventilation may develop tension physiology and therefore require concomitant tube thoracostomy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Post-obstructive pulmonary edema",
"      </strong>",
"      &ndash; When intubation is performed to relieve upper airway obstruction, the resultant changes in intrathoracic pressure can lead to pulmonary edema [",
"      <a class=\"abstract\" href=\"UTD.htm?28/48/29450/abstract/72,73\">",
"       72,73",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Post-obstructive pulmonary edema, also known as negative pressure pulmonary edema, is difficult to prevent once obstruction has occurred.",
"     </li>",
"     <li>",
"      Treatment is supportive with supplemental O2, positive pressure ventilation, and diuretics in patients who have no hemodynamic compromise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Adverse events from medications",
"      </strong>",
"      &ndash; Complications related to medications for sedation and neuromuscular blockade may also occur. This may include medication-specific adverse reactions as well as complications from dosing outside the therapeutic window. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific indications for intubation fall into four different categories (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Inadequate oxygenation or ventilation (",
"      <a class=\"graphic graphic_table graphicRef61637 \" href=\"UTD.htm?27/39/28285\">",
"       table 1",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link&amp;anchor=H16#H16\">",
"       \"Emergent evaluation of acute respiratory compromise in children\", section on 'Evaluation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Inability to maintain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      protect the airway",
"     </li>",
"     <li>",
"      Potential for clinical deterioration",
"     </li>",
"     <li>",
"      Prolonged diagnostic studies or transport in an unstable patient",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assessment and management of the airway is always the first priority in caring for acutely ill or injured children. Thus, there are no absolute contraindications for endotracheal intubation (ETI) by appropriately trained providers. Relative contraindications are uncommon, but do exist and primarily relate to the need to move to a more controlled environment or to perform a surgical approach to the airway. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Contraindications and precautions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anatomic features of the airways of infants and children that affect the approach to intubation are reviewed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=see_link\">",
"       \"Emergency airway management in children: Unique pediatric considerations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Success in airway management depends on careful patient assessment, implementation of an appropriate endotracheal intubation plan, and gathering and testing of all necessary equipment. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate equipment size by age and the key steps in successful performance of oral endotracheal intubation in children are shown in the tables (",
"      <a class=\"graphic graphic_table graphicRef73906 \" href=\"UTD.htm?24/40/25228\">",
"       table 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef72932 \" href=\"UTD.htm?2/4/2123\">",
"       table 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef64481 \" href=\"UTD.htm?41/54/42860\">",
"       table 10",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A mnemonic (STOP MAID!) has been developed to help practitioners remember the preparatory tools and steps for endotracheal intubation (",
"      <a class=\"graphic graphic_table graphicRef79150 \" href=\"UTD.htm?25/44/26315\">",
"       table 11",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Immediately following intubation, placement of the endotracheal (ET) tube in the trachea must be confirmed using an end-tidal CO2 detector and clinical assessment. A self-inflating bulb may also be used for children weighing more than 20 kg, and may be particularly useful for confirming tube position in patients in cardiac arrest. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Confirming tube position'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/1\">",
"      Losek JD, Olson LR, Dobson JV, Glaeser PW. Tracheal intubation practice and maintaining skill competency: survey of pediatric emergency department medical directors. Pediatr Emerg Care 2008; 24:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/2\">",
"      Sagarin MJ, Chiang V, Sakles JC, et al. Rapid sequence intubation for pediatric emergency airway management. Pediatr Emerg Care 2002; 18:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/3\">",
"      Gentleman D, Dearden M, Midgley S, Maclean D. Guidelines for resuscitation and transfer of patients with serious head injury. BMJ 1993; 307:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/4\">",
"      Gabriel EJ, Ghajar J, Jagoda A, et al. Guidelines for prehospital management of traumatic brain injury. J Neurotrauma 2002; 19:111.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Surgeons Committee on Trauma. Advanced Trauma Life Support for Doctors, Student Course Manual, 8th ed, American College of Surgeons, Chicago 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/6\">",
"      Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet 1996; 348:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/7\">",
"      Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/8\">",
"      Broussard DL, Altschuler SM. Central integration of swallow and airway-protective reflexes. Am J Med 2000; 108 Suppl 4a:62S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/9\">",
"      Moulton C, Pennycook A, Makower R. Relation between Glasgow coma scale and the gag reflex. BMJ 1991; 303:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/10\">",
"      Davies AE, Kidd D, Stone SP, MacMahon J. Pharyngeal sensation and gag reflex in healthy subjects. Lancet 1995; 345:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/11\">",
"      Bleach NR. The gag reflex and aspiration: a retrospective analysis of 120 patients assessed by videofluoroscopy. Clin Otolaryngol Allied Sci 1993; 18:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/12\">",
"      Brownstein D, Shugerman R, Cummings P, et al. Prehospital endotracheal intubation of children by paramedics. Ann Emerg Med 1996; 28:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/13\">",
"      Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial. JAMA 2000; 283:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/14\">",
"      Fine GF, Borland LM. The future of the cuffed endotracheal tube. Paediatr Anaesth 2004; 14:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/15\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/16\">",
"      Browning DH, Graves SA. Incidence of aspiration with endotracheal tubes in children. J Pediatr 1983; 102:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/17\">",
"      Sheridan RL. Uncuffed endotracheal tubes should not be used in seriously burned children. Pediatr Crit Care Med 2006; 7:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/18\">",
"      Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus uncuffed endotracheal tubes in pediatric intensive care. J Pediatr 2004; 144:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/19\">",
"      Galinski M, Tr&eacute;oux V, Garrigue B, et al. Intracuff pressures of endotracheal tubes in the management of airway emergencies: the need for pressure monitoring. Ann Emerg Med 2006; 47:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/20\">",
"      Hoffman RJ, Parwani V, Hahn IH. Experienced emergency medicine physicians cannot safely inflate or estimate endotracheal tube cuff pressure using standard techniques. Am J Emerg Med 2006; 24:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/21\">",
"      Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in pediatric intensive care. J Pediatr 1994; 125:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/22\">",
"      Weiss M, Dullenkopf A, Fischer JE, et al. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth 2009; 103:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/23\">",
"      King BR, Baker MD, Braitman LE, et al. Endotracheal tube selection in children: a comparison of four methods. Ann Emerg Med 1993; 22:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/24\">",
"      Khine HH, Corddry DH, Kettrick RG, et al. Comparison of cuffed and uncuffed endotracheal tubes in young children during general anesthesia. Anesthesiology 1997; 86:627.",
"     </a>",
"    </li>",
"    <li>",
"     Wheeler, M, Cot&eacute;, CJ, Todres, ID. The pediatric airway. In: A Practice of Anesthesia for Infants and Children, 4th, Cot&eacute;, C, Lerman, J, Todres, ID  (Eds), Saunders-Elsevier, Philadelphia 2009. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/26\">",
"      Luten RC, Wears RL, Broselow J, et al. Length-based endotracheal tube and emergency equipment in pediatrics. Ann Emerg Med 1992; 21:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/27\">",
"      Daugherty RJ, Nadkarni V, Brenn BR. Endotracheal tube size estimation for children with pathological short stature. Pediatr Emerg Care 2006; 22:710.",
"     </a>",
"    </li>",
"    <li>",
"     Wheeler, DS, Spaeth, JP, Mehta, R, et, al. Assessment and management of the pediatric airway. In: Pediatric Critical Care Medicine: Basic Science and Clinical Evidence,, Wheeler, DS, Wong, HR, Shanley, TP (Eds), Springer-Verlag, London 2007. p.223.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/29\">",
"      Levitan RM, Pisaturo JT, Kinkle WC, et al. Stylet bend angles and tracheal tube passage using a straight-to-cuff shape. Acad Emerg Med 2006; 13:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/30\">",
"      Gerling MC, Davis DP, Hamilton RS, et al. Effects of cervical spine immobilization technique and laryngoscope blade selection on an unstable cervical spine in a cadaver model of intubation. Ann Emerg Med 2000; 36:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/31\">",
"      Mellick LB, Edholm T, Corbett SW. Pediatric laryngoscope blade size selection using facial landmarks. Pediatr Emerg Care 2006; 22:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/32\">",
"      Sharieff GQ, Rodarte A, Wilton N, et al. The self-inflating bulb as an esophageal detector device in children weighing more than twenty kilograms: a comparison of two techniques. Ann Emerg Med 2003; 41:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/33\">",
"      Xue FS, Tong SY, Wang XL, et al. Study of the optimal duration of preoxygenation in children. J Clin Anesth 1995; 7:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/34\">",
"      Morrison JE Jr, Collier E, Friesen RH, Logan L. Preoxygenation before laryngoscopy in children: how long is enough? Paediatr Anaesth 1998; 8:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/35\">",
"      Baraka AS, Taha SK, Aouad MT, et al. Preoxygenation: comparison of maximal breathing and tidal volume breathing techniques. Anesthesiology 1999; 91:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/36\">",
"      Goutcher CM, Lochhead V. Reduction in mouth opening with semi-rigid cervical collars. Br J Anaesth 2005; 95:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/37\">",
"      Nishisaki A, Scrattish L, Boulet J, et al. Effect of cervical spine immobilization technique on pediatric advanced airway management: a high-fidelity infant simulation model. Pediatr Emerg Care 2008; 24:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/38\">",
"      Santoni BG, Hindman BJ, Puttlitz CM, et al. Manual in-line stabilization increases pressures applied by the laryngoscope blade during direct laryngoscopy and orotracheal intubation. Anesthesiology 2009; 110:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/39\">",
"      Thiboutot F, Nicole PC, Tr&eacute;panier CA, et al. Effect of manual in-line stabilization of the cervical spine in adults on the rate of difficult orotracheal intubation by direct laryngoscopy: a randomized controlled trial. Can J Anaesth 2009; 56:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/40\">",
"      Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med 2012; 59:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/41\">",
"      Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure in preventing gastric inflation during bag-mask ventilation in pediatric patients. Anesthesiology 1974; 40:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/42\">",
"      Moynihan RJ, Brock-Utne JG, Archer JH, et al. The effect of cricoid pressure on preventing gastric insufflation in infants and children. Anesthesiology 1993; 78:652.",
"     </a>",
"    </li>",
"    <li>",
"     Murphy, MF, Barker, TD, Schneider, RE. Endotracheal intubation. In: Manual of Emergency Airway Management, 3rd, Walls, RM, Murphy, MF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2000. p.62.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/44\">",
"      Knill RL. Difficult laryngoscopy made easy with a \"BURP\". Can J Anaesth 1993; 40:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/45\">",
"      Takahata O, Kubota M, Mamiya K, et al. The efficacy of the \"BURP\" maneuver during a difficult laryngoscopy. Anesth Analg 1997; 84:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/46\">",
"      Snider DD, Clarke D, Finucane BT. The \"BURP\" maneuver worsens the glottic view when applied in combination with cricoid pressure. Can J Anaesth 2005; 52:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/47\">",
"      Hartsilver EL, Vanner RG. Airway obstruction with cricoid pressure. Anaesthesia 2000; 55:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/48\">",
"      Benumof JL, Cooper SD. Quantitative improvement in laryngoscopic view by optimal external laryngeal manipulation. J Clin Anesth 1996; 8:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/49\">",
"      Levitan RM, Mickler T, Hollander JE. Bimanual laryngoscopy: a videographic study of external laryngeal manipulation by novice intubators. Ann Emerg Med 2002; 40:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/50\">",
"      Freeman JA, Fredricks BJ, Best CJ. Evaluation of a new method for determining tracheal tube length in children. Anaesthesia 1995; 50:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/51\">",
"      Goel S, Lim SL. The intubation depth marker: the confusion of the black line. Paediatr Anaesth 2003; 13:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/52\">",
"      Phipps LM, Thomas NJ, Gilmore RK, et al. Prospective assessment of guidelines for determining appropriate depth of endotracheal tube placement in children. Pediatr Crit Care Med 2005; 6:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/53\">",
"      Bloch EC, Ossey K, Ginsberg B. Tracheal intubation in children: a new method for assuring correct depth of tube placement. Anesth Analg 1988; 67:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/54\">",
"      Bednarek FJ, Kuhns LR. Endotracheal tube placement in infants determined by suprasternal palpation: a new technique. Pediatrics 1975; 56:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/55\">",
"      Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10: pediatric advanced life support. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102:I291.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Emergency Physicians. Verification of endotracheal intubation: Policy statement; revised 2009. file://www.acep.org/practres.aspx?id=29846 (Accessed April 24, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/57\">",
"      Carlson J, Mayrose J, Krause R, Jehle D. Extubation force: tape versus endotracheal tube holders. Ann Emerg Med 2007; 50:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/58\">",
"      Salem MR. Verification of endotracheal tube position. Anesthesiol Clin North America 2001; 19:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/59\">",
"      Werner SL, Smith CE, Goldstein JR, et al. Pilot study to evaluate the accuracy of ultrasonography in confirming endotracheal tube placement. Ann Emerg Med 2007; 49:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/60\">",
"      Galicinao J, Bush AJ, Godambe SA. Use of bedside ultrasonography for endotracheal tube placement in pediatric patients: a feasibility study. Pediatrics 2007; 120:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/61\">",
"      Sim SS, Lien WC, Chou HC, et al. Ultrasonographic lung sliding sign in confirming proper endotracheal intubation during emergency intubation. Resuscitation 2012; 83:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/62\">",
"      Jin-Hee K, Ro YJ, Seong-Won M, et al. Elongation of the trachea during neck extension in children: implications of the safety of endotracheal tubes. Anesth Analg 2005; 101:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/63\">",
"      Toung TJ, Grayson R, Saklad J, Wang H. Movement of the distal end of the endotracheal tube during flexion and extension of the neck. Anesth Analg 1985; 64:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/64\">",
"      Yoo SY, Kim JH, Han SH, Oh AY. A comparative study of endotracheal tube positioning methods in children: safety from neck movement. Anesth Analg 2007; 105:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/65\">",
"      LIPTON EL, STEINSCHNEIDER A, RICHMOND JB. THE AUTONOMIC NERVOUS SYSTEM IN EARLY LIFE. N Engl J Med 1965; 273:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/66\">",
"      Raju TN, Vidyasagar D, Torres C, et al. Intracranial pressure during intubation and anesthesia in infants. J Pediatr 1980; 96:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/67\">",
"      Burney RG, Winn R. Increased cerbrospinal fluid pressure during laryngoscopy and intubation for induction of anesthesia. Anesth Analg 1975; 54:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/68\">",
"      Sakles JC, Laurin EG, Rantapaa AA, Panacek EA. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med 1998; 31:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/69\">",
"      Timmermann A, Russo SG, Eich C, et al. The out-of-hospital esophageal and endobronchial intubations performed by emergency physicians. Anesth Analg 2007; 104:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/70\">",
"      Guggenberger H, Lenz G, Federle R. Early detection of inadvertent oesophageal intubation: pulse oximetry vs. capnography. Acta Anaesthesiol Scand 1989; 33:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/71\">",
"      Vaghadia H, Jenkins LC, Ford RW. Comparison of end-tidal carbon dioxide, oxygen saturation and clinical signs for the detection of oesophageal intubation. Can J Anaesth 1989; 36:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/72\">",
"      Ringold S, Klein EJ, Del Beccaro MA. Postobstructive pulmonary edema in children. Pediatr Emerg Care 2004; 20:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/48/29450/abstract/73\">",
"      Deepika K, Kenaan CA, Barrocas AM, et al. Negative pressure pulmonary edema after acute upper airway obstruction. J Clin Anesth 1997; 9:403.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6316 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-C070ECA3F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29450=[""].join("\n");
var outline_f28_48_29450=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS AND PRECAUTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Rapid assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Intubation plan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Patient counseling/Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Materials, equipment, and personnel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2371996\">",
"      - Preintubation supplies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Endotracheal tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1618840\">",
"      Cuffed versus uncuffed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1618848\">",
"      Endotracheal tube size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1618872\">",
"      Stylet",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Laryngoscope handle and blade",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2372004\">",
"      - Postintubation and alternative airway supplies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Preoxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Suction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cervical spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Sedation and neuromuscular blockade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cricoid pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Laryngoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Passing the endotracheal tube",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Depth of insertion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Initiate positive pressure ventilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Confirming tube position",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10899057\">",
"      - Securing the tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Post-intubation care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Before laryngoscopy/intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      During laryngoscopy/intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      After intubation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6316\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6316|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/55/35698\" title=\"figure 1\">",
"      Oral cavity anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/26/44452\" title=\"figure 2\">",
"      Lateral airway anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/36/2626\" title=\"figure 3\">",
"      Modified Mallampati airway classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/40/1669\" title=\"figure 4\">",
"      Direct laryngoscopy curved blade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/39/32374\" title=\"figure 5\">",
"      Direct laryngoscopy straight blade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/27/21936\" title=\"figure 6\">",
"      Endotracheal intubation position child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/28/43470\" title=\"figure 7\">",
"      Jaw thrust",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/2/14369\" title=\"figure 8\">",
"      Pediatric manual C-spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/53/22354\" title=\"figure 9\">",
"      Sellick maneuver",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/29/26064\" title=\"figure 10\">",
"      Tongue sweep",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/10/23715\" title=\"figure 11\">",
"      Anatomic landmarks during direct laryngoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/11/44213\" title=\"figure 12\">",
"      Endotracheal tube insertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/11/36031\" title=\"figure 13\">",
"      Mouth retraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/15/24831\" title=\"figure 14\">",
"      Passing endotracheal tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/28/7617\" title=\"figure 15\">",
"      Securing endotracheal tube",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6316|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/45/23248\" title=\"picture 1\">",
"      Airway view of glottis and esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/44/5827\" title=\"picture 2\">",
"      Laryngeal inlet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/36/27215\" title=\"picture 3\">",
"      Endotracheal tube hockey stick",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/55/1908\" title=\"picture 4\">",
"      Pediatric position for ventilation and intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/4/33857\" title=\"picture 5\">",
"      Prominent occiput with pediatric airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/19/39219\" title=\"picture 6\">",
"      Scissor technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6316|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/39/28285\" title=\"table 1\">",
"      Causes acute respiratory distress in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/10/25773\" title=\"table 2\">",
"      Epiglottitis in children &ndash; Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/15/44283\" title=\"table 3\">",
"      Congenital features difficult airway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/46/747\" title=\"table 4\">",
"      LEMON mnemonic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/52/4939\" title=\"table 5\">",
"      Difficult airway children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/35/10812\" title=\"table 6\">",
"      Pediatric airway equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/4/2123\" title=\"table 7\">",
"      Endotracheal tube size formula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/40/25228\" title=\"table 8\">",
"      Pediatric intubation equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/26/17837\" title=\"table 9\">",
"      Rapid overview of rapid sequence intubation in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/54/42860\" title=\"table 10\">",
"      Procedure table child endotracheal intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/44/26315\" title=\"table 11\">",
"      Mnemonic for tracheal intubation preparation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?18/26/18849?source=related_link\" title=\"calculator 1\">",
"      Calculator: Endotracheal tube size for children (Age 1 to 8 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/44/22218?source=related_link\">",
"      Acute severe asthma exacerbations in children: Intensive care unit management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=related_link\">",
"      Basic airway management in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=related_link\">",
"      Carbon dioxide monitoring (capnography)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39337?source=related_link\">",
"      Devices for difficult endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=related_link\">",
"      Direct laryngoscopy and tracheal intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15111?source=related_link\">",
"      Emergency airway management in acute severe asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17367?source=related_link\">",
"      Emergency airway management in children: Unique pediatric considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=related_link\">",
"      Emergent evaluation of acute respiratory compromise in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/61/10201?source=related_link\">",
"      Emergent evaluation of acute upper airway obstruction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=related_link\">",
"      Emergent surgical cricothyrotomy (cricothyroidotomy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12553?source=related_link\">",
"      Epiglottitis (supraglottitis): Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=related_link\">",
"      Initial assessment and stabilization of children with respiratory or circulatory compromise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=related_link\">",
"      Mechanical ventilation in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/3/16441?source=related_link\">",
"      Needle cricothyroidotomy with percutaneous transtracheal ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=related_link\">",
"      Pediatric cervical spine immobilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=related_link\">",
"      Rapid sequence intubation (RSI) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15481?source=related_link\">",
"      The difficult pediatric airway",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_48_29451="Bacterial pathogens in AECOPD";
var content_f28_48_29451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Relative frequency of bacterial pathogens isolated from 14 antibiotic comparison trials in acute exacerbations of chronic obstructive pulmonary disease*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Pathogen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percentage of bacterial isolates (range)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Haemophilus influenzae",
"        </em>",
"       </td>",
"       <td>",
"        13 to 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Moraxella catarrhalis",
"        </em>",
"       </td>",
"       <td>",
"        9 to 21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Streptococcus pneumoniae",
"        </em>",
"       </td>",
"       <td>",
"        7 to 26",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         Pseudomonas aeruginosa",
"        </em>",
"       </td>",
"       <td>",
"        1 to 13",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *Enterobacteriaceae have been isolated from the respiratory tract of 3 to 19 percent of patients with COPD exacerbations and Staphylococcus aureus has been isolated from the respiratory tract of 1 to 20 percent of patients with COPD exacerbations, but their pathogenic significance in this setting has not been defined. Haemophilus parainfluenzae has been isolated from the respiratory tract of 2 to 32 percent of patients with COPD exacerbations, but these organisms are unlikely to cause COPD exacerbations.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from the American Thoracic Society. Copyright &copy; 2004 American Thoracic Society. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2004; 1:109. Official Journal of the American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29451=[""].join("\n");
var outline_f28_48_29451=null;
var title_f28_48_29452="Causes of cardiac arrest in pregnancy";
var content_f28_48_29452=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Some causes of cardiac arrest in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pulmonary causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Embolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thromboembolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amniotic fluid embolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asthma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiac causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital valvular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomyopathy of pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hemorrhagic causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uterine atony",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormally adherent placentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abruptio placentae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placenta previa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disseminated intravascular coagulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infection/sepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Anesthesia-related causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Failed intubation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aspiration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravascular injection of local anesthetics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hypertensive complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preeclampsia/eclampsia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Medication-related complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tocolytic toxicities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Illicit drug use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypermagnesemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anaphylaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intimate partner violence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motor vehicle accident",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Zelop CM, Grimes EP. Cardiopulmonary resuscitation in pregnancy. In: Textbook of Emergency Cardiovascular Care and CPR, Field JM, Bresler MJ, Mattu A, et al (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29452=[""].join("\n");
var outline_f28_48_29452=null;
var title_f28_48_29453="Age at onset of renal dz in SSD";
var content_f28_48_29453=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F68540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F68540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Age of presentation of renal disease in patients with sickle cell disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 254px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As shown in this bar graph, the age at presentation of the different manifestations of renal disease varies widely among patients with sickle cell disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Saborio, P, Scheinman, JI. J Am Soc Nephrol 1999; 10:187",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29453=[""].join("\n");
var outline_f28_48_29453=null;
var title_f28_48_29454="Reported pertussis US 1922 to 2005";
var content_f28_48_29454=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Reported pertussis cases, United States, 1922 to 2005",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 307px; background-image: url(data:image/gif;base64,R0lGODlhYQIzAdUAAP///wAAAAAz/4iIiP9/f/9AQERERBERETMzM/+/v+7u7ru7u6qqqv8AAFVVVd3d3Xd3d5mZmczMzCIiImZmZv8QEP+fn//f3//Pz/9gYH+Z//9wcP/v7/8gIP8wMP+vr7/M/+/y/xBA//9QUP+Pj0Bm/2CA/9/l/zBZ/5+y/yBN/4+l/8/Z/6+//1Bz/3CN/wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABhAjMBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzMsBz9DR0tPU1dbX2Nna29zd3t/g4eLj5OXN51oB6OtL6uzvUe7w8wDy9PdH9vjo+vv7/f6cBRwIcCCyggbZIUxIbCHDZg4fAosoMRnFirwuYiymcSOujh6DgQxJayTJXiZPwkqpMhfLlqxewqwlcyaqmjZj4cxJaifP/1Y+f4IKKjQVxQHQBggx8IyCEaYBnAJYcCDABAkAHiB4FqGoIqJeTXVkEEDBgAkKHhxgQORs2rUADiiFgACAAwcAyCoIewgs31Edz9qFsFTpEAeEARgYIKHsVHVw6y34W8gv5aFOHjybvHip1MKeF7gTrXlyva71ol3mY3l1p46NHyAGfTjx4sZ7RcdlK9lIa9dZfgPPRNHAZLIS3KplO+CAWbTL486tezev4yLCh1fJrr3S0aRLmwpxYBiqVKpWsWrlmq+7He7uJeFU4DxdfDrw7z/K/4S/fiX+/ffVewLCEWCBfRGIYBsHLkhIgwA6yAaEEgJCIRIXFphhhawpyP/hGRt+mEeIRJB4n4ki1oFiPSmasWKLcaz4onYzwuiGjDaOUWOOa+DIIxg7/oiGj0J2EWSRZRCJpH1LvtZEBFUF0JVm4BFhnhDoXZXVVlK21ySTX2pCEQRdNZdVAA8coRxccgFAl1146eVbmMHRKSYUDBxw5jN4ETGbYow5pltkAZhWIoIgoPACCGocaaeRTzwwAW9CSNDmEJ0pRoFuj5UmRJepQYOgBgKUKoIJKYTg4qOYXGQpalYaNp5tgeYGGW+FzllgCaX2WioKGrCgI6uXHKWlEAMQZulkzT33FlttvlmdnNgh6Ou1pqKqqheOElsnExNEE8EC4QaQGHnhRYX/ZVVargdqtQKCgO28pabArbfeZUHfXt/+Ryq92GpwL76TKHkfrwBfKzCkBMvnoX4JBzxww5AY7J68Efu6MBfdKkHfMwik6S5qVxZRMlIBILDXyBo+HN+/GZe68RYdN4EAYdOWtSalAOzcGFY3w2kdv/pZ3B3CMQswM5iIKDBBV4Qu8GemsxY2QF09G7Dbp4ae6LJ7Sfe6dL+HUBCA1r2dlqkBnwHq2QBoC5braQIaPRzGYY+NRc1MOOBU1FPLOpjVWMO9ddqhqraa3cDBnLTeV/B9RAR9IoBXzs5G54DWPgcANM5xXuflZYy7hvTjExciAZchb8meYuLFZdrJIK/M/yWso1NW+mphi536JQygzbFru1OGd96/2yL5LcX/5TjqDLtE/NfDnQ798Losr/yTUZIcu5WxZ6ne7bl317vv0X80PRNk9qznzm1Bx+Z0QlN7aHzHI58+8+s7kefgbqtNYXDzmMPN7X7ued71aLYL7dEkUpMKINtiFZrRoGluoJLGwc4ns+Q9cHFOeFXVAjjC2wjqVlzT1R0ytgsOdnB/2wMhE86CFWTJjznOgV+0qBM6og2hRizMAqc4kT/9YU96MlxCudhTMnTBTl1TYdf4XgevFUasCAqwihSGyAQEGMZdiSGEAhfINP4l0Qr7KiMdgjiEqx2ga03gIgAoYADcPf8mAIapjqR4FgjrGZGB2evfHIB4RSJMYAAUkArKzjaVcnWFXKIqAuUOQAEfZspyIxTCIQFAHwZAsktmYyLcnhYlwYnBhS88ovrOKAdCJowIolEAVRTQGOZo7QBd+V+b5Fiid2XqkwcIIwAiMIFhFhOXedHTEChQFwO0zgDCJEMR/6jGD5KOenJg4xzFRUxkGYBK0NBMmng5yUpSsAiXEgJ9FoCACIDzGQ9ozjOK+cutGKCGYxgjGclmxmuqKA9s7CSyEPAzu9wSd21CShHoaEfaYKo+bUGAMpEpBM2wBQL0NKXfyuBHavIzhv7ED0ALOUxlnkkCoZyA1j5ZzAiATB//oYTGI6FRTCoR1AhZNAxLnziBjKbrWGNAZSoBicSQDnKkr2zCRtMwyz1MUwAlEEHGIGcFB2KzKM0bBFRal4ag7UGfIQjBClSQMKpup4GCbOXR5uUCIoDABfQyKxWs+s8+JCCQdR0OvVpghBO8QKoa82BJ+sCBBuBVpHeblwiUkAIUoE+V/dRDAgxb1KMOZ4wmYAIITKA0wc7CUZPlQGXVWr15CasJJziBZ2UB2gbcdZU2+2I0TFky8bnuXQh0zbxU8Aa6cnKre3EpNDjzPUzFDmUqu21Dc5sHArh2tEgQDR4riiY13VA6buLh0FS4mmmuoLeIeIABFOA0pXSzjddF/++zCho0zCXBUc79AHSTkClw9kmAgCLgoHAFRxY1bl6qvREjvDhM8ATOT7S6mjcN2N8f9sG5BJgvEqhWqXRKcFMW9BTdqrgax16rBAZahIKJ4FIJrK1tJzZcz4qJQVhRow8ZqECEYcsECjsUgCa0FYM/pbjVhGBe9gJvIpjpQ64dGL+LGbHhovbePhSgABuQ8BEylSwALMt9mZtfdusnOge7pgXz2paAD6GVtjmgK1DKMls2t+L1eg4A7e1hk/lQAAIUQMqwpGkjn3Gu8oRPisot319egK3MhvgQwp1nz55B0ZK9MV2KrF2g57wHD9gZz09I40f54mFf8fXQmQjeav/n4FoPYLpHrvnxtXgbI7TywbCUjSxpLwPma71g1jTOA6xP3SjXEPpapwV1ru+AgQ4AoAGilXWrO3wtFFiW129IwJ0L8FqQPvsvqvbVd3GtbDtIGwDUHraw+VJrXwV42dB2gwVGAG75dlvIlPl1r9p67XfTgQARxre44f2XTtcLselug771bW8GXSbbphIzuvd973xHueAToswJ4OorQ9fb2ngogHy/DXFU80UDgPUVowDO8DmEm+NMwECyxXJVmICArNhiNck7DoeTmzrlMr5Jy08ycYDdOq9zeAAE4okAPurhSBW4gBBinQQMVMDSOncCgSH9lD+nZ9IctgnIE3b/7ovDoTmNCYBJO7SHWDP9CE63AMGTYAGl34kJ0jUM/NQbnR1yucj+tcnLI+bsna+BLi5FitHxcCSzr9wIaQfA2pFQAXcT5wmZOnIJa1VAJmed5xSP2LaBLoezOOCCg79DkAo7hHCjvQIWEMLijXCBBsz48U5YW3lQPHtOkabF3D3J1mOmcK+/QS1nK7EfgoRy0xch8UIgQQaUYIEG3PntTYg8rRA8wBPuOHG+DcXek0Zvv6+BAUWPgCmPvofiO34IF0A9EVB+hA3EeBMaofJ1m6VD+rn38hUJAWd7F2Tvp0EBW9FO1dUHxPd8ivd66FcBRcB+RkBtSQd9SiBdWvRE/1LhRLUFaCyTexWxAiGXNItFeHaAFM6URaHnf2WQAMZWBATwcAdoBAzIgEWAbBoHgVWgaXvjEYniQhZngmdAF+BnUcM3Bx/QABiggq+3gi5ogEIAg0OAgi0IezOXEPonVMHGg2bQHHRhNmlCgHPgXCyoeq8Hgy94c0egfADwAUpoCVkFDxwoVN0nenfAJVDEhXIwAhuQgkOQASTQhGmoeF+4dEkwAnuYfjS4cAORgy4kAi/QdXBoB2bRPkygAMA1aSUDPlCEXLZDRYLWBtTWAdUGbtWWAGQ4BKt3bEnQAUUIAA/YKlZ4CC3Qe24AArIIArBYBFPoQiiQKnRIB0JHdP8lOATiRV6bhDlzZ0Nu9jl3R2lwgGzuRwTGZ4pGaARnNwSkJwQzyIqcFwkh4FinUoVnAAIpoAElAHPYggIlUAIvoAEasAIa4AIdGDYmMHJBWAdgx2hQQGCAM31INgBKdkv8pYxXwAEIGAWE6HRE4AGfOI0bMJDQaARoSIoMWTCtOAgs8I4qsAKM2ASzuJGz2Hss0ALtSI5C1TsqoAEZSXZ0AHh4FAC/GFEppDazd05so2JyYxrv8mJagAFESAUc5wGOd3bIVgTPuHSHR4os+JDYGIWOkAIJ4wKfpgQsII4jOZVhUwL9Jwgr4nmg1wREJgT5eGOB04/Xt4lU0Hx/+AT/ZggAadmQ1viJoNiAbmmNjkeISel7i7B/EaOIjHgCK+COVPmXeWkC3oiVdgB8dfRmSlBmftJD8MNmnYOM90eWU7ABHoCHUbCQQpB+yXZ2QzmUbymNbicEq6iGE+kH23g+uZgCJiCSgNmaq7YCtUiYdsAAEKAA4scEiaZFGehos3NckpaBGLIFGoeKTTeKzlhtHpB6xSaU5wcAxCmUcbmczticEpmNilCRrpmdgOkC8pgIM0Je5PUFogZDVZB0G3CWQ0AC0ygEz6mW7MaAq7eenrlu0VgspakFIHCSWLAC2tmfQqWXjrAikhgNLWmXBKmA0nkEI/Bc0kgEhcUB8DmQ//JJnRkwkB+AkASQAQXgeg5jnWUQAr+mAbE5BbcYMH3pny6kAufYO7kYCVlpFRMgUQ3WiFiAlJ6IBB0AdQtonCNgAfRJBEhIBOtZighZBOkHZSSQAJjpovdpBS3QgSJwlVVwAv7WKyVQhS3wAqyJor2CAi6gAS3gjSEAAiBpAuNYaN25H3ZAFxAwdIiJklcQpM3Ieg3wo0SAlENgAXU2kOwnikewetWoBKXICDKRm8QFRbYFnMxFBj03LyWQplEAAu8oACKweX11ohFTAmA6ol/AAiCwArCZL3UAeE/DkvOIBT0qBAbpkAWwqkA6kIVVoQuohEy4en66BIO6CIVaTP90p2XSImf4FwZtmDAmwKlJwJ/YUgL6aYstsJq9ogImsAKDKRJ24FLocQBbCKdW0J4dQJ2YOZpCkKpFMAI5t36jWKsDGaRKsJZqagWJphSBo18ohDheRgYsUKW56EciIFdDAAJSiS2VOgWeaqwTcQd7IQEQgE/aSgWBqpbLVwRFWgCpd5wO2QDUyXR4CqR/mKvr14eEqgUldmK2d0E22VDZEQLPowL9BwJ+pAJPWQT+2lFWuqz+sCJa0RUQIDwLOwW3mpkKGIOipa5EeQQVEJdMN6gMuKRKwIS6SjNSQyvyen0aJAbbZyoiagSblayqFQJZWqWK9bISkZW8WkunagX/7AoAPmmuSziKdGkEbSeNK4e0aeiZSdihVXBmJaVm2PWr25V1r6gFIZB5pWICNHsCeNmlYeMCBFuza4o1JFi2VaCHRUAC7EaKD9uwTIsExie30MkEmeudV4AyjWZ17UI+3HUCIrCvi6sEw1oqV+oEhouaJQC2GLEiLgUBDKCFkEsFRUoErbdy4oq21Xa2S2B8klu3RNCeSdCwAfoweKmyVMCyvuKyUoCykwpVX7oC+TkTLyKHbbMHOBGUEDuxqhiasioEStsE1/iZsxqDTrCeTct5KRByKACpjCWSAVsFKGsCYEqLXjEjybJcI4IFCUoEP+qqAGCndJsEa0e3zAu//w3KpNlovTO7BBTcK4q4uv+Rfdw2BXbqoEH5watqARWQik6grgvMdAWsBBAMuh56wQJQrEdguB2YixpcN65mBelLBKl6vkNQwjEWl0vQs+IbwUvosUegvI1QOiCKwTPzVr7SjUViIgygFHi3i1WwvkWgp8IrlBVQAEX5vpuZBEz3uRRbMX4Xu6Wiso3lKza8JCbig122u1IAriCsk0ZAAujpBNcIwUe7x3ApwUo5w4ebLdP6IyaCFAGIAIw8o00KAG2roE/WBUjIvAdZbRzbuWjsoUjAAgjzxnRiIgMqDQXawUigdvhGAHsoBBnrtg0AyDxpaplrfDucBFq8xK3IAv+HDMd2wE7gecUg2AQylspFq3qwrIrUiQXINsvVtsBGkMkJwskUo4FyIAEMkK1YzMJA+nzBe8qhKZwfwMylJ8R/GpEDIs3TvKhxEFPjN8BMEMkc0AGpp8RmsIIfrMnOacK4as4uPMjpHKxugBSIwRQKS36em4YW0AGtxwaiyLFK28L12a7+/M/1OgdvwkmmygRkMQSGSoFVd4m/abrByQStDG4FYJxo8Mr8vHYQbcCVK9FnoKgVTdGS2QbNMQC0+ab09QwczavGGB29ygDsBTp9W9MQ6YIN8LBrcNIrPWMrvLRI7L6yiQaROdM0DdBtAIDQ8L1JMETvimOCE5aF44//L2nUYKigq7wG8cXAM2bGHeu5DfDNdDwGlqfOV/0pBhvAT0BOnnNiMkkBNMliJftD09AE3SwHk0XOT+jWfMgEzafY7jwkg4195VDZln3ZmJ3Zmm0O5DkIvCQZkgfWYlnX1BzIdsCgR4CUQrsET20EG4DafxAgpD3S7dAEEUERuM0EuV3btt3bvh0hvB3cwA1ZhTBEeJtmjck5NzTUyUjbSkDPcbAB+ty+T/i+TFAAHZDWsa0GVe3cAOndZp13w/3dZn0Ru63b6C3c5F3aVZUIUNElous9UPRoHr1oKZOJuMXeQjoIHFfL2rwEFeDD250GMg3e4X3bvz3eBq7feJ3g/+vN4OK94Fht1TeoCeNJ3EZgyXb1fM58BBDdetBMo3e9s2/ATo4c2UnA2N7G4ZBtxEggbSVN4iP+yF9AtoEQESpeB3QJ3UnQu0iwgjluoDMu5GugFYjRpths0IJ6zLoGiFDQ4XrY2uA75DLeBmRBoHP9qoRAWS2Nz0dQpF2OzlQ+bnGgAAxw5jgNzH53vIJgWFJuy5AdlGE+0V31RVySGMg1RflN4PQNSRT1eWezFzHVIKtDunqOGpjIBlDyOhd4dR0dD44YgC6V5CiuuS3e5EEOAIdNBNLJ45XOBnE3HnixRwWlYN19BihjGrukM2ihGISRSG8QAcryZnaHOcz9d/9l8j7XZXfnNVcheDYqk9FVLgQ+HgiomOkcy8Xsm+VqcEl9ghjIYWVlMdtpkCs55ZW02eoKllInXgZZJAFRGzVi6Qb/E6/W99VSsCI+GDLCPuVLMOd2QG2rzQSLhwGOR3C3POxo8EvlEkx2wWhlgXsMYhqiy5LucgBYIwQUMHZrAE0F1CktFthusEcXNrLZKnyQTo/BhAC6m80eXgjyzs8/joAZQIbX6N9KDgc2hl1tpCfULtlFUFCHcV8PvwYAKBXhzl/jvgYiBNZRWyLdHt5q4L0DnuIo/QfUhvIMzIKtJ77PGeJifgY2ZgAQFUXwCqwT0jVaobNIMRk3RUegTlH/Xml/PXTrakBDQb231IFmVd8feQ2JzA4AmU4H1NbhR4ByGVDy8hWoxOvuJa5nNlVDoWTnmpgGi+QUwuUA/BIuTzMeIFPQZzDoTpGoppvoa7BEXdLoWhLfU/Ai8QT3Hj+5Si0Iemj3yNt6F3Ceck+Gc89vY07jXgB8xeX3I18I+ObpL/58eX+GpraWrT9mry/icgABcpG7B0T77Sfye4Bv8H7EkBzXAPCgPhzJoR/8hhgHI/a41T/Otu9cUkCIu0/saJiQN279wv8GtEn8bQoBx5/yR2D6zTUClvkEcQ396Pvah1fEyEvk5g8EAOGQWDQekcZAktl0MiEB6TTAeF6x/1niktngaMFhrKVSCDcyGeKnUykWEkmSW1xvcu15/Z7f9/8BAwPxBLUeGBATGRQK/wiPGholARIazMAaGi6IOCzf4pAIIiezHklPUVNVV1mfTFth/V6HMDpi9So3ztSKPHSJRiySCjRvi2aNk5WXmVORYRUgEKYRFpqTnhMur68qCcJGMIwIPooIvpE8GkCVn7nf4ePlh9xZB6iq5oWeLUb0k7w1OpfEUrll9f4lVLhQEEJV9x4okJjw2UCGtNY1srCtyIUKFttdFDmSpB6HqRQgGJCIkb5s7ERmLKQNiTaQyU6W1LnzYs5TEg5QseKEAZ4HCKREEGJACgUjTAM4Bf9wLwACRkeTMvHJsIG4mR6QkMjwgaOxrTzRpuV2VlIUChDgPnACdYgDBwCKKhgwQcGDA0OF7O37V0IACQAQQABgF2+AlkfYJhzVaHKRDQRoHsS3mXNnz59BhxY9mnRp06dRp1a9mnVrz9eKys2yAM/ffQscKAZgYACR3EsHDEAQ2AAA2wACWEMS+R9MQZWJFPjgUW1169exN1lwgFq1J7TpKQ8QgfdSqcDNDyg+dQJy8Ur3bc5+qsImIx3iQJ+/n3//hEWF+q62oZL7bbfe6tKNN+GIM45A5SDzrxA4IBGiPgkxzFBDYyTq8ArwhGAsL8H8ssKB4kgkzDDEFBPRMWz/NvSDwiJqEWLGGHHMUcc9HoDLR9mYgGo8ALAacremhDhAOaikosoqIpEycrkd87jMiMyko1LLLbk8AsApAOuDgfVk6RKMm4Qg4Bc0zWzTTQkVSISCJ1168wo1jbASADbt7NNP64qCUB7mqMwsOlDI+lPRRXXqES6kwoyH0B0NHaICryplVNNN5fmyKoo4JQIDOoiYjLpQUU1VmTgTUWjSHaFLwJYh9FPV1lvb8vHHf17VEbpELbUP12GJ9UMBziKFp9ccPYDpphuLjVbaMBJxQAoDgBzUVmgzICE6g6YNV1wnJGBqAgR53RZcAKDlc9x3xY0iAAgeS1fVmy4cwl14//kl9tgAJuhOUEltBamTIoDtV+Fo/8Un2XeWxfGDS4VIACwiMl1YY1s77BhUW8kQp5+OSN3Y5JNviTjHkNmsFeWXYW5E5ZUr8ECYIvKNWeedHSHWApkO5Vnooe2YWUcMvnhjXaKZbhrGdzf4xempqd4HXjacwCABAkbo4OKqwebX6DY78CoJrzewAAOXw26b2LHN3IAXJC6oLGe38X6b31GZ2CjovAHHFW4zPViaiAzQEQLxwBlPKwIqrGHyKSSnkuLJIuGbkl8S/EECPyLwbFz0kiJob4gUw0S9sMMSW+yuvJ6Gt+6kO4q1rNFxT+hxKXozsLwEgWNwquKOSy52eP+DOcJvUWfN3fmFHi8XQQPOOzC99fZyb5/MOVPYgq8PT5zW58l3FTcF0V0MfeHVc/C249/txOwhPi+i/vLxb8YBpSI4QC++SrQYFAFQRaxr0etepLl+hYwIdTtClvIXQWVQ5QDwkZxxlkQ5J10lSpmL0MIYKITlmUN8EjQhN8YEiMG9KYSLM4JYThhD/6yQhRS7H8ZuJ0MdqoWGNfyAyxy4QyFWp4cs9AQSvOCE6QyRifMoIgu9hQRoGYEDGWhACZuYxYM4LXlIwIAHCkCCHGqRjLB4IqcIUABhEYEM3whiGeEYizNuKgFWHAE7qlgBdtwwjn1ExRw5xQECdKADFrD/WAFoBwAX+pGRpAAkqjZyRSOMsJGVbIjb1jiEN1pyRxdIwCdBGUpRjpKUbnqktPjISQxdwAIZaEMBYBlLWc6SlrRURyZwOcYMnTJai1Rlf1jpygqMgATzCxcvi0XJX14nmG0gpjHfhUxibXKZaGmmJYp5MmkSK5XVvMg1C4CZmG1zWL4cwmXOcQ6peXMZ4BQnz8iJK2UCoI3pJAAYE8lOVrjTOfDM3dpgAtAicGAEHsikPifBgQ+40hLvnFo8cTWHEWyCAxWIohEyQDGE2kFrovyAPdWpjnD286HPy+M956a8CtzMkp4UJUjPMQJb4pKmHaglTB2KN4gSy2IeyKcR/yZ20WnGggOkTAAJQLoBWtI0E2WYJTrtachRMnGnxTroEUaViVimE5R+ukA+rchUsY6VrGU1q1ZriTiQjvKqZcScVuBY1AR8VE2wJCQB2qojQVagAhnwSgZ8utF4uKhex/hlHRswgg+EMq/GkGsp+7DXDFwAAxn1QEF/KlhmFG9gW6imIGdZAbE6dZY4Ne1p7alUWopWrLUswC1xCcZYqhW1qe3rGjmwkcxq9iDvoYdrgBtc4Q6XuMU17nGRm1zlLpe5zV1udjhbh8EBkrqqmGN1rSuzQkx3u93VLnYIK93vOmMV183uecnr3UGMV4XqvSR23ipe954Cu39Er33v2//e9+5Xv+tlryn/68jy5ncS9cUvf3s23zIhuL9v4i6BCwzhAEdYwnyA24P9m2EGmwnDB/awgNMb4g8nWMMNJrGJUczhCUvCwCAeMYVFnGILr3gPF2Yxb3GcYx3vmMc99vGPgRzkTUGATNYKgAEYIa8JHEYCUapeEvyinAVMIAAVBIACglIVuWwHYIehFh6c5GUA0AZBGxSDSoRQJN1QgApQysqXhzDlKsNnAVESApeXLAYi1+VajKDyFJRyQTBEOc1R0o2REXCY+IKhKKeznKINHRjLFbYITdbgpN1sJEEfQQFQuVwHl0I5IimpCf178wXxfBhTS+kIlo7KnYOS57f/Ytly2TKCkiH9ZjNLurNEcHWTMJ1qIlEhffO5VmD4spsWHYYxEVDM6ppAFeUcoDe0qVfrqA0AaYSBLgCAtvCAEoDeQLt1WqCNuEN0lwdMwAoUqF54tdBt41TbMQ949RCyvW0wHJs9jDCAboRQmAegDgzSTjeR2M2AA8gFAU6Bdxa6/e3hMGbdDCA3wI/gbG8b5uKua8z/BvOwNCNZAefy+IgIaAWDQ0EpAzhAvwOY7+FAoOUvT4LGoS3zkydQCOVGggOYfRfCdhwAu+v1EHDO8RVhuzfbtret+9M+bSdbeEKAwF2GcCwxa8Uax0LQca48gQgUhhEgAgOIisLkelfQ/+TsI1O8EYQArP+GzQCzRnTPzgWvJ4kBex4C2cfMFqlDgOrDGQL11IeeMBgPMXOHgL17Ux68m5sLad94Shzv9idoXfOc9V2xkYBmz6MvPFdQeOIPBHiz48XmTdC66pcw+ZJ7MAlXd597NK/wQG3eMG6H/bClgHX/SL1I3Inzwonw7yswnoL5AACbiwMi2kBdQHyusmFM3nbsmQ4Mv5NzlTFOgZczntVYMHvzx5RlBDxA+gGgvhOIHyXjC0Hhcvkd4hcv5T8f4IDTkAv5ae9D8MDIgkIBvo//pC575kIxErA9APD+nuwIhOcBp+c8GK8JKs56doMC2k82MnABA+/O3P8PAIUA+r4D+QCwAWljAezt6IpA+VSQC6bv77Jt+N7u4Iouz4QgJSIQGwYG2uqCAn4vDFYvMCoIH4LD8KSu+0CvBkXw9i5wNkxhdRwg7oTwRYoQC5awLoTP5FDvd/ats6iNfYZj8qTQCFyuCMZQCW/QCHgwMNgQCs9H8ZJgTlpi9OgwCpEAKODj84aQD53gDS8vBM3QAXqQCErHyzjL7epuClzwyhoODoljCA8P9LJjCysncuhkzKwMC6LwKIojArBO7uZN2wwv74pgO9LH5IiOCV/QfxDjMCigOB7uDIkAFKfiSZjOFMUAE+9BOVyuJQgu/15RL5BvTnaO0qqPCFT/Mfn8pxWPYDsyp+MIaxiP4CjeDYFALoDehwn2QswITue+0QmkkQh0jrBEseeE7wgMYBOHbukArgWZoBwDDh5LcdsG4NlIrT+oQC6oTOyAbwoeoBHvLQmo4tV2xwEYwdXWjxO7jNsA7fl4pwi8cNekUAraw96qwssQLdfK7wqEhH+CryWMDMkcUge1oB8B4B/hA8vSZ9O0cAqcQiMTLdQ2MtMC8AlCUiLRDfhqsnKqQhmHgCCdwsziCyaLYHcwEidtEthE7Qj+LCtQLdYOIyo/ciipwCmE7a0Y8v0CUgoeIL4sUh7rMCuB8kmE7fswTsjYsi3d8i3hMi7lci7psi7tyfIu8TIv9XIv+bIv/fIvATMwBXMwCbMwDfMwF+IeDI/KchIxHXM/kCI4juwxKVNCaOMAMFMuyuVa5CLLAuAuosAB+K8ySZMh6g5BJsB/Hqd6qGwB5GVeSjM2/8HebK4wqGDmhCIKLFE2ebMZjqX1UhNI7oEWq0A3e/M43+E3/05IFBIpuKM4exI5pXM6qbM6rfM6sTM7tXM7ubM7vfM7wTM8xXM8ybM8zfM80TM91XM92bM93fM94TM+5XM+6bM+7fM+8TM/FyIIAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006; 55(RR-17):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29454=[""].join("\n");
var outline_f28_48_29454=null;
var title_f28_48_29455="Pancreatic calcifications";
var content_f28_48_29455=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pancreatic calcifications",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of the abdomen shows pancreatic calcifications (arrows) in a patient with chronic pancreatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from: Steer ML, Waxman I, Freedman SD. N Engl J Med 1995; 332:1482.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_48_29455=[""].join("\n");
var outline_f28_48_29455=null;
